SCHEDULE 14A
(Rule 14a-101)

INFORMATION REQUIRED IN PROXY STATEMENT

 

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No.   )

 

Check the appropriate box:

TRIPLECROWN ACQUISITION CORP.

(Name of Registrant As Specified in Its Charter)

(Name of Person(s) Filing Proxy Statement, if Other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

Common Stock and Warrants

217,455,000

$9.68 and $0.18, respectively

$1,353,564,400

$75,528.81

$75,528.81

Form S-4, Registration Statement File No. 333-161773

Cullen Agricultural Holding Corp.

September 4, 2009

TABLE OF CONTENTS

TRIPLECROWN ACQUISITION CORP.
970 WEST BROADWAY, PMB 402
JACKSON, WYOMING 83001

NOTICE OF SPECIAL MEETING OF STOCKHOLDERS
OF TRIPLECROWN ACQUISITION CORP.
TO BE HELD ON OCTOBER 21, 2009

To the Stockholders of Triplecrown Acquisition Corp.:

NOTICE IS HEREBY GIVEN that the special meeting of stockholders of Triplecrown Acquisition Corp. (“Triplecrown”), a Delaware corporation, will be held at 10:00 a.m. eastern time, on October 21, 2009, at the offices of Graubard Miller, Triplecrown’s counsel, at The Chrysler Building, 405 Lexington Avenue, 19th Floor, New York, New York 10174. You are cordially invited to attend the meeting, which will be held for the following purposes:

These items of business are described in the attached proxy statement/prospectus, which you are encouraged to read in its entirety before voting. Only holders of record of Triplecrown common stock at the close of

TABLE OF CONTENTS

business on September 30, 2009 are entitled to notice of the special meeting of stockholders and to vote and have their votes counted at the special meeting and any adjournments or postponements of the special meeting of stockholders.

All Triplecrown stockholders are cordially invited to attend the special meeting in person. To ensure your representation at the special meeting, however, you are urged to complete, sign, date and return the enclosed proxy card as soon as possible. If you are a stockholder of record of Triplecrown common stock, you may also cast your vote in person at the special meeting. If your shares are held in an account at a brokerage firm or bank, you must instruct your broker or bank on how to vote your shares or, if you wish to attend the meeting and vote in person, obtain a proxy from your broker or bank. If you do not submit your proxy or vote in person at the special meeting or, if you hold your shares through a broker or bank, if you do not instruct your broker how to vote your shares or obtain a proxy from your broker or bank to vote in person at the special meeting, it will have the same effect as a vote against the approval of the initial charter proposals, the merger proposal and the secondary charter proposals.

The officers, directors and stockholders of Triplecrown prior to its initial public offering have agreed to vote the shares of Triplecrown common stock they received before such initial public offering in accordance with the majority of the votes cast at the special meeting of stockholders with respect to the merger proposal by the holders of shares sold in Triplecrown’s initial public offering.

A complete list of Triplecrown stockholders of record entitled to vote at the special meeting will be available for ten days before the special meeting at the principal executive offices of Triplecrown for inspection by stockholders during ordinary business hours for any purpose germane to the special meeting.

Your vote is important regardless of the number of shares you own. Whether you plan to attend the special meeting or not, please sign, date and return the enclosed proxy card as soon as possible in the envelope provided. If your shares are held in “street name” or are in a margin or similar account, you should contact your broker to ensure that votes related to the shares you beneficially own are properly counted.

Thank you for your participation. We look forward to your continued support.

October 13, 2009		By Order of the Board of Directors,
		Jonathan J. Ledecky President, Secretary and Director

IF YOU RETURN YOUR PROXY CARD WITHOUT AN INDICATION OF HOW YOU WISH TO VOTE, YOUR SHARES WILL BE VOTED IN FAVOR OF EACH OF THE PROPOSALS AND YOU WILL NOT BE ELIGIBLE TO HAVE YOUR SHARES CONVERTED INTO A PRO RATA PORTION OF THE TRUST ACCOUNT IN WHICH A SUBSTANTIAL PORTION OF THE NET PROCEEDS OF TRIPLECROWN’S INITIAL PUBLIC OFFERING (“IPO”) ARE HELD. YOU MUST AFFIRMATIVELY VOTE AGAINST THE MERGER PROPOSAL AND DEMAND THAT TRIPLECROWN CONVERT YOUR SHARES INTO CASH NO LATER THAN THE CLOSE OF THE VOTE ON THE MERGER PROPOSAL TO EXERCISE YOUR CONVERSION RIGHTS. IN ORDER TO CONVERT YOUR SHARES, YOU MUST TENDER YOUR STOCK TO TRIPLECROWN’S STOCK TRANSFER AGENT PRIOR TO THE SPECIAL MEETING OF TRIPLECROWN STOCKHOLDERS. YOU MAY TENDER YOUR STOCK, AT YOUR OPTION, BY EITHER DELIVERING YOUR STOCK CERTIFICATE TO THE TRANSFER AGENT OR BY DELIVERING YOUR SHARES ELECTRONICALLY THROUGH THE DEPOSITORY TRUST; PROVIDED, HOWEVER, THAT DUE TO THE SHORT PERIOD OF TIME BETWEEN THE DATE OF THIS PROXY STATEMENT/PROSPECTUS AND THE MEETING DATE, TRIPLECROWN WILL ALLOW HOLDERS OF CERTIFICATES TO DELIVER SUCH CERTIFICATES AFTER THE MEETING IN ORDER TO PROPERLY EXERCISE CONVERSION RIGHTS. IF THE MERGER IS NOT COMPLETED, THEN THESE SHARES WILL NOT BE CONVERTED INTO CASH. IF YOU HOLD THE SHARES IN STREET NAME, YOU WILL NEED TO INSTRUCT THE ACCOUNT EXECUTIVE AT YOUR BANK OR BROKER TO WITHDRAW THE SHARES FROM YOUR ACCOUNT IN ORDER TO EXERCISE YOUR CONVERSION RIGHTS. SEE “SPECIAL MEETINGS OF TRIPLECROWN STOCKHOLDERS AND WARRANTHOLDERS- CONVERSION RIGHTS” FOR MORE SPECIFIC INSTRUCTIONS.

TABLE OF CONTENTS

TRIPLECROWN ACQUISITION CORP.
970 WEST BROADWAY, PMB 402
JACKSON, WYOMING 83001

NOTICE OF SPECIAL MEETING OF WARRANTHOLDERS
OF TRIPLECROWN ACQUISITION CORP.
TO BE HELD ON OCTOBER 21, 2009

To the Warrantholders of Triplecrown Acquisition Corp.:

NOTICE IS HEREBY GIVEN that the special meeting of warrantholders of Triplecrown Acquisition Corp. (“Triplecrown”), a Delaware corporation, will be held at 10:00 a.m. eastern time, on October 21, 2009, at the offices of Graubard Miller, Triplecrown’s counsel, at The Chrysler Building, 405 Lexington Avenue, 19th Floor, New York, New York 10174. You are cordially invited to attend the meeting, which will be held for the following purposes:

These items of business are described in the attached proxy statement/prospectus, which you are encouraged to read in its entirety before voting. Only holders of record of Triplecrown warrants at the close of business on September 30, 2009 are entitled to notice of the special meeting of warrantholders and to vote and have their votes counted at the special meeting and any adjournments or postponements of the special meeting of warrantholders.

The approval of the warrant amendment proposals is a condition to the consummation of the merger discussed above. Triplecrown’s officers, directors and stockholders prior to Triplecrown’s initial public offering have indicated they intend to vote in favor of the warrant amendment proposals at the special meeting of warrantholders.

Although an exchange of warrants in a reorganization generally does not result in gain or loss to the warrant holder, the approval of the amendment increasing the exercise price of Triplecrown’s warrants, extending the expiration date of the warrants and increasing the price at which the stock must trade for the warrants to be called for redemption constitutes an exchange for a materially different property under the applicable rules and regulations of the Internal Revenue Serivce, resulting in the recognition of gain or loss measured by the difference between the fair market value of the new CAH warrant received and the tax basis

TABLE OF CONTENTS

of the Triplecrown warrant surrendered. For more information on the tax consequences of the transaction, see the section entitled “U.S. Federal Income Tax Considerations to Triplecrown Stockholders and Warrantholders.”

All Triplecrown warrantholders are cordially invited to attend the special meeting in person. To ensure your representation at the special meeting, however, you are urged to complete, sign, date and return the enclosed proxy card as soon as possible. If you are a warrantholder of record of Triplecrown, you may also cast your vote in person at the special meeting. If your warrants are held in an account at a brokerage firm or bank, you must instruct your broker or bank on how to vote your warrants or, if you wish to attend the meeting and vote in person, obtain a proxy from your broker or bank. If you do not vote or do not instruct your broker or bank how to vote, it will have the same effect as voting against the warrant amendment proposals.

A complete list of Triplecrown warrantholders of record entitled to vote at the special meeting of warrantholders will be available for ten days before the special meeting at the principal executive offices of Triplecrown for inspection by warrantholders during ordinary business hours for any purpose germane to the special meeting of warrantholders.

Your vote is important regardless of the number of warrants you own. Whether you plan to attend the special meeting or not, please sign, date and return the enclosed proxy card as soon as possible in the envelope provided. If your warrants are held in “street name” or are in a margin or similar account, you should contact your broker to ensure that votes related to the warrants you beneficially own are properly counted.

Thank you for your participation. We look forward to your continued support.

October 13, 2009		By Order of the Board of Directors,
		Jonathan J. Ledecky President, Secretary and Director

IF YOU RETURN YOUR PROXY CARD WITHOUT AN INDICATION OF HOW YOU WISH TO VOTE, YOUR WARRANTS WILL BE VOTED IN FAVOR OF EACH OF THE PROPOSALS. IF THE MERGER IS NOT COMPLETED AND TRIPLECROWN DOES NOT COMPLETE AN INITIAL BUSINESS COMBINATION PRIOR TO OCTOBER 22, 2009, THEN THE WARRANTS WILL EXPIRE WORTHLESS.

TABLE OF CONTENTS

PROXY STATEMENT FOR SPECIAL MEETINGS OF STOCKHOLDERS AND WARRANTHOLDERS
OF
TRIPLECROWN ACQUISITION CORP.
PROSPECTUS FOR UP TO
69,455,000 SHARES OF COMMON STOCK
AND
74,000,000 WARRANTS
AND
74,000,000 SHARES OF COMMON STOCK UNDERLYING SUCH WARRANTS
OF
CULLEN AGRICULTURAL HOLDING CORP.

Triplecrown Acquisition Corp. (“Triplecrown”) is pleased to report that its board of directors has approved an Agreement and Plan of Reorganization, dated as of September 4, 2009, as amended, pursuant to which (i) Triplecrown will merge with and into Cullen Agricultural Holding Corp. (“CAH”) with CAH surviving the merger and becoming the new publicly-traded corporation of which the present holders of Triplecrown securities will be security holders and (ii) CAT Merger Sub, Inc. (“Triplecrown Merger Sub”) will merge with and into Cullen Agricultural Technologies Inc. (“Cullen Agritech”) with Cullen Agritech surviving the merger and becoming a wholly-owned subsidiary of CAH. We refer to the Agreement and Plan of Reorganization throughout this proxy statement/prospectus as the “merger agreement.” This is the only business combination that Triplecrown will propose to stockholders prior to the time that it is required to liquidate pursuant to its amended and restated certificate of incorporation.

Upon completion of the transactions described in this proxy statement/prospectus, the current holders of common stock of Triplecrown will own 57,740,000 shares of CAH stock (assuming no holders of shares of Triplecrown common stock sold in its initial public offering elect to convert their shares into a portion of Triplecrown’s trust account or sell such shares back to Triplecrown upon closing of the transaction and assuming the officers, directors and founders of Triplecrown cancel an aggregate of 11,260,000 shares they will receive upon exchange of their Triplecrown common stock in connection with the merger, all as described in more detail in this proxy statement/prospectus) and the current holder of common stock of Cullen Agritech will own 15,881,148 shares of CAH common stock (valued by the parties at $155 million, or $9.76 per share), excluding warrants held by Mr. Watson. Of the shares of CAH common stock to be owned by the holder of Cullen Agritech common stock, approximately 10% of the shares to be issued in the merger (1,588,114 shares) will be placed in escrow to provide a fund to satisfy indemnification obligations under the merger agreement. See the section entitled “The Merger Proposal — Structure of the Merger.” It is possible that the parties could use all of the funds held in Triplecrown’s trust account to make purchases (and for conversions) and the parties could consummate the mergers contemplated by this proxy statement/prospectus leaving CAH with no funds for additional working capital. In that event, Cullen Agritech would need to raise capital from other sources in order to implement its business plan to any extent. Cullen Agritech has no current plans in place to raise such capital. If it cannot raise such capital, Cullen Agritech would not be worth the $155 million agreed upon valuation.

As a result of the transaction, holders of Triplecrown securities will become holders of CAH securities. CAH is a newly-formed Delaware corporation that will commence operations as a holding company of Cullen Agritech upon completion of the transactions described in this proxy statement/prospectus. Cullen Agritech is a newly-formed company committed to the development and commercialization of advanced agricultural technologies. Cullen Agritech’s principal focus will be to improve agricultural yields through forage and animal sciences. Cullen Agritech will do this through the use of intellectual property related to a proprietary farming system that Cullen Agritech will acquire upon consummation of this transaction. For a complete description of the intellectual property that will be owned by Cullen Agritech upon consummation of this transaction, see the section entitled “Business of Cullen Agritech — Intellectual Property.” Cullen Agritech will primarily be engaging in dairy farming operations in the Southeastern United States through its wholly owned subsidiary, Natural Dairy, Inc. (“Natural Dairy”). It will also provide advisory services associated with the development and implementation of efficient farming techniques both in the United States and abroad.

The sole stockholder of Cullen Agritech is Cullen Inc. Holdings Ltd. (“Cullen Holdings”), an entity controlled by Eric J. Watson, Triplecrown’s chairman of the board and treasurer. Eric Watson is currently also the sole officer of Cullen Agritech. Based on the number of shares expected to be outstanding after the consummation of the transactions contemplated by this proxy statement/prospectus, Mr. Watson will effectively control CAH. Dr. Richard Watson, Eric Watson’s half-brother, is currently the sole officer of Natural Dairy. Additionally, Triplecrown’s other officers and

TABLE OF CONTENTS

directors have interests in the merger that differ from, or are in addition to, those of Triplecrown’s stockholders generally. For more information on the conflicts of interest involved in this transaction, see the section entitled “Interests of Triplecrown’s Directors and Officers and Others in the Merger” contained on page 40 of this proxy statement/prospectus.

In connection with the merger, Triplecrown is seeking to amend the terms of the warrant agreement governing its outstanding warrants exercisable for shares of Triplecrown common stock. The amendments to the warrant agreement will provide that (i) the exercise price of Triplecrown’s warrants will be increased from $7.50 per share to $12.00 per share, (ii) the expiration date of the warrants will be extended from October 21, 2012 to October 21, 2013 and (iii) the price at which the stock must trade for the warrants to be called for redemption will be increased from $13.75 per share to $17.00 per share. The approval of the warrant amendment proposals is a condition to the consummation of the merger, although this condition may be waived upon mutual consent of the parties.

Although an exchange of warrants in a reorganization generally does not result in gain or loss to the warrant holder, the approval of the amendment increasing the exercise price of Triplecrown’s warrants, extending the expiration date of the warrants and increasing the price at which the stock must trade for the warrants to be called for redemption constitutes an exchange for a materially different property under the applicable rules and regulations of the Internal Revenue Service, resulting in the recognition of gain or loss measured by the difference between the fair market value of the new CAH warrant received and the tax basis of the Triplecrown warrant surrendered. For more information on the tax consequences of the transaction, see the section entitled “The Material U.S. Federal Income Tax Considerations to Triplecrown Stockholders and Warrantholders.”

Pursuant to Triplecrown’s amended and restated certificate of incorporation and as disclosed in the prospectus included in the registration statement for Triplecrown’s IPO, Triplecrown undertook to consummate an initial business combination in which it acquired an operating business in the financial services industry with a fair market value equal to at least 80% of the balance in Triplecrown’s trust account (excluding deferred underwriting discounts and commissions) and resulting in the ownership by Triplecrown of not less than 50% of the voting securities of the target business. Accordingly, as described in more detail in this proxy statement/prospectus, the proposed merger does not satisfy the requirements set forth in Triplecrown’s amended and restated certificate of incorporation or IPO prospectus.

Proposals to approve the merger agreement and the other matters discussed in this proxy statement/prospectus will be presented at the special meetings of stockholders and warrantholders of Triplecrown scheduled to be held on October 21, 2009.

Triplecrown’s common stock, units and warrants are currently listed on the NYSE Amex under the symbols TCW, TCW.U and TCW.WS, respectively. Triplecrown’s units, common stock and warrants will no longer be traded following consummation of the merger. The parties intend to seek to have the common stock and warrants of CAH listed on the New York Stock Exchange or NASDAQ following consummation of the merger. However, there is no assurance that the common stock and warrants will be listed on any exchange following consummation of the merger.

This proxy statement/prospectus provides you with detailed information about the merger and other matters to be considered by the Triplecrown stockholders and warrantholders. Such proxy statement/prospectus highlights and provides detailed information relating to the options available to stockholders and warrantholders in voting on the proposals, including perfecting conversion rights, exercising appraisal rights and potential securities law claims for recission or damages against Triplecrown. These options may impact your decision on how to vote on the proposals. For instance, a holder voting against the merger proposal and seeking conversion would not be entitled to seek appraisal rights. For more information on your options in determining how to vote and what actions to take, see the question and answer discussion titled “What are my options in determining how to vote and what actions to take?” set forth on page 10 of this proxy statement/prospectus. You are encouraged to carefully read the entire document and the documents incorporated by reference. IN PARTICULAR, YOU SHOULD CAREFULLY CONSIDER THE MATTERS DISCUSSED UNDER “RISK FACTORS” BEGINNING ON PAGE 26.

TABLE OF CONTENTS

Your vote is very important.  Whether or not you expect to attend the special meetings, the details of which are described on the following pages, please complete, date, sign and promptly return the accompanying proxy in the enclosed envelope.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this proxy statement/prospectus. Any representation to the contrary is a criminal offense.

The proxy statement/prospectus statement is dated October 13, 2009, and is first being mailed on or about October 13, 2009.

Triplecrown consummated its initial public offering (“IPO”) on October 25, 2007. Citigroup Global Markets Inc. (“Citigroup”) acted as lead manager for the IPO and Jefferies & Company, Ladenburg Thalmann & Co. Inc. and Broadband Capital Management LLC acted as co-managers for the IPO. Under the terms of the underwriting agreement executed in connection with Triplecrown’s IPO, Triplecrown would be required to pay the underwriters $19,320,000 of deferred underwriting discounts and commissions upon consummation of an “initial business combination” (as defined therein). Triplecrown is currently negotiating with the underwriters with respect to the amount to be paid at the closing of the merger. No agreement has been reached as of the date hereof. If the merger is not consummated and Triplecrown is required to be liquidated, the underwriters will not receive any of such funds and the entirety of the $19,320,000 of underwriting discounts and commissions held in the trust account will be returned to stockholders upon Triplecrown’s liquidation.

TABLE OF CONTENTS

CULLEN AGRICULTURAL HOLDING CORP.

TABLE OF CONTENTS

		Page
Summary of the Material Terms of the Merger			1
Questions and Answers for Triplecrown Stockholders and Warrantholders About the Proposals			6
Selected Historical Consolidated Financial Information			19
Selected Unaudited Pro Forma Condensed Combined Financial Information			23
Risk Factors			26
Forward-Looking Statements			39
Interests of Triplecrown’s Directors and Officers and Others in the Merger			40
Special Meetings of Triplecrown Stockholders and Warrantholders			42
Proposals to be Considered by the Triplecrown Stockholders			48
The Initial Charter Proposals			48
The Merger Proposal			51
The Merger Agreement			78
The Material U.S. Federal Income Tax Considerations to Triplecrown and Triplecrown Stockholders and Warrantholders			86
Unaudited Pro Forma Condensed Combined Financial Information			88
The Secondary Charter Proposals			97
The Stockholder Adjournment Proposal			99
Proposals to Be Considered by the Triplecrown Warrantholders			100
The Warrant Amendment Proposals			100
The Warrantholder Adjournment Proposal			101
Other Information Related to Triplecrown			102
Business of Cullen Agritech			112
Cullen Agritech’s Management’s Discussion and Analysis of Financial Condition and Results of Operations			142
Management of CAH Following the Merger			148
Comparison of Rights of Triplecrown and CAH			157
Beneficial Ownership of Securities			158
Certain Relationships and Related Transactions			161
Description of Securities			165
Price Range of Securities and Dividends			169
Stockholder Proposals			170
Legal Matters			170
Experts			170
Delivery of Documents to Stockholders			171
Where You Can Find More Information			171
Index to Financial Statements			F-1

TABLE OF CONTENTS

		Page
ANNEXES
Agreement and Plan of Reorganization			A-1
CAH Amended and Restated Certificate of Incorporation			B-1
CAH Bylaws			C-1
Employment Agreement			D-1
Form of Escrow Agreement			E-1
Tax Opinion of Graubard Miller			F-1
Triplecrown Amended and Restated Certificate of Incorporation			G-1
2009 Long-Term Incentive Equity Plan			H-1
Opinion of Richards, Layton & Finger, P.A.			I-1
Lock-Up Agreement			J-1
Fairness Opinion of Duff & Phelps			K-1
Section 262 of the Delaware General Corporation Law			L-1

TABLE OF CONTENTS

SUMMARY OF THE MATERIAL TERMS OF THE MERGER

TABLE OF CONTENTS

TABLE OF CONTENTS

TABLE OF CONTENTS

All such activity will be carried out in full compliance with applicable state laws and federal securities laws.

TABLE OF CONTENTS

TABLE OF CONTENTS

QUESTIONS AND ANSWERS
FOR TRIPLECROWN STOCKHOLDERS AND WARRANTHOLDERS ABOUT THE PROPOSALS

The following questions and answers briefly address some commonly asked questions about Triplecrown’s special meetings of stockholders and warrantholders. The following questions and answers may not include all the information that is important to stockholders and warrantholders of Triplecrown. We urge stockholders and warrantholders to read carefully this entire proxy statement/prospectus, including the annexes and the other documents referred to herein.

Q. Why am I receiving this proxy statement/ prospectus?		A. Triplecrown has agreed to a business combination with Cullen Agritech under the terms of the Agreement and Plan of Reorganization that is described in this proxy statement/prospectus. A copy of the merger agreement is attached to this proxy statement/prospectus as Annex A, which you are encouraged to read.
		Stockholders are being asked to consider and vote upon proposals entitled “Initial Charter Proposals,” “The Merger Proposal,” “The Secondary Charter Proposals” and “The Stockholder Adjournment Proposal,” all as described in more detail in this proxy statement/prospectus. Warrantholders are being asked to consider and vote upon proposals entitled “The Warrant Amendment Proposals” and “The Warrantholder Adjournment Proposal,” all as described in more detail in this proxy statement/prospectus.
		The approval of each of the initial charter proposals, the merger proposal, the secondary charter proposals and the warrant amendment proposals is a condition to the consummation of the merger. If any of the initial charter proposals, the merger proposal, the secondary charter proposals or the warrant amendment proposals is not approved, the other proposals will not be presented to stockholders and warrantholders for a vote and the merger will not be consummated.
		This proxy statement/prospectus contains important information about the proposed merger and the other matters to be acted upon at the special meetings of stockholders and warrantholders. You should read it carefully.
		Your vote is important. You are encouraged to vote as soon as possible after carefully reviewing this proxy statement/prospectus and its annexes.
Q. What are the economic terms of the proposed transaction?		A. Upon completion of the transactions described in this proxy statement/prospectus, Cullen Holdings, the current holder of common stock of Cullen Agritech which is beneficially owned and controlled by Eric Watson, will be issued 15,881,148 shares of CAH common stock (valued at $155 million, or $9.76 per share) for his interest in Cullen Agritech. Cullen Agritech is a newly formed company. To date, Mr. Watson has invested only $22,568 directly in Cullen Agritech for operational start-up costs and has invested approximately $9.2 million on the research and testing on the intellectual property that will be transferred to Cullen Agritech upon consummation of the transactions contemplated by this proxy statement/prospectus. Accordingly, the value of the stock he will receive upon consummation of the transactions is approximately $145.8 million more than the amount he has invested to date on the business of Cullen Agritech.

TABLE OF CONTENTS

Q. What is the structure of the merger?		A. Prior to the closing, (i) CAH, the issuer of the securities being registered by the registration statement of which this proxy statement/prospectus forms a part, is a wholly owned subsidiary of Triplecrown and Triplecrown Merger Sub is a wholly owned subsidiary of CAH and (ii) Cullen Agritech is a wholly owned subsidiary of Cullen Holdings and Natural Dairy is a wholly owned subsidiary of Cullen Agritech. Upon closing of the transaction, (i) Triplecrown will merge with and into CAH with CAH surviving the merger and becoming the public company, (ii) Triplecrown Merger Sub will merge with and into Cullen Agritech with Cullen Agritech surviving the merger and becoming

TABLE OF CONTENTS

		a wholly owned subsidiary of CAH and (iii) Natural Dairy will remain as a wholly owned subsidiary of Cullen Agritech. The following is a graphic display of the pre-and post-closing structures:
		Pre Closing

TABLE OF CONTENTS

Q. What is the ownership structure of the parties to the transaction?		A. The following is a summary of the parties to the transaction, the material affiliates, their ownership structure, and percentage of ownership, both prior to and as a result of the transaction:

				Prior to Closing		Post Closing No Conversion		Post Closing Max Conversion
		Cullen Holdings		100% owned by Cullen Investments Ltd, an entity 100% beneficially owned and controlled by Eric Watson		100% owned by Cullen Investments Ltd (ultimately 100% beneficially owned and controlled by Eric Watson)		100% owned by Cullen Investments Ltd (ultimately 100% beneficially owned and controlled by Eric Watson)
		Triplecrown		10% owned by Cullen Investments Ltd, an entity controlled by Eric Watson, 10% owned by Triplecrown Founders and other board members, 80% owned by Public Shareholders		Will merge into CAH		Will merge into CAH
		CAH*		100% owned by Triplecrown		21% Owned by Cullen Holdings (ultimately 100% beneficially owned and controlled by Eric Watson), 4% owned by Triplecrown Founders, other board members & consultants, 75% owned by CAH Public Shareholders		28% Owned by Cullen Holdings (ultimately 100% beneficially owned and controlled by Eric Watson), 5% owned by Triplecrown Founders, other board members & consultants, 67% owned by CAH Public Shareholders
		Triplecrown Merger Sub		100% owned by CAH		Will merge into Cullen Agritech and be 100% owned by CAH		Will merge into Cullen Agritech and be 100% owned by CAH
		Cullen Agritech		100% owned by Cullen Holdings, an entity 100% beneficially owned and controlled by Eric Watson		A wholly owned subsidiary of CAH		A wholly owned subsidiary of CAH
		Natural Dairy		A wholly owned subsidiary of Cullen Agritech		A wholly owned subsidiary of Cullen Agritech		A wholly owned subsidiary of Cullen Agritech

*CAH is the issuer of the securities being registered by the registration statement of which this proxy statement/prospectus forms a part.

TABLE OF CONTENTS

Q. What are my options in determining how to vote and what actions to take?		A. Stockholders and warrantholders have several options available to them that should be considered in determining how to vote at the meetings and what actions they may wish to take. These include voting in favor of the proposals, voting against the proposals and/or exercising conversion rights or appraisal rights, all as described in more detail below and elsewhere in this proxy statement/prospectus. You cannot seek conversion or appraisal rights unless you affirmatively vote against the merger proposal. Additionally, if you seek conversion, you will not be entitled to appraisal rights and if you seek appraisal rights, you will not be entitled to seek conversion rights. Each person who purchased Public Shares in the IPO and still held such shares upon learning of differences between what was described in Triplecrown’s IPO prospectus and what is presented in this proxy statement/prospectus may have securities law claims against Triplecrown for rescission (under which a successful claimant has the right to receive the total amount paid for his or her securities pursuant to an allegedly deficient prospectus, plus interest and less any income earned on the securities, in exchange for surrender of the securities) or damages (compensation for loss on an investment caused by alleged material misrepresentations or omissions in the sale of a security). How you vote on the merger proposal would not limit your rights to seek rescission or damages as described above. You should carefully consider the foregoing when deciding how to vote on the proposals and what actions you wish to take.
Q. Do I have conversion rights?		A. If you are a holder of Public Shares, you have the right to vote against the merger proposal and demand that Triplecrown convert such shares into a pro rata portion of the trust account in which a substantial portion of the net proceeds of Triplecrown’s IPO are held. These rights to vote against the merger and demand conversion of the Public Shares into a pro rata portion of the trust account are sometimes referred to herein as conversion rights.
Q. How do I exercise my conversion rights?		A. If you are a holder of Public Shares and wish to exercise your conversion rights, you must (i) vote against the merger proposal, (ii) demand that Triplecrown convert your shares into cash, and (iii) deliver your stock to Triplecrown’s transfer agent, at your option, either physically or electronically through the Depository Trust Company prior to the vote at the meeting; provided, however, that due to the short period of time between the date of this proxy statement/prospectus and the meeting date, Triplecrown will allow holders of certificates to deliver such certificates after the meeting in order to properly exercise conversion rights.
		Any action that does not include an affirmative vote against the merger will prevent you from exercising your conversion rights. Your vote on any proposal other than the merger proposal will have no impact on your right to convert.

TABLE OF CONTENTS

		You may exercise your conversion rights either by checking the box on the proxy card or by submitting your request in writing to Mark Zimkind of Continental Stock Transfer & Trust Company, Triplecrown’s transfer agent, at the address listed at the end of this section. If you (i) initially vote for the merger proposal but then wish to vote against it and exercise your conversion rights or (ii) initially vote against the merger proposal and wish to exercise your conversion rights but do not check the box on the proxy card providing for the exercise of your conversion rights or do not send a written request to Triplecrown to exercise your conversion rights, or (iii) initially vote against the merger but later wish to vote for it, you may request Triplecrown to send you another proxy card on which you may indicate your intended vote. You may make such request by contacting Triplecrown at the phone number or address listed at the end of this section.
		Any request for conversion, once made, may be withdrawn at any time up to the vote taken with respect to the merger proposal. If you delivered your shares for conversion to Triplecrown’s transfer agent and decide prior to the special meeting of stockholders not to elect conversion, you may request that Triplecrown’s transfer agent return the shares (physically or electronically). You may make such request by contacting Triplecrown’s transfer agent at the phone number or address listed at the end of this section.
		Any corrected or changed proxy card must be received by Triplecrown’s secretary prior to the special meeting of stockholders. No demand for conversion will be honored unless the holder’s stock has been delivered (either physically or electronically) to the transfer agent prior to the vote at the special meeting.
		A holder voting through his broker would be able to correct or change his vote immediately by having such broker submit a corrected or changed vote electronically. A holder voting by submitting a proxy card would need to send in a corrected or changed proxy card and it would then take several days thereafter for Triplecrown or Triplecrown’s transfer agent to receive the revised proxy card once it is mailed by the holder. A holder may obtain a new proxy card by requesting Triplecrown or its transfer agent to provide a new one (which will be done by Triplecrown or the transfer agent promptly after such request) or print a copy of such proxy card which is an exhibit to the registration statement of which this proxy statement/prospectus forms a part from the SEC’s website at www.sec.gov.
		If the merger is completed, then, if you have also properly exercised your conversion rights, you will be entitled to receive a pro rata portion of the trust account, including any interest earned thereon, calculated as of two business days prior to the date of the consummation of the merger. As of September 4, 2009, there was $538,796,312 in the trust account, which would amount to approximately $9.76 per Public Share upon conversion. If you exercise your conversion rights, then you will be exchanging your shares of Triplecrown common stock for cash and will no longer own these shares.

TABLE OF CONTENTS

		Exercise of your conversion rights does not result in either the exercise or loss of any Triplecrown warrants that you may hold. Your warrants will continue to be outstanding following a conversion of your common stock, will be automatically converted into warrants to purchase shares of CAH’s common stock with new terms as contemplated by the warrant amendment proposals and will become exercisable upon consummation of the merger. A registration statement must be in effect to allow you to exercise any warrants you may hold or to allow CAH to call the warrants for redemption if the redemption conditions are satisfied. If the merger is not consummated and Triplecrown does not complete a different business combination on or prior to October 22, 2009, the warrants will not become exercisable and will be worthless upon dissolution of Triplecrown in accordance with its charter.
Q. Do I have appraisal rights if I object to the proposed merger?		A. Triplecrown stockholders may have appraisal rights in connection with the mergers contemplated by this proxy statement/prospectus. If appraisal rights are available, holders of shares of Triplecrown common stock who do not vote in favor of the merger proposal and who properly demand appraisal of their shares will be entitled to appraisal rights in connection with the mergers under Section 262 of the Delaware General Corporation Law (“DGCL”). Holders of Public Shares electing to exercise conversion rights will not be entitled to appraisal rights. Appraisal rights are not available to holders of Triplecrown warrants. For additional information, including the procedures for properly demanding appraisal, see “The Merger Proposal — Appraisal Rights.”

TABLE OF CONTENTS

Q. What happens to the funds deposited in the trust account after consummation of the merger?		A. At the closing of the merger, the funds in Triplecrown’s trust account will be released to pay approximately $4 million to $6 million of transaction fees and expenses, up to approximately $7 million for the balance of the purchase price for the land to be used by CAH following consummation of the merger, up to approximately $19.3 million deferred underwriting discounts and commissions, as well as tax liabilities, if any, and approximately $150,000 to $250,000 of reimbursement of expenses of the Triplecrown Founders and to make purchases of Public Shares, if any. The balance of the funds will be released to CAH to pay Triplecrown stockholders who properly exercise their conversion rights and for working capital and general corporate purposes of CAH and Cullen Agritech. Although Cullen Agritech would need approximately $400 million to fully implement its business plan, Cullen Agritech anticipates initially implementing its business plan with only $150 million after the consummation of the transactions contemplated by this proxy statement/prospectus. Accordingly, if CAH has access to more than $150 million after closing of the merger, CAH intends to use such funds, in excess of $150 million, depending on market conditions, to repurchase shares of common stock at prices and in amounts to comply with Rule 10b-18 under the Exchange Act. The funds available to CAH after the consummation of the transactions, up to $150 million, will be used to initially implement Cullen Agritech’s business model. If less than $150 million is available to Cullen Agritech, the business model will be initially implemented to such lesser extent and Cullen Agritech would attempt to raise additional capital from other sources. If a significant amount of the trust fund proceeds are used to purchase Public Shares or for conversions, Cullen Agritech may not have any funds available to implement its business plan. Cullen Agritech has not taken any steps to secure any additional financing or funding and there is no assurance that such financing or funding would be available on terms favorable to Cullen Agritech or at all. If such financing or funding is not available, Cullen Agritech may not be able to implement its business plan to any extent and therefore would not be worth the $155 million being paid for it by Triplecrown.
Q. What conflicts of interest exist in this transaction?		A. The sole stockholder of Cullen Agritech is Cullen Holdings, an entity controlled by Eric J. Watson, Triplecrown’s chairman of the board and treasurer. Additionally, Triplecrown’s other officers and directors have interests in the merger that differ from, or are in addition to, those of Triplecrown’s stockholders generally. For more information on the conflicts of interest involved in this transaction, see the section entitled “Interests of Triplecrown’s Directors and Officers and Others in the Merger” contained on page 40 of this proxy statement/prospectus.

TABLE OF CONTENTS

Q. How is this transaction different from the type of transaction that Triplecrown was required to pursue pursuant to Triplecrown’s amended and restated certificate of incorporation and IPO prospectus?		A. You should be aware that Triplecrown’s amended and restated certificate of incorporation and IPO prospectus require Triplecrown to complete a business combination in which it acquires a target business in the financial services industry having a fair market value equal to at least 80% of Triplecrown’s trust account balance (excluding deferred underwriting discounts and commissions) and resulting in the ownership by Triplecrown of not less than 50% of the voting securities of the target business and restricts Triplecrown from completing a business combination with a target business that is affiliated with any of the Triplecrown Founders. Furthermore, Triplecrown’s IPO prospectus did not disclose that funds in its trust account might be used, directly or indirectly, to purchase Public Shares from holders who have indicated their intention to vote against the merger and seek conversion of their shares to cash (as Triplecrown may contemplate doing). Also, Triplecrown’s IPO prospectus stated that specific provisions in Triplecrown’s amended and restated certificate of incorporation may not be amended prior to the consummation of an initial business combination but that Triplecrown had been advised that such provision limiting its ability to amend its amended and restated certificate of incorporation may not be enforceable under Delaware law.
Q. Since Triplecrown’s amended and restated certificate of incorporation and IPO prospectus contained certain differences from what is being proposed at the special meeting of stockholders, what are my legal rights?		A. Because of the differences discussed above, each person who purchased Public Shares in the IPO and still held such shares upon learning of these facts may have securities law claims against Triplecrown for rescission (under which a successful claimant has the right to receive the total amount paid for his or her securities pursuant to an allegedly deficient prospectus, plus interest and less any income earned on the securities, in exchange for surrender of the securities) or damages (compensation for loss on an investment caused by alleged material misrepresentations or omissions in the sale of a security).
		Such claims may entitle stockholders asserting them to as much as $10.00 or more per share, based on the initial offering price of the IPO units comprised of stock and warrants, less any amount received from sale of the original warrants, plus interest from the date of Triplecrown’s IPO (which, in the case of holders of Public Shares, may be more than the pro rata share of the trust account to which they are entitled on conversion or liquidation). See “The Merger Proposal — Rescission Rights.”
Q. What happens if the merger is not consummated or the merger agreement is terminated?		A. If the merger is not consummated by the date on which Triplecrown must liquidate, either party may terminate the merger agreement. If Triplecrown is unable to complete the merger by October 22, 2009, its amended and restated certificate of incorporation provides that it must liquidate. In any liquidation of Triplecrown, the funds deposited in the trust account, plus any interest earned thereon, less claims requiring payment from the trust account by creditors who have not waived their rights against the trust account, if any, will be distributed pro rata to the holders of Triplecrown’s Public Shares. Triplecrown would expect to make such liquidating distributions prior to December 31, 2009. Holders of Triplecrown common stock issued prior to the IPO, including all of Triplecrown’s officers and directors, have waived any right to any liquidation distribution with respect to those shares. Eric J. Watson, Triplecrown’s chairman and treasurer, and Jonathan J. Ledecky, Triplecrown’s president and secretary, have agreed to be personally liable under certain circumstances to ensure that the proceeds in the trust account are not reduced by the claims of prospective target businesses and vendors or other entities that are owed money by Triplecrown for services rendered or products sold to it, but only to the extent such entities have not signed a waiver. Triplecrown cannot assure you that Messrs. Watson and Ledecky will be able to satisfy those obligations. See the section entitled “Other Information Related to Triplecrown — Liquidation If No Business Combination” for additional information.

TABLE OF CONTENTS

Q. When do you expect the merger to be completed?		A. It is currently anticipated that the merger will be consummated promptly following the Triplecrown special meetings on October 21, 2009. For a description of the conditions for the completion of the merger, see the section entitled “The Merger Agreement — Conditions to Closing of the Merger.”
Q. What do I need to do now?		A. Triplecrown urges you to read carefully and consider the information contained in this proxy statement/prospectus, including the annexes, and to consider how the merger, warrant amendment and other proposals will affect you as a stockholder or warrantholder of Triplecrown. You should then vote as soon as possible in accordance with the instructions provided in this proxy statement/prospectus and on the enclosed proxy card.
Q. How do I vote?		A. If you are a holder of record of Triplecrown common stock or warrants, you may vote in person at the special meetings or by submitting a proxy for the special meetings. You may submit your proxy by completing, signing, dating and returning the enclosed proxy card in the accompanying pre-addressed postage paid envelope. In order to arrive in time, you should mail the enclosed proxy card in the accompanying pre-addressed postage paid envelope no later than October 16, 2009. If you hold your shares or warrants in “street name,” which means your shares or warrants are held of record by a broker, bank or nominee, you should contact your broker to ensure that votes related to the shares or warrants you beneficially own are properly counted. In this regard, you must provide the record holder of your shares or warrants with instructions on how to vote your shares or warrants or, if you wish to attend the meetings and vote in person, obtain a proxy from your broker, bank or nominee. Stockholders and warrantholders who hold their securities in “street name” through a broker or bank will have the option to authorize their proxies to vote their securities electronically through the Internet or by telephone. 55,099,700 of the 55,200,000 outstanding Public Shares (99.8%) and all of the 55,200,000 outstanding public warrants (100%) are held in street name. If you hold your securities through a broker, bank or other nominee, you should check your proxy card or voting instruction card forwarded by your broker, bank or other nominee who holds your securities for instructions on how to vote by these methods. Votes submitted at any time prior to the meeting will be accepted. However, to ensure that your vote is properly counted and to avoid any problems or unforeseen delays, you should submit your vote as early as possible and prior to midnight on the day before the meeting. After such time, a holder would need to contact his bank, broker or nominee directly to vote or change his vote.
Q. What will happen if I sign and return my proxy card without indicating how I wish to vote?		A. Signed and dated proxies received by Triplecrown without an indication of how the stockholder or warrantholder intends to vote on a proposal will be voted in favor of each proposal presented to the stockholders or warrantholders, as the case may be.
		Stockholders will not be entitled to exercise their conversion rights if such stockholders return proxy cards to Triplecrown without an indication of how they desire to vote with respect to the merger proposal or, for stockholders holding their shares in “street name,” if such stockholders fail to provide voting instructions to their banks, brokers or other nominees.

TABLE OF CONTENTS

Q. If my shares or warrants are held in “street name,” will my broker, bank or nominee automatically vote my shares or warrants for me?		A. No. Your broker, bank or nominee cannot vote your shares or warrants unless you provide instructions on how to vote in accordance with the information and procedures provided to you by your broker, bank or nominee.
Q. May I change my vote after I have mailed my signed proxy card?		A. Yes. Send a later-dated, signed proxy card to Triplecrown’s secretary at the address set forth below so that it is received by Triplecrown’s secretary prior to the special meetings or attend the special meetings in person and vote. You also may revoke your proxy by either sending a notice of revocation to Triplecrown’s secretary, which must be received by Triplecrown’s secretary prior to the special meetings, or attending the special meetings and revoking your proxy and voting in person. To ensure that your revised vote is properly counted and to avoid any problems or unforeseen delays, you should submit the notice of revocation and new proxy as early as possible and prior to midnight on the day before the meeting. After such time, a holder would need to contact his bank, broker or nominee directly to vote or change his vote.
Q. What should I do with my stock, warrant and unit certificates?		A. Upon consummation of the merger, Triplecrown’s units will automatically separate and no longer be traded as a separate security.
		If you are not electing conversion in connection with your vote on the merger proposal, the merger is approved and consummated, and you hold your securities in Triplecrown in certificate form, as opposed to holding your securities through your broker, you do not need to exchange your existing certificates for certificates issued by CAH. Your current Triplecrown certificates will automatically represent your rights in CAH’s securities. You may, however, exchange your certificates if you choose, by contacting CAH’s transfer agent, Continental Stock Transfer & Trust Company (Reorganization Department), after the consummation of the merger and following their requirements for reissuance.
		Triplecrown stockholders who affirmatively vote against the merger and exercise their conversion rights must deliver their shares to Triplecrown’s transfer agent (either physically or electronically) as instructed by Triplecrown or Triplecrown’s transfer agent prior to the vote at the special meeting of stockholders.
Q. What should I do if I receive more than one set of voting materials?		A. You may receive more than one set of voting materials, including multiple copies of this proxy statement/prospectus and multiple proxy cards or voting instruction cards. For example, if you hold your shares or warrants in more than one brokerage account, you will receive a separate voting instruction card for each brokerage account in which you hold shares or warrants. If you are a holder of record and your shares or warrants are registered in more than one name, you will receive more than one proxy card. Please complete, sign, date and return each proxy card and voting instruction card that you receive in order to cast a vote with respect to all of your Triplecrown shares or warrants.

TABLE OF CONTENTS

Q. Who can help answer my questions?		A. If you have questions about the merger or if you need additional copies of the proxy statement/prospectus or the enclosed proxy card you should contact:
		Mr. Jonathan J. Ledecky Secretary Triplecrown Acquisition Corp. c/o Paul Vassilakos 590 Madison Avenue, 21st Floor New York, New York 10022 Tel: (212) 521-5396 Fax: (212) 521-4389    or
		Morrow & Co., LLC 470 West Avenue Stamford, Connecticut 06902 Tel: (800) 662-5200
		You may also obtain additional information about Triplecrown from documents filed with the Securities and Exchange Commission (“SEC”) by following the instructions in the section entitled “Where You Can Find More Information.”
		If you intend to affirmatively vote against the merger and seek conversion of your shares, you will need to deliver your stock (either physically or electronically) to Triplecrown’s transfer agent prior to the vote at the special meeting of stockholders.
		If you have questions regarding the certification of your position or delivery of your stock, please contact:
		Mr. Mark Zimkind Continental Stock Transfer & Trust Company 17 Battery Place New York, New York 10004 Tel: (212) 845-3287 Fax: (212) 616-7616

TABLE OF CONTENTS

SELECTED HISTORICAL CONSOLIDATED FINANCIAL INFORMATION

Triplecrown and CAH are providing the following selected historical financial information to assist you in your analysis of the financial aspects of the merger.

CAH’s balance sheet data as of August 31, 2009 is derived from CAH’s audited financial statements, which are included elsewhere in this proxy statement/prospectus.

Cullen Agritech’s balance sheet data as of August 18, 2009 is derived from Cullen Agritech’s audited financial statements, which are included elsewhere in this proxy statement/prospectus.

Triplecrown’s balance sheet data as of December 31, 2008 and December 31, 2007 and statements of income data for the year ended December 31, 2008, and for the period from June 8, 2007 (inception) through December 31, 2007 and 2008 are derived from Triplecrown’s audited financial statements, which are included elsewhere in this proxy statement/prospectus. Triplecrown’s balance sheet data as of June 30, 2009 and statements of income data for the six months ended June 30, 2009 and 2008 are derived from Triplecrown’s unaudited financial statements, which are included elsewhere in this proxy statement/prospectus.

The information is only a summary and should be read in conjunction with each of Triplecrown’s, CAH’s and Cullen Agritech’s historical financial statements and related notes and “Other Information Related to Triplecrown — Triplecrown’s Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Cullen Agritech’s Management’s Discussion and Analysis of Financial Condition and Results of Operations” contained elsewhere herein. The historical results included below and elsewhere in this proxy statement/prospectus are not indicative of the future performance of CAH or Cullen Agritech.

TABLE OF CONTENTS

SELECTED HISTORICAL CONSOLIDATED FINANCIAL INFORMATION — CAH
(AUDITED)

		August 31, 2009
Balance Sheet:
Total assets		$	—
Total liabilities			1,000
Stockholder’s deficit			(1,000	)

SELECTED HISTORICAL COMBINED FINANCIAL INFORMATION — 
CULLEN AGRICULTURAL TECHNOLOGIES INC.
(AUDITED)

		August 18, 2009
Balance Sheet:
Total assets		$	22,568
Total liabilities			44,730
Stockholder’s deficit			(22,162	)

TABLE OF CONTENTS

SELECTED HISTORICAL FINANCIAL INFORMATION — TRIPLECROWN

		For the Six Months Ended June 30, (Unaudited)								For the Year Ended December 31, 2008 (Audited)				For the Period from June 8, 2007 (Inception) Through December 31, 2007 (Audited)
Income Statement Data:		2009				2008
Revenue			—				—				—				—
Loss from operations			(1,267,364	)			(681,939	)			(1,484,138	)			(180,350	)
Interest and dividend income			172,901				5,506,806				8,443,326				3,573,186
Net (loss) income attributable to common stockholders			(869,886	)			3,255,003				4,074,811				1,824,397
Basic and diluted net (loss) income per share			(0.02	)			0.06				0.08				0.07
Weighted average shares outstanding excluding shares subject to possible conversion – basic and diluted			52,440,001				52,440,001				52,440,001				26,554,952

Balance Sheet Data:		June 30, 2009 (Unaudited)				December 31, 2008 (Audited)				December 31, 2007 (Audited)
Working capital			3,319,032				4,505,229				1,793,077
Trust account, restricted			539,328,529				538,876,656				536,930,000
Total assets			543,418,160				543,786,567				540,426,916
Total liabilities			770,599				404,682				1,703,839
Value of common stock which may be redeemed for cash			161,798,549				161,662,987				161,078,990
Stockholders’ equity			380,849,012				381,718,898				377,644,087

		For the Six Months Ended June 30, (Unaudited)								For the Year Ended December 31, 2008 (Audited)				For the Period from June 8, 2007 (Inception) Through December 31, 2007 (Audited)
Cash Flow Data:		2009				2008
Net cash (used in) provided by operating activities			(1,383,383	)			1,464,793				3,289,954				3,506,866
Net cash (used in) provided by investing activities			766,203				(1,760,678	)			(3,475,261	)			(540,108,633	)
Net cash provided by financing activities			505,574				—				—				536,898,680
Net (decrease) increase in cash			(111,606	)			(295,885	)			(185,307	)			296,913

TABLE OF CONTENTS

SELCTED UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS

The selected unaudited pro forma condensed combined financial information has been derived from, and should be read in conjunction with, the unaudited pro forma condensed combined financial information included elsewhere in this proxy statement/prospectus.

The following unaudited pro forma condensed combined statement of operations for the six months ended June 30, 2009, statement of operations for the year ended December 31, 2008 and balance sheet at June 30, 2009 are based on the historical financial statements of Triplecrown and Cullen Agritech after giving effect to the merger.

The unaudited condensed combined pro forma statements of operations for the six months ended June 30, 2009 and the year ended December 31, 2008 give pro forma effect to the merger as if it had occurred on January 1, 2008. The unaudited pro forma condensed combined balance sheet at June 30, 2009 assumes that the merger was effective on June 30, 2009.

The unaudited condensed combined pro forma statement of operations for the six months ended June 30, 2009 was derived from Triplecrown’s unaudited condensed financial statements for the six months ended June 30, 2009, and the unaudited condensed combined pro forma statement of operations for the year ended December 31, 2008 was derived from Triplecrown’s audited financial statements for the year ended December 31, 2008. The unaudited pro forma condensed combined balance sheet at June 30, 2009 was derived from Triplecrown’s unaudited condensed financial statements and Cullen Agritech’ audited financial statements as of June 30, 2009 and August 18, 2009, respectively.

The historical financial information has been adjusted to give effect to pro forma events that are related and/or directly attributable to the Acquisition, are factually supportable and, in the case of the unaudited pro forma statement of operations data, are expected to have a continuing impact on the combined results. The adjustments presented on the unaudited pro forma condensed combined financial information have been identified and presented in “Unaudited Pro Forma Condensed Combined Financial Data” to provide relevant information necessary for an accurate understanding of the combined company upon consummation of the Acquisition.

This information should be read together with the consolidated financials statements of CAH and Cullen Agritech and the notes thereto, the balance sheet of the Triplecrown and the notes thereto, “Unaudited Pro Forma Condensed Combined Financial Data,” “Cullen Agritech’s Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and “Triplecrown’s Management’s Discussion and Analysis of Financial Condition and Results of Operations” included elsewhere in this proxy statement/prospectus.

Cullen Agritech and Triplecrown have assumed that no warrants will be exercised immediately following the consummation of the merger because the expected book value per share of Cullen Agritech’s common stock will be below the amended strike price of the warrants. Accordingly, the unaudited pro forma condensed combined financial statements do not reflect the modification of the warrants. The increase in the exercise price and the extended expiration date of the warrants would not result in any incremental fair value adjustment as a result of the modification of the warrants.

Consummation of the merger is conditioned on (i) the holders of (a) a majority of the Public Shares present and entitled to vote at a meeting called for this and other related purposes, approving the merger and (b) a majority of Triplecrown’s outstanding common stock on the record date, at a meeting called for this and other related purposes, approving the merger proposal, (ii) the holders of fewer than 30.0% of the Public Shares voting against the merger and properly demanding that their Public Shares be converted into a pro-rata portion of the trust account, calculated as of two business days prior to the anticipated consummation of the merger, (iii) the holders of a majority of Triplecrown’s common stock outstanding on the record date approving the initial charter proposals and the subsequent filing of Triplecrown’s second amended and restated certificate of incorporation, (iv) the holders of a majority of Triplecrown’s common stock outstanding on the record date approving the secondary charter proposals and (v) the holders of a majority of Triplecrown’s warrants outstanding on the record date approving the warrant amendment proposals (although this condition may be waived upon mutual consent of Triplecrown and Cullen Agritech):

TABLE OF CONTENTS

Notwithstanding the foregoing, since there is no minimum amount of funds that must be left for CAH after any purchases of Public Shares are made (as described elsewhere in this proxy statement/prospectus), the parties could use all of the funds held in the trust account to make such purchases (and for conversions) and the parties could consummate the mergers contemplated by this proxy statement/prospectus leaving CAH with no funds for additional working capital. The unaudited pro forma condensed combined financial statements do not reflect this scenario, although stockholders should be aware that this is a possibility. In the event this occurs, Cullen Agritech would need to raise capital from other sources in order to implement its business plan. Cullen Agritech has not taken any steps to secure any additional financing or funding and there is no assurance that such financing or funding would be available on terms favorable to Cullen Agritech or at all.

The unaudited pro forma condensed combined financial statements are provided for informational purposes only and are subject to a number of uncertainties and assumptions and do not purport to represent what the companies’ actual performance or financial position would have been had the transaction occurred on the dates indicated and does not purport to indicate the financial position or results of operations as of any future date or for any future period. Please refer to the following information in conjunction with the accompanying notes to these pro forma financial statements and the historical financial statements and the accompanying notes thereto and the sections entitled “Unaudited Pro Forma Condensed Combined Financial Data,” “Other Information Related To Triplecrown — Triplecrown’s Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and “Cullen Agritech’s Management’s Discussion and Analysis of Financial Condition and Results of Operations”.

TABLE OF CONTENTS

SELECTED UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION
(USD)

		Pro Forma No Conversion				Pro Forma Maximum Conversion
Consolidated Pro Forma Income Statement Data for Six months ended June 30, 2009:
Net sales		$	—			$	—
Net loss available to common stockholders			(864,486	)			(916,336	)
Basic and diluted net income (loss) per share			(0.01	)			(0.02	)
Shares Outstanding			74,076,148				57,516,149
Weighted average number of shares			74,076,148				57,516,149
Consolidated Pro Forma Income Statement Data for Year ended December 31, 2008:
Net sales		$	—			$	—
Net loss available to common stockholders			4,152,718				1,611,167
Basic and diluted net income per share			0.06				0.03
Shares Outstanding			74,076,148				57,516,149
Weighted average number of shares			74,076,148				57,516,149
Consolidated Pro Forma Balance Sheet Data at June 30, 2009:
Total assets		$	518,615,154			$	356,952,167
Total liabilities			309,755				309,755
Long-term debt			—				—
Total stockholders' equity			518,305,399				356,642,412

TABLE OF CONTENTS

COMPARATIVE SHARE INFORMATION

The following table sets forth selected historical equity ownership information for Triplecrown and Cullen Agritech and unaudited pro forma combined per share ownership information after giving effect to the merger, and presented to reflect the following:

This information is being provided to aid you in your analysis of the financial aspects of the merger. This information should be read together with the consolidated financials statements of Triplecrown and the notes thereto, the financial statements of Cullen Agritech and the notes thereto, “Unaudited Pro Forma Condensed Combined Financial Data,” “Triplecrown’s Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and “Cullen Agritech’ Management’s Discussion and Analysis of Financial Condition and Results of Operations” included elsewhere in this proxy statement/prospectus.

As a result of the proposed merger, CAH will own all of the outstanding Cullen Agritech shares. Since, Cullen Agritech’s Chief Executive Officer is currently the sole officer and director of CAH, Cullen Agritech is deemed to be a related party. Consequently, CAH’s accounting for the purchase of Cullen Agritech will include consolidating Cullen Agritech’s assets and liabilities at carrying value with those of CAH. The cost of the purchase will be based on the CAH common stock issued to the Cullen Agritech stockholder.

The unaudited pro forma consolidated per share information does not purport to represent what the actual results of operations of Triplecrown and Cullen Agritech would have been had the merger been completed or to project Triplecrown’s or Cullen Agritech’ results of operations that may be achieved after the merger. The unaudited pro forma book value per share information below does not purport to represent what the value of Triplecrown and Cullen Agritech would have been had the merger been completed nor the book value per share for any future date or period.

Since there is no minimum amount of funds that must be left for CAH after any purchases of Public Shares are made (as described elsewhere in this proxy statement/prospectus), the parties could use all of the funds held in the trust account to make such purchases (and for conversions) and the parties could consummate the mergers contemplated by this proxy statement/prospectus leaving CAH with just the shares held by Cullen Holdings and the Triplecrown Founders. In the event this occurs, Cullen Agritech would need to raise capital from other sources in order to implement its business plan. Cullen Agritech has not taken any steps to secure any additional financing or funding and there is no assurance that such financing or funding would be available on terms favorable to Cullen Agritech or at all. The unaudited pro forma condensed combined financial statements do not reflect this scenario, although stockholders should be aware that this is a possibility.

Unaudited Pro Forma Consolidated Per Share Information

		Triplecrown Acquisition Corp.				Cullen Agricultural Technologies Inc.				Pro Forma No Conversion				Pro Forma Maximum Conversion
Six Months ended June 30, 2009
Basic earnings per share		$	(0.02	)		$	0.00			$	(0.01	)		$	(0.02	)
Diluted earnings per share		$	(0.02	)		$	0.00			$	(0.01	)		$	(0.02	)
Cash dividends declared per share(3)			—				—				—				—
Book value per share at June 30, 2009(1)(2)		$	7.20			$	(110.81	)		$	7.00			$	6.20
Year ended December 31, 2008
Basic earnings per share(4)		$	0.08			$	0.00			$	0.06			$	0.03
Diluted earnings per share(4)		$	0.08			$	0.00			$	0.06			$	0.03

TABLE OF CONTENTS

TABLE OF CONTENTS

RISK FACTORS

You should carefully consider the following risk factors, together with all of the other information included in this proxy statement/prospectus, before you decide whether to vote or instruct your vote to be cast to approve the proposals described in this proxy statement/prospectus. The risks and uncertainties described below are not the only risks and uncertainties which CAH or Cullen Agritech will face in the future. Additional risks and uncertainties not presently known or that are currently considered to be immaterial may materially and adversely affect the business operations or stock price of CAH or Cullen Agritech following the transactions described in this proxy statement/prospectus. If any of the following risks or uncertainties occur, CAH’s or Cullen Agritech’s business, financial condition or operating results could materially suffer. In that event, the trading price of your securities could decline and you may lose all or part of your investment.

Risks Related to Cullen Agritech’s Business and Operations Following the Merger

Risks Related to Cullen Agritech’s Business

Cullen Agritech has no operating history and may not be able to successfully operate its business or generate sufficient revenue to make or sustain distributions to its stockholders.

Cullen Agritech was incorporated in June 2009, is a development stage company and has no operating history. Cullen Agritech has no significant assets and will commence operations only upon consummation of the transactions described in this proxy statement/prospectus. Cullen Agritech cannot assure you that it will be able to operate its business successfully or implement its policies and strategies as described in this proxy statement/prospectus. Additionally, the past performance of key personell of Cullen Agritech or its subsidiaries should not be viewed as an indication of the future performance of CAH and Cullen Agritech.

Cullen Agritech’s independent registered public accounting firm’s report contains an explanatory paragraph that expresses substantial doubt about Cullen Agritech’s ability to continue as a “going concern.”

Cullen Agritech had a net loss of $22,362 for the period from June 3, 2009 (inception) through August 18, 2009, and has no cash as of August 18, 2009. To date, Cullen Agritech’s operations have been funded by Cullen Holdings. These factors, among others, raise substantial doubt about Cullen Agritech’s ability to continue as a going concern. Cullen Agritech’s ability to continue as a going concern is dependent on the ability of Cullen Holdings to finance operations through debt and equity financing. Cullen Holdings or Cullen Agritech may have difficulty in obtaining financing on favorable terms, if at all. The financial statements contained elsewhere in this proxy statement/prospectus do not include any adjustments that might result from Cullen Agritech’s inability to consummate the merger or Cullen Agritech’s or our inability to continue as a going concern.

The recent disruptions in the overall economy and the financial markets may adversely impact Cullen Agritech’s business and results of operations.

The agricultural industry is sensitive to changes in general economic conditions, both nationally and locally. Recent disruptions in global financial markets and banking systems have made it more difficult for companies to access credit and capital markets. The economic crisis may adversely affect Cullen Agritech in a variety of ways. Access to lines of credit or the capital markets may be severely restricted, which may preclude Cullen Agritech from raising funds required for operations and to fund continued expansion. It may be more difficult for Cullen Agritech to complete strategic transactions with third parties. Continuing volatility in the credit and capital markets could potentially impair Cullen Agritech’s customers’ ability to access these markets and increase associated costs, and Cullen Agritech may be materially affected by these financial market disruptions as economic events and circumstances continue to evolve. The financial and credit market turmoil could also negatively impact Cullen Agritech’s potential suppliers and customers, which could decrease Cullen Agritech’s ability to source, produce and distribute Culen Agritech’s products and could decrease demand for its products.

If economic conditions continue to worsen, it is possible these factors could significantly impact Cullen Agritech’s financial condition and ability to implement its strategic growth plan.

TABLE OF CONTENTS

Any negative public perception regarding Cullen Agritech’s products or industry, or any ill effects of product liability claims, could harm Cullen Agritech’s reputation, damage its brand, result in costly and damaging recalls and expose Cullen Agritech to government investigations and sanctions, which would materially and adversely affect its results of operations.

Cullen Agritech will sell products for human consumption, which involves a number of risks. Product contamination, spoilage or other adulteration could result in the inability to sell Cullen Agritech’s products. Cullen Agritech also may be subject to liability if its products or operations violate applicable laws or regulations or in the event its products cause injury, illness or death. A significant product liability or other legal judgment against Cullen Agritech or a widespread product recall may negatively impact Cullen Agritech’s profitability. Even if a product liability or consumer fraud claim is unsuccessful or is not merited, the negative publicity surrounding such assertions regarding Cullen Agritech’s products or processes could materially and adversely affect Cullen Agritech’s reputation, brand image and results of operations. Finally, serious product quality concerns could result in governmental action against Cullen Agritech, which, among other things, could result in the suspension of production or distribution of Cullen Agritech’s products, loss of certain licenses, or other governmental penalties, including possible criminal liability.

If Cullen Agritech is unable to purchase certain assets material to the implementation of its business in a timely manner or at all, such inability would materially adversely affect Cullen Agritech’s business and results of operations.

Cullen Agritech is a development stage company with no operating history, significant assets or revenues. The implementation of Cullen Agritech’s business plan will rely on its ability to purchase land, livestock and other material assets crucial to its business plan. Cullen Agritech would need approximately $400 million to fully implement its business plan. Cullen Agritech anticipates initially implementing its business plan with only $150 million after the consummation of the transactions contemplated by this proxy statement/prospectus. Accordingly, if CAH has access to more than $150 million after closing of the merger, CAH intends to use such funds in excess of $150 million, depending on market conditions, to repurchase shares of common stock at prices and in amounts to comply with Rule 10b-18 under the Exchange Act. The funds available to CAH after the consummation of the transactions, up to $150 million, will be used to initially implement Cullen Agritech’s business model. If less than $150 million is available to Cullen Agritech, the business model will be initially implemented to such lesser extent and Cullen Agritech would attempt to raise additional capital from other sources. If a significant amount of the trust fund proceeds are used to purchase Public Shares or for conversions, Cullen Agritech may not have any funds available to implement its business plan. Cullen Agritech has not taken any steps to secure any additional financing or funding and there is no assurance that such financing or funding would be available on terms favorable to Cullen Agritech or at all. If such financing or funding is not available, Cullen Agritech may not be able to implement its business plan to any extent. If Cullen Agritech is unable to obtain such assets in a timely manner or at all due to lack of availability of financing or otherwise, such inability will negatively affect Cullen Agritech’s operating results and its value.

Cullen Agritech may not realize anticipated benefits from its strategic growth plan.

Cullen Agritech will implement a strategic growth plan, which includes a number of initiatives, that it believes are necessary in order to position Cullen Agritech’s business for future success and growth. Over the next several years, these initiatives will require investments in people, systems, tools and facilities. Cullen Agritech’s success and earnings growth depends in part on Cullen Agritech’s ability to maintain budgeted costs and efficiencies. If Cullen Agritech is unable to successfully implement these initiatives, or fails to implement them as timely as anticipated, Cullen Agritech’s results of operations could be adversely impacted.

Cullen Agritech’s business will be subject to various environmental laws, which may increase Cullen Agritech’s compliance costs.

Cullen Agritech’s business operations will be subject to various environmental and governmental regulations. These laws and regulations cover the discharge of pollutants, wastewater, and hazardous materials into the environment. In addition, various laws and regulations addressing climate change are being considered or implemented at the federal and state levels. New legislation, as well as current federal and other state regulatory initiatives, relating to these environmental matters could require Cullen Agritech to replace equipment,

TABLE OF CONTENTS

install additional pollution controls, purchase various emission allowances or curtail operations. These costs could adversely affect CAH’s results of operations and financial condition.

Cullen Agritech’s operations will be subject to numerous laws and regulations, exposing it to potential claims and compliance costs that could adversely affect its business.

Cullen Agritech will be subject to Federal, state and local laws and regulations relating to the manufacturing, labeling, packaging, health and safety, sanitation, quality control, fair trade practices, and other aspects of its business. In addition, zoning, construction and operating permits are required from governmental agencies which focus on issues such as land use, environmental protection, waste management, and the movement of animals across state lines. These laws and regulations may, in certain instances, affect its ability to develop and market new products and to utilize technological innovations in our business. In addition, changes in these rules might increase the cost of operating Cullen Agritech’s facilities or conducting its business which would adversely affect its finances.

Cullen Agritech’s dairy business will be affected by Federal price support programs and federal and state pooling and pricing programs to support the prices of certain products we sell. Federal and certain state regulations help ensure that the supply of raw milk flows in priority to fluid milk and soft cream producers before producers of hard products such as cheese and butter. If any of these programs was no longer available to Cullen Agritech, the prices it pays for milk could increase and reduce its profitability.

Several states also have laws that restrict the ability of corporations to engage in farming activities. These regulations may require Cullen Agritech to alter or restrict its operations or cause it to incur additional costs in order to comply with the regulations.

Inability to protect Cullen Agritech’s trademarks and other proprietary rights could damage its competitive position.

Cullen Agritech will acquire certain intellectual property pursuant to the Deed of Acknowledgement Relating to Intellectual Property (the “IP Transfer Agreement”, as described in more detail in the section titled “Business of Cullen Agritech — Intellectual Property” on page 136) upon completion of the Merger. Cullen Agritech will rely on licenses, copyrights, trademarks, trade secrets, know-how confidentiality provisions and licensing arrangements to establish and protect its intellectual property and may rely on patents to further protect its licensors and intellectual property in the future. Any infringement or misappropriation of Cullen Agritech’s intellectual property could damage its value and could limit its ability to compete. Cullen Agritech may have to engage in litigation to protect its rights to intellectual property, which could result in significant litigation costs and require a significant amount of management’s time.

Cullen Agritech believes that the know-how associated with Cullen Agritech’s farming systems for the production of raw milk are trade secrets. In addition, Cullen Agritech has amassed a large body of knowledge regarding animal nutrition and pasture-based farming which it believes to be proprietary. Because most of this proprietary information is not patented, it may be more difficult to protect. Cullen Agritech relies on security procedures and confidentiality agreements to protect this proprietary information, however such agreements and security procedures may be insufficient to keep others from acquiring this information. Any such dissemination or misappropriation of this information could deprive Cullen Agritech of the value of its proprietary information and negatively affect its results.

Cullen Agritech’s proprietary farming system could be replicated creating additional competition in the grass-fed dairy industry.

Despite Cullen Agritech’s first mover advantage and the substantial amount of research and development that it believes would be required to replicate its farming system, it is possible that other producers could replicate Cullen Agritech’s model with a certain degree of success. This could put Cullen Agritech’s market share and competitive advantages at risk.

The efficiencies of Cullen Agritech’s farming system may not be scalable.

Cullen Agritech’s farming system has only been tested on a farm which is smaller than those farms it is expecting to roll-out in the future. If its system is not as efficient on a larger scale, this could impair Cullen Agritech’s ability to implement its strategic plan and negatively affects its operating results.

TABLE OF CONTENTS

Key assets such as land, livestock and infrastructure could increase in price, reducing the ability to roll-out farms under the current budgeted capital requirements.

An increase in the cost of Cullen Agritech’s key capital items such as land, livestock and infrastructure could reduce Cullen Agritech’s ability to roll-out farms with its planned amount of capital. Key assets may increase substantially in price and additional capital may not be available to Cullen Agritech on acceptable terms when needed.

The price of land could decrease, reducing the underlying asset value of the business.

Cullen Agritech’s current business plan involves buying land assets. If these assets were to be acquired and then the value of these assets decrease, this could reduce the strength of Cullen Agritech’s balance sheet in the future and affect its ability to obtain additional capital and implement its business plan.

Cullen Agritech may establish and maintain relationships with only a small number of co-operatives for the collection and processing of its raw milk.

The dairy processing industry is made up of a number of co-operatives that collect and process all raw milk produced at farms. Cullen Agritech’s business plan anticipates that it will establish and maintain relationships with co-operatives for the collection and processing of its raw milk. It is anticipated that it will not initially, if at all, establish contracts with a large number of different co-operatives, which could expose Cullen Agritech to a customer concentration risk.

Milk and corn price volatility could reduce revenues and negatively affect Cullen Agritech’s results of operations.

If the price of milk decreased to that which is substantially lower than expected, this could result in a material reduction in Cullen Agritech’s revenues and negatively affect Cullen Agritech’s results of operations.

Cullen Agritech’s feeding strategy will utilize a certain proportion of other feedstocks, some of which are corn-based, the price of which fluctuates according to the price of corn. If corn prices were to rise significantly, Cullen Agritech could experience a material reduction in its operating margins.

Raw milk production is influenced by a number of factors that are beyond Cullen Agritech’s control, such factors may have a material adverse effect on Cullen Agritech’s business.

Raw milk production is influenced by a number of factors that are beyond Cullen Agritech’s control, including, not limited to, the following:

Such factors could have a material adverse effect on Cullen Agritech’s business.

The milk production business is highly competitive and, therefore, Cullen Agritech faces substantial competition in connection with the sale of its products.

Cullen Agritech faces competition from other milk producers across the U.S. Most of Cullen Agritech’s competitors are well established, have greater financial, marketing, personnel and other resources, have been in business for longer periods of time than Cullen Agritech has, and have products that have gained wide

TABLE OF CONTENTS

customer acceptance in the marketplace. Cullen Agritech may be unable to compete successfully or its competitors may develop products which have superior qualities or gain wider market acceptance than Cullen Agritech’s.

Large-scale disease could harm a significant portion of Cullen Agritech’s livestock, reducing its ability to produce revenue.

The productivity and profitability of Natural Dairy’s businesses depend on animal and crop health and on disease control. Natural Dairy will face the risk of outbreaks of BSE (bovine spongiform encephalopathy) which could lead to decreased milk and livestock sales and increased costs to produce its products. There have been three confirmed cases as having BSE in the United States in Washington, Alabama and Texas. Various countries have halted the import of U.S. fed beef in response to the discovery of BSE in the U.S. marketplace. In response to the discovery of BSE in the U.S. marketplace, the USDA has increased testing requirements for cows and is exploring additional inspection requirements which could increase the cost of production of dairy products. The discovery of additional cases of BSE could lead to widespread destruction of dairy cows, could cause consumer demand for dairy products to decrease and could result in increased inspection costs and procedures as well as reduce revenues from the sale of livestock. If this occurs, Natural Dairy could have decreased production and sales of its dairy products due to decreased consumer demand or decreased milk supply and decreased operating margins as a result of increased dairy production costs.

Natural Dairy will face the risk of outbreaks of foot-and-mouth disease, which could lead to a significant destruction of cloven-hoofed animals such as dairy cattle, beef cattle, swine, sheep and goats and significantly reduce the demand for meat products. Because foot-and-mouth disease is highly contagious and destructive to susceptible livestock, any outbreak of foot-and-mouth disease could result in the widespread destruction of all potentially infected livestock. If this happens, Natural Dairy could also have difficulty procuring the livestock it needs for its dairy operations and incur increased cost to produce its dairy products, which could reduce its production, sales and operating margins.

Cullen Agritech’s ability to produce revenue will be dependent on the continual survival and health of Natural Dairy’s livestock. If a significant number of Natural Dairy’s livestock died or were infected with a disease, Natural Dairy’s ability to produce revenue form the sale of milk would be reduced.

Cullen Agritech’s results of operations will fluctuate by season and will be affected by weather conditions.

Any adverse or major deviations from the typical weather conditions expected in a region could negatively impact Cullen Agritech’s ability to produce revenue under Cullen Agritech’s current strategy. In addition, severe weather conditions and natural disasters, such as floods, droughts, frosts or earthquakes, or adverse growing conditions, diseases and insect-infestation problems may reduce the quantity and quality of its milk production. For example, dairy cows produce less milk when subjected to extreme weather conditions, including hot and cold temperatures. A significant reduction in the quantity or quality of milk produced due to adverse weather conditions, disease, insect problems or other factors could result in increased processing costs and decreased production, with adverse financial consequences to Cullen Agritech.

A change in the water availability may negatively impact the efficiency of the business model.

The success of Cullen Agritech’s farming system is dependent on the availability of water to successfully grow forage. If there was a reduction in water availability on a farm subsequent to acquiring and converting that property, due to drought, contamination or otherwise, Cullen Agritech’s ability to produce milk on that farm could be negatively affected.

Cullen Agritech will depend upon its key personnel and its ability to retain and recruit additional qualified personnel to implement its business strategy. The loss of such key personnel or the inability to retain or recruit qualified personnel in the future could have a material adverse impact on the implementation of the business strategy.

Cullen Agritech’s success will depend largely on its ability to attract, develop, motivate and retain highly skilled professionals. It will rely upon the efforts and abilities of Dr. Richard H. Watson, its Chief Scientific Officer, as well as the members of its Advisory Board, to successfully implement and build its large-scale

TABLE OF CONTENTS

farming operation and consulting business. The loss or unavailability of Dr. Watson or the inability to train and retain additional qualified personnel and advisory board members for any significant period of time or at all would have a material adverse effect on the business, prospects, financial condition and results of operations.

Cullen Agritech may be unable to develop and implement a marketing strategy for its advisory and consulting services, which may have a material adverse effect on its business.

Cullen Agritech does not have any long-term agreements with clients for the provision of advisory and consulting services it intends to offer. Although Cullen Agritech has not included consulting revenues in its forecasts, the success of its business will depend in part on its ability to secure advisory clients. If Cullen Agritech is unable to secure advisory clients due to ineffective marketing, because of an economic downturn decreasing the demand for outsourced professional services or otherwise, Cullen Agritech’s business is likely to be materially adversely affected.

Inability to obtain required import permits could reduce the ability of Cullen Agritech to achieve certain long term operating efficiencies.

Cullen Agritech’s business plan includes the potential future requirement for importation of certain farm products, technologies or animal products into the US as well as movement of these products or technologies between States within the US. The importation of Agritech products from New Zealand into the US is subject to various regulatory and licensing restrictions including but not limited to those imposed by the US Customs Service; the United States International Trade Commission; the United States Department of Agriculture; the Food and Drug Administration; the Animal & Plant Health Inspection Service; the Farm Service Agency; the Environmental Protection Agency and the Occupational Health & Safety Administration. Cullen Agritech might also be exposed to certain quota limitations. Specifically, for animal products including semen and embryos, the US Federal Law requires that the USDA Animal and Plant Health Inspection Service (APHIS) issue a permit. The current regulatory environment in the US in regards to importation of Agritech products from New Zealand could change sometime in the future. As such, it is possible that Cullen Agritech might be unable to obtain such permits or its activities will be limited by an inability to comply with the required regulatory and licensing restrictions. This could limit the ability for it to achieve its financial forecasts.

A forage-based strategy could result in reduced production in the winter months.

Due to the reliance on forage as a primary feed source, the colder winter months could reduce forage growth and therefore reduce feed availability for the farm’s livestock. This could result in either the requirement to increase the use of supplemental feed or reduced milk production. This could negatively impact Cullen Agritech’s ability to produce milk or maintain expected operating margins.

Risks Related to Triplecrown and the Merger and the Securities of CAH Following the Merger

If Triplecrown is unable to effect a business combination and is forced to liquidate, its warrants will expire worthless.

If Triplecrown does not complete the merger or another business combination by October 22, 2009, its amended and restated certificate of incorporation provides that its corporate existence will automatically terminate and it will distribute to all holders of Public Shares, in proportion to the number of Public Shares held by them, an aggregate sum equal to the amount in the trust fund, inclusive of any interest, plus any remaining net assets. In such event, there will be no distribution with respect to Triplecrown’s outstanding warrants. Accordingly, the warrants will expire worthless.

If Triplecrown is forced to liquidate, Triplecrown’s stockholders may be held liable for claims by third parties against Triplecrown to the extent of distributions received by them.

Triplecrown’s amended and restated certificate of incorporation provides that Triplecrown will continue in existence only until October 22, 2009. If Triplecrown has not completed a business combination by such date and amended this provision in connection thereto, pursuant to the DGCL, its corporate existence will cease except for the purposes of winding up its affairs and liquidating. Under Sections 280 through 282 of the

TABLE OF CONTENTS

DGCL, stockholders may be held liable for claims by third parties against a corporation to the extent of distributions received by them in a dissolution. If the corporation complies with certain procedures set forth in Section 280 of the DGCL intended to ensure that it makes reasonable provision for all claims against it, including a 60-day notice period during which any third-party claims can be brought against the corporation, a 90-day period during which the corporation may reject any claims brought, and an additional 150-day waiting period before any liquidating distributions are made to stockholders, any liability of stockholders with respect to a liquidating distribution is limited to the lesser of such stockholder’s pro rata share of the claim or the amount distributed to the stockholder, and any liability of the stockholder would be barred after the third anniversary of the dissolution. However, it is Triplecrown’s intention to make liquidating distributions to its stockholders prior to December 31, 2009 and, therefore, it does not intend to comply with those procedures.

Because Triplecrown will not be complying with those procedures, it is required, pursuant to Section 281 of the DGCL, to adopt a plan that will provide for its payment, based on facts known to it at such time, of (i) all existing claims, (ii) all pending claims and (iii) all claims that may be potentially brought against it within the subsequent 10 years. Accordingly, Triplecrown would be required to provide for any creditors known to it at that time or those that it believes could be potentially brought against it within the subsequent 10 years prior to distributing the funds held in the trust to stockholders. Triplecrown cannot assure you that it will properly assess all claims that may be potentially brought against it. As such, Triplecrown’s stockholders could potentially be liable for any claims to the extent of distributions received by them (but no more) and any liability of Triplecrown’s stockholders may extend well beyond the third anniversary of such date. Accordingly, there can be no assurance that third parties will not seek to recover from Triplecrown’s stockholders amounts owed to them by Triplecrown.

If Triplecrown is forced to file a bankruptcy case or an involuntary bankruptcy case is filed against it which is not dismissed, any distributions received by stockholders could be viewed under applicable debtor/creditor and/or bankruptcy laws as either a “preferential transfer” or a “fraudulent conveyance.” As a result, a bankruptcy court could seek to recover all amounts received by Triplecrown’s stockholders. Furthermore, because Triplecrown intends to distribute the proceeds held in the trust fund to its public stockholders promptly after October 22, 2009 if it has not completed a business combination by such date, this may be viewed or interpreted as giving preference to Triplecrown’s public stockholders over any potential creditors with respect to access to or distributions from Triplecrown’s assets. Furthermore, Triplecrown’s board may be viewed as having breached their fiduciary duties to Triplecrown’s creditors and/or may have acted in bad faith; thereby exposing itself and Triplecrown to claims of punitive damages, by paying public stockholders from the trust fund prior to addressing the claims of creditors. There can be no assurance that claims will not be brought against Triplecrown for these reasons.

You will not be able to exercise your warrants if an effective registration statement is not in place when you desire to do so.

None of the warrants issued by CAH to the public holders of Triplecrown warrants will be exercisable and CAH will not be obligated to issue shares of common stock unless, at the time a holder seeks to exercise such public warrant, a prospectus relating to the common stock issuable upon exercise of the warrant is current. Under the terms of the warrant agreement, CAH will be required to use its best efforts to meet these conditions and to maintain a current prospectus relating to the shares of common stock issuable upon exercise of the warrants until the expiration of the warrants. However, there can be no assurance that CAH will be able to do so, and if it does not maintain a current prospectus related to the shares of common stock issuable upon exercise of the warrants, holders will be unable to exercise their warrants. Additionally, CAH will have no obligation to settle the warrants for cash or “net cash settle” any warrant exercise. Accordingly, if the prospectus relating to the common stock issuable upon the exercise of the warrants is not current, the warrants may have no value, the market for the warrants may be limited and the warrants may expire worthless. If the warrants expire worthless, this would mean that a person who paid $10.00 for a unit in Triplecrown’s IPO and who did not sell the warrant included in the unit would have effectively paid $10.00 for one share of CAH common stock.

TABLE OF CONTENTS

An investor will only be able to exercise a warrant if the issuance of CAH shares of common stock upon such exercise has been registered or qualified or is deemed exempt under the securities laws of the state of residence of the holder of the warrants.

None of the warrants issued by CAH to the holders of Triplecrown warrants will be exercisable and CAH will not be obligated to issue shares of common stock unless the shares of common stock issuable upon such exercise have been registered or qualified or deemed to be exempt under the securities laws of the state of residence of the holder of the warrants. At the time that the warrants become exercisable (following completion of the merger), CAH expects to become listed on the New York Stock Exchange or NASDAQ, which would provide an exemption from registration in every state. Accordingly, CAH believes holders in every state will be able to exercise their warrants as long as its prospectus relating to the shares of common stock issuable upon exercise of the warrants is current. However, there can be no assurance of this fact. If a warrant holder is unable to exercise his warrants in a particular state, he may be forced to sell his warrant and therefore lose the benefit of purchasing CAH stock. Furthermore, the price he receives for his warrant may not equal the difference between the exercise price and the stock price.

CAH’s warrants may be exercised in the future, which would increase the number of shares eligible for future resale in the public market.

Following consummation of the merger, outstanding warrants to purchase an aggregate of 55,200,000 shares of CAH common stock (issued in exchange for Triplecrown warrants issued in the IPO), warrants to purchase an aggregate of 13,800,000 shares of common stock (issued in exchange for the Founders’ Warrants) and 5,000,000 shares of common stock (issued in exchange for the warrants sold to the Triplecrown Founders simultaneously with the consummation of the IPO (“Sponsors’ Warrants”)) will become exercisable after the consummation of the merger. To the extent such warrants are exercised, additional shares of CAH common stock will be issued, which would dilute the ownership of existing stockholders.

Triplecrown’s stockholders will experience immediate dilution as a consequence of the issuance of common stock as consideration in the merger.

CAH will issue 15,881,148 shares of common stock at the closing of the merger to Cullen Holdings. As a result, holders of Triplecrown common stock will experience immediate dilution as a consequence. The ability of the former Triplecrown stockholders following the merger to influence management of CAH through the election of directors will be reduced as a result of this dilution.

Eric J. Watson will effectively control CAH following consummation of the transactions contemplated by this proxy statement/prospectus.

Upon consummation of this offering, Eric Watson will beneficially own 15,881,148 shares of CAH common stock and will effectively control CAH through such ownership. Because of this ownership, he will be able to have considerable influence over CAH’s corporate actions following the successful consummation of the transactions contemplated by this proxy statement/prospectus.

If Triplecrown stockholders fail to vote against the merger proposal and fail to deliver their shares in accordance with the conversion requirements specified in this proxy statement/prospectus, they will not be entitled to convert their shares of common stock of Triplecrown into a pro rata portion of the trust account.

Triplecrown stockholders holding Public Shares who affirmatively vote against the merger proposal may demand that Triplecrown convert their shares into a pro rata portion of the trust account, calculated as of two business days prior to the anticipated consummation of the merger. Triplecrown stockholders who seek to exercise this conversion right must affirmatively vote against the merger and deliver their stock (either physically or electronically) to Triplecrown’s transfer agent prior to the vote at the meeting. Any Triplecrown stockholder who fails to vote against the merger proposal and who fails to deliver his or her stock will not be entitled to convert his or her shares into a pro rata portion of the trust account for conversion of his or her shares. See the section entitled “The Merger Proposal — Conversion Rights” for the procedures to be followed if you wish to convert your shares to cash.

TABLE OF CONTENTS

Triplecrown’s ability to request indemnification from Cullen Holdings for damages arising out of the merger is limited to those claims where damages exceed $500,000 and is also limited to the shares of CAH’s common stock placed in escrow.

To provide a fund to secure the indemnification obligations of Cullen Holdings to Triplecrown against losses that the surviving entity of the merger may sustain as a result of (i) the inaccuracy or breach of any representation or warranty made by Cullen Agritech in the merger agreement or any schedule or certificate delivered by it in connection with the merger agreement and (ii) the non-fulfillment or breach of any covenant or agreement made by Cullen Agritech in the merger agreement, an aggregate of 10% of the initial shares to be issued in the merger (1,588,114 shares of CAH common stock) will be placed in escrow (with an independent escrow agent), which will be canceled to the extent that Triplecrown has damages for which it is entitled to indemnification. The escrow will be the sole remedy for Triplecrown for its rights to indemnification pursuant to the merger agreement. Claims for indemnification may be asserted against the escrow by Triplecrown once its damages exceed a deductible and will be reimbursable to the full extent of the damages in excess of such amount up to a maximum of the escrowed shares. Triplecrown may assert claims for indemnification until the 30^th day after the date CAH has filed with the SEC its Annual Report on Form 10-K for the year ending December 31, 2010 (but in any event no later than April 16, 2011). As a consequence of these limitations, Triplecrown may not be able to be entirely compensated for indemnifiable damages that it may sustain.

The New York Stock Exchange or NASDAQ may not list CAH’s securities on its exchange, which could limit investors’ ability to make transactions in CAH’s securities and subject CAH to additional trading restrictions.

CAH will seek listing of its common stock and warrants on the New York Stock Exchange or NASDAQ as soon as practicable in connection with the merger. CAH will be required to meet the initial listing requirements to be listed. CAH may not be able to meet those initial listing requirements. Even if such application is accepted and CAH’s securities are so listed, CAH may be unable to maintain the listing of its securities in the future.

If either the New York Stock Exchange or NASDAQ do not list CAH’s securities for trading on its exchange, CAH could face significant material adverse consequences, including:

CAH’s stock price could fluctuate and could cause you to lose a significant part of your investment.

Following consummation of the merger, the market price of CAH’s securities may be influenced by many factors, some of which are beyond its control, including those described above and the following:

TABLE OF CONTENTS

Future sales of CAH’s common stock may cause the market price of its securities to drop significantly, even if its business is doing well.

In accordance with the lock up agreement executed on September 4, 2009, Cullen Holdings will be able to sell the shares of common stock of CAH it receives in the merger beginning on the first anniversary of the consummation of the merger. In addition, the Triplecrown Founders will be entitled to demand that CAH register the resale of its securities at any time generally commencing nine months after the consummation of the merger. In accordance with SEC regulations, the Triplecrown Founders will not be able to sell any of the CAH securities they receive in exchange for their Triplecrown securities until the first anniversary of the consummation of the merger, subject to certain exceptions. The presence of these additional securities trading in the public market may have an adverse effect on the market price of CAH’s securities. The sale by any of the foregoing, or entities they control or their permitted transferees, could cause the market price of CAH’s securities to decline.

CAH may apply the net proceeds released from the trust account in a manner that does not improve its results of operations or increase the value of your investment.

At the closing of the merger, the funds in Triplecrown’s trust account will be released to pay approximately $4 million to $6 million of transaction fees and expenses, up to approximately $7 million for the balance of the purchase price for the land to be used by CAH following consummation of the merger, up to approximately $19.3 million of deferred underwriting discounts and commissions, as well as tax liabilities, if any, and approximately $150,000 to $250,000 of reimbursement of expenses of the Triplecrown Founders and to make purchases of Public Shares, if any. The balance of the funds will be released to CAH to pay Triplecrown stockholders who properly exercise their conversion rights and for working capital and general corporate purposes of CAH and Cullen Agritech. Although Cullen Agritech would need approximately $400 million to fully implement its business plan, Cullen Agritech anticipates initially implementing its business plan with only $150 million immediately after the consummation of the transactions contemplated by this proxy statement/prospectus. Accordingly, if CAH has access to more than $150 million after closing of the merger, CAH intends to use such funds, depending on market conditions, to repurchase shares of common stock. Other than these uses, CAH does not have specific plans for the funds and will have broad discretion regarding how it uses such funds. These funds could be used in a manner with which you may not agree or applied in ways that do not improve CAH’s results of operations or increase the value of your investment.

Triplecrown’s current directors and executive officers own securities of Triplecrown that will be worthless if the merger is not approved. Such interests may have influenced their decision to approve the business combination with CAH.

Triplecrown’s Founders beneficially own Founders’ Units that they purchased prior to its IPO and 5,000,000 Sponsors’ Warrants they purchased in a private placement that occurred simultaneously with Triplecrown’s IPO. Such persons are not entitled to receive any of the cash proceeds that may be distributed upon Triplecrown’s liquidation with respect to shares they acquired prior to its IPO. Therefore, if the merger is not approved and Triplecrown does not consummate another business combination by October 22, 2009 and is forced to liquidate, such Founders’ Units and Sponsors’ Warrants held by such persons will be worthless. As of September 30, 2009, the record date for the special meetings, Triplecrown’s Founders held $134,550,000 in units (based on a market price of $9.75) and $450,000 in warrants (based on a market price of $0.09). The Triplecrown Founders have agreed to contribute an aggregate of 11,260,000 of the 13,800,000 the Founders’ Shares to Triplecrown for cancellation. Furthermore, Eric J. Watson is the chief executive officer of Cullen Agritech and controls Cullen Holdings. As a result, he will benefit to the extent of the 15,881,148 shares being received by Cullen Holdings in the merger. See the section entitled “The Merger Proposal — Interests of Triplecrown’s Directors and Officers and Others in the Merger.”

TABLE OF CONTENTS

These financial interests of Triplecrown’s Founders may have influenced their decision to approve Triplecrown’s merger with CAH and to continue to pursue the merger. In considering the recommendations of Triplecrown’s board of directors to vote for the merger proposal and other proposals, you should consider these interests.

Triplecrown’s chairman and president are liable to ensure that proceeds of the trust are not reduced by vendor claims in the event the merger is not consummated. Such liability may have influenced their decision to approve the merger with CAH.

If Triplecrown liquidates prior to the consummation of a business combination, Eric J. Watson, Triplecrown’s chairman and treasurer, and Jonathan J. Ledecky, Triplecrown’s president and secretary, will be personally liable to ensure that the proceeds in the trust account are not reduced by the claims of target businesses or claims of vendors or other entities that are owed money by Triplecrown for services rendered or contracted for or products sold to Triplecrown, but only if such entities did not execute a waiver. On the other hand, if Triplecrown consummates the merger, CAH will be liable for all such claims. Neither Triplecrown nor Messrs. Watson and Ledecky has any reason to believe that Messrs. Watson and Ledecky will not be able to fulfill their indemnity obligations to Triplecrown if required to do so.

Additionally, if Triplecrown is required to be liquidated and there are no funds remaining to pay the costs associated with the implementation and completion of such liquidation, Messrs. Watson and Ledecky have agreed to advance Triplecrown the funds necessary to pay such costs and complete such liquidation (currently anticipated to be no more than approximately $15,000) and not to seek repayment for such expenses. If Triplecrown consummates the merger, Messrs. Watson and Ledecky will no longer be responsible for such expenses. See the section entitled “Other Information Related to Triplecrown —  Liquidation if No Business Combination” for further information.

These personal obligations may have influenced Messrs. Watson’s and Ledecky’s decision to approve Triplecrown’s merger with CAH and to continue to pursue the merger. In considering the recommendations of Triplecrown’s board of directors to vote for the merger proposal and other proposals, you should consider these interests.

The fairness opinion Triplecrown received relied upon certain assumptions, including that Cullen Agritech had access to the capital it needed to implement its business plan, some of which may not be correct. If the assumptions are incorrect, Cullen Agritech may not be worth as much as such valuation supposes.

In connection with its determination to approve the transactions contemplated by this proxy statement/prospectus, Triplecrown’s board of directors engaged Duff & Phelps to provide it with a “fairness opinion” on which the board relied. The purpose of the fairness opinion was to determine whether the valuation of Cullen Agritech negotiated between Triplecrown and Cullen Agritech is fair, from a financial point of view, to Triplecrown. In coming to a valuation range for Cullen Agritech, Duff & Phelps relied upon certain assumptions, including that Cullen Agritech would have access to the capital it needed to implement its business plan, regardless of whether such capital was from Triplecrown’s trust account or from separate funding from third parties. As a result of purchases of Public Shares and holders of Public Shares exercising their conversion rights, Cullen Agritech may not have access to all the capital it needs from the consummation of our transaction. Cullen Agritech has not taken any steps to secure any additional financing or funding and there is no assurance that such financing or funding would be available on terms favorable to Cullen Agritech or at all. Accordingly, if Cullen Agritech does not have access to capital as required, or any other assumption relied upon by Duff & Phelps proves to be incorrect, Cullen Agritech could be worth significantly less than the value that Duff & Phelps placed on it.

The fairness opinion Triplecrown received did not indicate whether the valuation of Cullen Agritech negotiated between Triplecrown and Cullen Agritech was fair, from a financial point of view, to the unaffiliated stockholders of Triplecrown.

In connection with its determination to approve the transactions contemplated by this proxy statement/prospectus, Triplecrown’s board of directors engaged Duff & Phelps to provide it with a “fairness opinion” on which the board relied. The purpose of the fairness opinion was to determine whether the valuation of Cullen Agritech negotiated between Triplecrown and Cullen Agritech is fair, from a financial point of

TABLE OF CONTENTS

view, to Triplecrown. However, Duff & Phelps was not asked to address whether such valuation was fair, from a financial point of view, to the unaffiliated stockholders of Triplecrown. Accordingly, such opinion may not be as informative as an opinion which specifically addressed the fairness to unaffiliated stockholders.

If the merger is completed, a large portion of the funds in the trust account established by Triplecrown in connection with its IPO for the benefit of the holders of the Public Shares may be used to pay converting stockholders or for the purchase, directly or indirectly, of Public Shares. As a consequence, if the merger is completed, such funds will not be available to CAH for working capital and general corporate purposes and the number of beneficial holders of Triplecrown’s and CAH’s securities may be reduced to a number that may preclude the quotation, trading or listing of CAH’s securities other than on the Over-the-Counter Bulletin Board.

Pursuant to Triplecrown’s amended and restated certificate of incorporation, holders of Public Shares may vote against the merger proposal and demand that Triplecrown convert their shares, calculated as of two business days prior to the anticipated consummation of the merger, into a pro rata share of the trust account where a substantial portion of the net proceeds of the IPO are held. Triplecrown will not consummate the merger if holders of 16,559,999 or more Public Shares exercise these conversion rights. Furthermore, a large portion of the funds in the trust account may be used to acquire Public Shares, either from holders thereof who vote against the merger proposal and elect to convert their shares into cash or from holders thereof who have indicated their intention to do so but first sell their shares to CAH, Triplecrown or their affiliates so that such shares will be voted in favor of the merger proposal. As a consequence of such purchases,

It is possible that the parties could use all of the funds held in Triplecrown’s trust account to make purchases (and for conversions) and the parties could consummate the mergers contemplated by this proxy statement/prospectus leaving CAH with no funds for additional working capital.

The Triplecrown Founders, Cullen Holdings and their respective affiliates may engage in transactions that provide inducements to certain holders of Public Shares to vote in favor of the merger proposal or acquire additional Public Shares and therefore such transactions may not be fair to and in the best interests of those holders of Public Shares not receiving such inducements.

The Triplecrown Founders, Cullen Holdings and their respective affiliates may engage in transactions that provide inducements to certain holders of Public Shares to vote in favor of the merger proposal or acquire additional Public Shares. These transactions may not be fair to and in the best interests of those stockholders who will not be offered or receive any such inducements.

Persons who purchased Public Shares in the IPO may have rights to rescind their purchases and assert a claim for damages therefor against CAH, its directors and officers and the former directors and officers of Triplecrown.

Triplecrown’s amended and restated certificate of incorporation and IPO prospectus require Triplecrown to complete a business combination in which it acquires a target business operating in the financial services industry having a fair market value equal to at least 80% of Triplecrown’s trust account balance (excluding deferred underwriting discounts and commissions) and resulting in the ownership of 50% or more of the voting securities of the target business and prohibit Triplecrown from consummating a business combination with a target business affiliated with any of the Triplecrown Founders. Furthermore, Triplecrown’s IPO prospectus did not disclose that funds in its trust account might be used, directly or indirectly, to purchase Public Shares from holders who have indicated their intention to vote against the merger and seek conversion of their shares to cash (as Triplecrown may contemplate doing). Also, Triplecrown’s IPO prospectus stated that specific provisions in Triplecrown’s amended and restated certificate of incorporation may not be amended prior to the

TABLE OF CONTENTS

consummation of an initial business combination but that Triplecrown had been advised that such provision limiting its ability to amend its amended and restated certificate of incorporation may not be enforceable under Delaware law. Consequently, any person who purchased Public Shares in the IPO and still held such shares upon learning of these facts may seek rescission of the purchase of the units he acquired in the IPO (under which a successful claimant has the right to receive the total amount paid for his or her securities pursuant to an allegedly deficient prospectus, plus interest and less any income earned on the securities, in exchange for surrender of the securities) or bring an action for damages (compensation for loss on an investment caused by alleged material misrepresentations or omissions in the sale of a security). Any holder of Public Shares who votes against the merger proposal and converts Public Shares into cash upon consummation of the merger will no longer own any stock in Triplecrown and therefore will not have any claim for rescission.

TABLE OF CONTENTS

FORWARD-LOOKING STATEMENTS

The statements contained in this proxy statement/prospectus that are not purely historical are forward-looking statements. You can identify these statements by forward-looking words such as “may,” “expect,” “anticipate,” “contemplate,” “believe,” “estimate,” “intends,” and “continue” or similar words. You should read statements that contain these words carefully because they:

Triplecrown, CAH and Cullen Agritech believe it is important to communicate their expectations to their stockholders. However, there may be events in the future that they are not able to predict accurately or over which they have no control. The risk factors and cautionary language discussed in this proxy statement/prospectus provide examples of risks, uncertainties and events that may cause actual results to differ materially from the expectations described by Triplecrown, CAH or Cullen Agritech in such forward-looking statements, including among other things:

Should one or more of these risks or uncertainties materialize, or should any of the underlying assumptions prove incorrect, actual results may vary in material respects from those expressed or implied by these forward-looking statements.

You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this proxy statement/prospectus.

All forward-looking statements included herein attributable to any of Triplecrown, CAH, Cullen Agritech or any person acting on such parties behalf are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. Except to the extent required by applicable laws and regulations, Triplecrown and CAH undertake no obligations to update these forward-looking statements to reflect events or circumstances after the date of this proxy statement/prospectus or to reflect the occurrence of unanticipated events.

Before you grant your proxy or instruct how your vote should be cast or vote on the merger proposal or any of the other proposals, you should be aware that the occurrence of the events described in the “Risk Factors” section and elsewhere in this proxy statement/prospectus may adversely affect Triplecrown, CAH and/or Cullen Agritech.

TABLE OF CONTENTS

INTERESTS OF TRIPLECROWN’S DIRECTORS AND OFFICERS
AND OTHERS IN THE MERGER

In considering the recommendation of the board of directors of Triplecrown to vote for the proposal to approve the merger proposal, you should be aware that Triplecrown’s directors and officers have agreements or arrangements that provide them with interests in the merger that differ from, or are in addition to, those of Triplecrown stockholders generally. In particular:

TABLE OF CONTENTS

Under the terms of the underwriting agreement executed in connection with Triplecrown’s IPO, Triplecrown would be required to pay the underwriters $19,320,000 of deferred underwriting discounts and commissions upon consummation of an “initial business combination” (as defined therein). Triplecrown is currently in negotiations with its underwriters with respect to the fee payable to them upon consummation of the merger. No agreement has been reached as of the date hereof. Additionally, Petrina Advisors and Miles Leahy, two consultants for Triplecrown, will receive an aggregate of 455,000 shares of CAH common stock upon closing of the merger. Such consultants have executed lockup agreements pursuant to which they have agreed that they will not sell any of such shares for a period of two years from the consummation of the transaction. Neither the underwriters nor the consultants will receive any of this consideration if the merger is not consummated.

TABLE OF CONTENTS

SPECIAL MEETINGS OF TRIPLECROWN STOCKHOLDERS AND WARRANTHOLDERS

General

Triplecrown is furnishing this proxy statement/prospectus to its stockholders and warrantholders as part of the solicitation of proxies by its board of directors for use at the special meetings of Triplecrown stockholders and warrantholders to be held on October 21, 2009, and at any adjournment or postponement thereof. This proxy statement/prospectus is first being furnished to Triplecrown stockholders and warrantholders on or about October 13, 2009 in connection with the vote on the proposals described herein. This proxy statement/prospectus provides you with information you need to know to be able to vote or instruct your vote to be cast at the special meetings.

Date, Time and Place

The special meetings of stockholders and warrantholders will be held on October 21, 2009, at 10:00 a.m., eastern time, at the offices of Graubard Miller, Triplecrown’s counsel, at The Chrysler Building, 405 Lexington Avenue, 19th Floor, New York, New York 10174, or such other date, time and place to which such meetings may be adjourned or postponed.

Purpose of the Triplecrown Special Meetings

At the special meeting of stockholders, Triplecrown will ask holders of its common stock to:

TABLE OF CONTENTS

At the special meeting of warrantholders, Triplecrown will ask holders of its warrants to:

Recommendation of Triplecrown Board of Directors

Triplecrown’s board of directors (except for Mr. Watson who abstained from the vote/recommendation due to his relationship with Cullen Agritech) :

You should be aware, however, that the Triplecrown Founders have conflicts of interest in approving the transactions as indicated in the section entitled “Interests of Triplecrown’s Directors and Officers and Others in the Merger” appearing on page 40 of this proxy statement/prospectus.

Record Date; Who is Entitled to Vote

Triplecrown has fixed the close of business on September 30, 2009, as the “record date” for determining Triplecrown stockholders and warrantholders entitled to notice of and to attend and vote at its special meetings. As of the close of business on September 30, 2009, there were 69,000,000 shares of Triplecrown’s common stock outstanding and entitled to vote and 74,000,000 warrants outstanding and entitled to vote. Each share of Triplecrown’s common stock is entitled to one vote per share at the special meeting of stockholders and each warrant is entitled to one vote per warrant at the special meeting of warrantholders.

Pursuant to agreements with Triplecrown, the 13,800,000 Founders’ Shares held by the Triplecrown Founders will be voted on the merger proposal in accordance with the majority of the votes cast at the special meeting of stockholders on such proposal by the holders of the Public Shares. Accordingly, the vote of such shares will not affect the outcome of the vote on the merger proposal.

The Triplecrown Founders have indicated that they intend to vote their Founders’ Shares, Founders’ Warrants and Sponsors’ Warrants in favor of all of the other proposals being presented at the special meetings.

TABLE OF CONTENTS

Quorum

A quorum of stockholders and warrantholders is necessary to hold a valid stockholders’ meeting and warrantholders’ meeting, respectively. The presence, in person or by proxy, of a majority of all the outstanding shares of common stock entitled to vote constitutes a quorum at the special meeting of stockholders. The presence, in person or by proxy, of a majority Triplecrown’s then outstanding warrants constitutes a quorum at the special meeting of warrantholders.

Abstentions and Broker Non-Votes

Proxies that are marked “abstain” and proxies relating to “street name” shares or warrants that are returned to Triplecrown but marked by brokers as “not voted” will be treated as shares or warrants present for purposes of determining the presence of a quorum on all matters. The latter will not be treated as shares or warrants entitled to vote on the matter as to which authority to vote is withheld from the broker. If you do not give the broker voting instructions, under applicable self-regulatory organization rules, your broker may not vote your shares or warrants on “non-routine” proposals, such as the initial charter proposals, the merger proposal, the secondary charter proposals and the warrant amendment proposals. Since a stockholder must affirmatively vote against the merger proposal to have conversion rights, individuals who fail to vote or who abstain from voting may not exercise their conversion rights. See the information set forth in “The Merger Proposal — Conversion Rights.”

Vote of Triplecrown’s Stockholders Required

The approval of the merger proposal will require (i) the affirmative vote of the holders of a majority of Triplecrown common stock outstanding on the record date (more than 50%, or 34,500,000, of the shares outstanding) and (ii) the affirmative vote for the proposal by the holders of a majority of the Public Shares present (in person or represented by proxy) and entitled to vote on the proposal at the special meeting of stockholders (more than 50%, or 27,600,000, of the Public Shares outstanding). Additionally, the merger will not be consummated if the holders of 30% (16,559,999) or more of the Public Shares vote against the merger proposal and properly demand that Triplecrown convert their Public Shares into their pro rata share of the trust account. Abstentions and broker non-votes will have the same effect as a vote “AGAINST” the merger proposal. You cannot seek conversion unless you affirmatively vote against the merger proposal. Additionally, if you seek conversion, you will not be entitled to such appraisal rights. However, voting in favor of the merger proposal would not limit your rights to seek rescission or damages as described in this proxy statement/prospectus. Such rights would not terminate upon consummation of the merger — instead, such rights generally would extend until the expiration of the applicable statute of limitations period, which, for claims made under Section 12 of the Securities Act and some state statutes, is one year from the time the claimant discovered or reasonably should have discovered the facts giving rise to the claim, but not more than three years from the occurrence of the event giving rise to the claim.

Each of the initial charter proposals and secondary charter proposals will require the affirmative vote of the holders of a majority of Triplecrown common stock outstanding on the record date (more than 50%, or 34,500,000, of the shares outstanding). Because these proposals require the affirmative vote of a majority of the shares of common stock outstanding for approval, abstentions and shares not entitled to vote because of a broker non-vote will have the same effect as a vote against these proposals. Additionally, because the Triplecrown Founders intend to vote their Founders’ Shares in favor of each of these proposals, such proposals will require only an additional 30% of the shares, or 20,700,000 shares, held by public stockholders voting in favor of the proposals in order to have them approved.

The approval of the stockholder adjournment proposal will require the affirmative vote of the holders of a majority of Triplecrown’s common stock represented and entitled to vote thereon at the special meeting of stockholders. Abstentions are deemed entitled to vote on such proposal. Therefore, they have the same effect as a vote against the proposal. Broker non-votes are not deemed entitled to vote on such proposals and, therefore, they will have no effect on the vote on such proposal.

The approval of the initial charter proposals, the merger proposal, the secondary charter proposals and the warrant amendment proposals is a condition to the consummation of the merger, although the condition of the approval of the warrant amendment proposals may be waived upon mutual consent of the parties. If any of

TABLE OF CONTENTS

the initial charter proposals, the merger proposal, the secondary charter proposals or warrant amendment proposals is not approved (or in the case of the warrant amendment proposals, waived), the other proposals will not be presented to stockholders and/or warrantholders for a vote and the merger will not be consummated.

Vote of Triplecrown’s Warrantholders Required

The approval of the warrant amendment proposals will require the affirmative vote of the holders of a majority of Triplecrown’s warrants outstanding on the record date (more than 50%, or 37,000,000, of the warrants outstanding). Because these proposals require the affirmative vote of a majority of the warrants outstanding for approval, abstentions and warrants not entitled to vote because of a broker non-vote will have the same effect as a vote against these proposals. Additionally, because the Triplecrown Founders intend to vote their Founders’ Warrants and Sponsors’ Warrants in favor of this proposal, such proposal will require only an additional 23% of the warrants, or 18,200,000 warrants, held by warrantholders voting in favor of the proposals in order to have them approved.

The approval of the warrantholder adjournment proposal will require the affirmative vote of the holders of a majority of Triplecrown’s warrants represented and entitled to vote thereon at the special meeting of warrantholders. Abstentions are deemed entitled to vote on such proposal. Therefore, they have the same effect as a vote against this proposal. Broker non-votes are not deemed entitled to vote on such proposal and, therefore, they will have no effect on the vote on such proposal.

The approval of each of the initial charter proposals, the merger proposal, the secondary charter proposals and the warrant amendment proposals is a condition to the consummation of the merger, although the condition relating to the approval of the warrant amendment proposals may be waived upon mutual consent of Triplecrown and Cullen Agritech. If either the initial charter proposals, the merger proposal or the secondary charter proposals is not approved, none of the proposals will be presented to warrantholders for a vote and the merger will not be consummated.

Voting Your Shares or Warrants

Each share of Triplecrown common stock or warrant of Triplecrown that you own in your name entitles you to one vote at the special meetings of stockholders and warrantholders, respectively. Your proxy card shows the number of shares of Triplecrown’s common stock or warrants that you own. If your shares or warrants are held in “street name” or are in a margin or similar account, you should contact your broker to ensure that votes related to the shares or warrants you beneficially own are properly counted. Votes submitted at any time prior to the meeting will be accepted. However, to ensure that your vote is properly counted and to avoid any problems or unforeseen delays, you should submit your vote as early as possible and prior to midnight on the day before the meeting. After such time, a holder would need to contact his bank, broker or nominee directly to vote or change his vote.

There are two ways to vote your shares of Triplecrown common stock or warrants at the special meetings:

Stockholders and warrantholders who hold their securities in “street name” through a broker or bank will have the option to authorize their proxies to vote their securities electronically through the Internet or by

TABLE OF CONTENTS

telephone. 55,099,700 of the 55,200,000 outstanding Public Shares (99.8%) and all of the 55,200,000 outstanding public warrants (100%) are held in street name. If you hold your securities through a broker, bank or other nominee, you should check your proxy card or voting instruction card forwarded by your broker, bank or other nominee who holds your securities for instructions on how to vote by these methods.

Revoking Your Proxy

If you give a proxy, you may revoke it at any time before it is exercised by doing any one of the following:

Who Can Answer Your Questions About Voting Your Shares or Warrants

If you have any questions about how to vote or direct a vote in respect of your shares of Triplecrown’s common stock or warrants, you may call Morrow & Co., LLC, Triplecrown’s proxy solicitor, at (800) 662-5200, or Jonathan J. Ledecky, Triplecrown’s secretary, at (212) 521-5396.

Proxy Solicitation Costs

Triplecrown is soliciting proxies on behalf of its board of directors. All solicitation costs will be paid by Triplecrown. This solicitation is being made by mail but also may be made by telephone or in person. Triplecrown and its directors, officers and employees may also solicit proxies in person, by telephone or by other electronic means, including email and facsimile.

Triplecrown has hired Morrow & Co., LLC to assist in the proxy solicitation process. It will pay that firm a fee of $15,000 plus disbursements. Such payments will be made from non-trust account funds. If the merger is successfully closed, Triplecrown will pay Morrow & Co., LLC an additional contingent fee of $30,000.

Triplecrown will ask banks, brokers and other institutions, nominees and fiduciaries to forward its proxy materials to their principals and to obtain their authority to execute proxies and voting instructions. Triplecrown will reimburse them for their reasonable expenses.

Triplecrown, CAH, Cullen Agritech and their respective directors and executive officers may be deemed to be participants in the solicitation of proxies.

Triplecrown Founders

As of September 30, 2009, the record date for the Triplecrown special meetings, the Triplecrown Founders beneficially owned and were entitled to vote 13,800,000 Founders’ Shares and 13,800,000 Founders’ Warrants. In connection with Triplecrown’s IPO, Triplecrown and Citigroup entered into agreements with each of the Triplecrown Founders pursuant to which each Triplecrown Founder agreed to vote his, her or its Founders’ Shares on the merger proposal in accordance with the majority of the votes cast by the holders of Public Shares. The Triplecrown Founders have indicated that they intend to vote their Founders’ Shares, Founders’ Warrants and Sponsors’ Warrants in favor of all of the other proposals being presented at the meetings. The Founders’ Shares have no liquidation rights and will be worthless if no business combination is effected by Triplecrown. In connection with the IPO, the Triplecrown Founders placed their Founders’ Shares and Founders’ Warrants in escrow with Continental Stock Transfer & Trust Company and agreed that they would not sell such securities until the earlier of twelve months after a business combination or Triplecrown’s liquidation, subject to earlier release within such twelve month period if (i) Triplecrown’s common stock has a last sales price equal to or exceeding $13.75 per share for any 20 trading days within any 30-trading day period commencing 90 days after the successful consummation of a business combination or (ii) Triplecrown consummates a subsequent liquidation, merger, stock exchange or other similar transaction that results in all of Triplecrown’s stockholders having the right to exchange their shares for cash, securities or other property. If the merger is consummated, the Triplecrown Founders have agreed to cancel 11,260,000 shares of CAH common stock they will receive in exchange for 11,260,000 of the Founders’ Shares.

TABLE OF CONTENTS

From the consummation of the IPO to September 30, 2009, no Triplecrown Founder has purchased any shares of Triplecrown common stock or warrants in the open market. If the Triplecrown Founders believe it would be desirable for them or their affiliates to purchase shares or warrants in advance of the special meetings, such determination would be based on factors such as the likelihood of approval or disapproval of the proposals, the number of shares for which conversion may be requested and the financial resources available to such prospective purchasers. Any additional shares or warrants purchased by the Triplecrown Founders will be voted by them in favor of the merger and the other proposals.

TABLE OF CONTENTS

PROPOSALS TO BE CONSIDERED BY THE TRIPLECROWN STOCKHOLDERS

THE INITIAL CHARTER PROPOSALS

Triplecrown is proposing to amend its amended and restated certificate of incorporation to revise the definition of a “business combination” and to remove the prohibition on Triplecrown consummating a business combination with an entity affiliated with any of the Triplecrown Founders. A “business combination” is defined in Triplecrown’s amended and restated certificate of incorporation as follows:

“A “Business Combination” shall mean the initial acquisition by the Corporation, whether by merger, capital stock exchange, asset or stock acquisition or other similar type of transaction, of one or more operating businesses in the financial services industry (“Target Businesses”), whose collective fair market value is equal to at least 80% of the balance in the Trust Fund (as defined below), excluding deferred underwriting discounts and commissions, and resulting in the ownership by the Corporation of not less than 50% of the voting securities of the Target Business or Businesses.

“Fair market value” for purposes of this Article SEVENTH shall be determined by the Board of Directors of the Corporation based upon financial standards generally accepted by the financial community, such as actual and potential gross margins, the values of comparable businesses, earnings and cash flow, and book value. If the Corporation’s Board of Directors is not able to determine independently that the Target Business or Businesses has a sufficient fair market value to meet the threshold criterion, it will obtain an opinion in that regard from an unaffiliated, independent investment banking firm that is a member of the Financial Industry Regulatory Authority and any successor organization thereto. The Corporation is not required to obtain an opinion from an investment banking firm as to the fair market value of the Target Business or Businesses if its Board of Directors independently determines that the Target Business or Businesses have sufficient fair market value to meet the threshold criterion.”

Additionally, the prohibition on Triplecrown consummating a business combination with an entity affiliated with any of the Triplecrown Founders contained in Triplecrown’s amended and restated certificate of incorporation is stated as follows:

“Unless and until the Corporation has consummated a Business Combination as permitted under this Article SEVENTH, the Corporation may not consummate any other business combination, whether by merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination or transaction or otherwise. The Corporation will not enter into a Business Combination with any entity which is affiliated with any of its officers, directors, initial stockholders or sponsors or any entity that has received a material financial investment from its initial stockholders or sponsors or any entity affiliated with our officers, directors, initial stockholders or sponsors.”

Because (i) the sole stockholder of CAH is controlled by Eric J. Watson, Triplecrown’s chairman of the board and treasurer, (ii) Triplecrown will ultimately be acquired by CAH and therefore not acquire at least 50% of the voting securities of the target business, (iii) Cullen Agritech is not an operating business in the financial services industry and (iv) the fair market value of Cullen Agritech on the date of the transaction is only approximately 29% of the balance of the trust account, the proposed transaction does not meet the requirements as set forth above. Accordingly, Triplecrown must amend its amended and restated certificate of incorporation immediately prior to consummation of the merger in order to allow Triplecrown to complete the proposed merger.

Triplecrown’s amended and restated certificate of incorporation purports to prohibit amendment to certain of its provisions, including the requirement to obtain approval of disinterested directors and a fairness opinion, prior to consummation of an initial business combination. However, Triplecrown believes that the proposed merger is an attractive opportunity in the current market environment and therefore, public stockholders should be given the opportunity to consider the business combination. In considering the initial charter proposals, Triplecrown’s board of directors came to the conclusion that the potential benefits of the proposed merger with CAH to Triplecrown and its stockholders outweighed the possibility of any liability described below as a result of the initial charter proposals being approved. Moreover, Triplecrown is still offering holders of Public Shares the right to affirmatively vote their Public Shares against the merger proposal and demand that such shares be converted into a pro rata portion of the trust account.

TABLE OF CONTENTS

Triplecrown has received an opinion from special Delaware counsel, Richards, Layton & Finger, P.A., concerning the validity of the initial charter proposals. Triplecrown did not request Richards, Layton & Finger to opine on whether the clause currently contained in Article Seventh of its amended and restated certificate of incorporation prohibiting amendment of Article Seventh prior to consummation of a business combination was valid when adopted and does not intend on seeking advice of counsel on that question from any other source. Richards, Layton & Finger concluded in its opinion, based upon the analysis set forth therein and its examination of Delaware law, and subject to the assumptions, qualifications, limitations and exceptions set forth in its opinion, that “the initial charter amendment, if duly adopted by the board of directors of Triplecrown (by vote of the majority of the directors present at a meeting at which a quorum is present or, alternatively, by unanimous written consent) and duly approved by the holders of a majority of the outstanding stock of the Company entitled to vote thereon, all in accordance with Section 242(b) of the DGCL, would be valid and effective when filed with the Secretary of State in accordance with Sections 103 and 242 of the DGCL.” A copy of Richards, Layton & Finger’s opinion is included as Annex I to this proxy statement/prospectus, and stockholders are urged to review it in its entirety.

Because Triplecrown’s amended and restated certificate of incorporation in its current form does not allow for Triplecrown to complete the proposed merger, each person who purchased his or her Public Shares in the IPO and still held such shares upon learning of the facts set forth above may have securities law claims against Triplecrown for rescission (under which a successful claimant has the right to receive the total amount paid for his or her securities pursuant to an allegedly deficient prospectus, plus interest and less any income earned on the securities, in exchange for surrender of the securities) or damages (compensation for loss on an investment caused by alleged material misrepresentations or omissions in the sale of a security).

Such claims may entitle stockholders asserting them to as much as $10.00 or more per share, based on the initial offering price of the IPO units comprised of stock and warrants, less any amount received from sale of the original warrants purchased with them, plus interest from the date of Triplecrown’s IPO (which, in the case of holders of Public Shares, may be more than the pro rata share of the trust account to which they are entitled on conversion or liquidation).

In general, a person who purchased shares pursuant to a defective prospectus or other representation must make a claim for rescission within the applicable statute of limitations period, which, for claims made under Section 12 of the Securities Act and some state statutes, is one year from the time the claimant discovered or reasonably should have discovered the facts giving rise to the claim, but not more than three years from the occurrence of the event giving rise to the claim. A successful claimant for damages under federal or state law could be awarded an amount to compensate for the decrease in value of his or her shares caused by the alleged violation (including, possibly, punitive damages), together with interest, while retaining the shares. Claims under the anti-fraud provisions of the federal securities laws must generally be brought within two years of discovery, but not more than five years after occurrence. Rescission and damages claims would not necessarily be finally adjudicated by the time the merger with CAH may be completed, and such claims would not be extinguished by consummation of that transaction.

Even if you do not pursue such claims, others, who may include all holders of Public Shares, may do so. Neither Triplecrown nor CAH can predict whether stockholders will bring such claims, how many might bring them or the extent to which they might be successful.

The approval of each of the initial charter proposals requires the affirmative vote of the holders of a majority of the outstanding shares of Triplecrown common stock on the record date.

TABLE OF CONTENTS

A copy of Triplecrown’s proposed second amended and restated certificate of incorporation is attached as Annex G to this proxy statement/prospectus. If the initial charter proposals are approved, Triplecrown will present the other proposals to stockholders and warrantholders for their approval. If all of such proposals are approved, the following will occur:

“A “Business Combination” shall mean any merger, capital stock exchange, asset, stock purchase, reorganization or other similar business combination between the Corporation and one or more entities or assets (“Target Business” or “Target Businesses”).”;

If any of the initial charter proposals are not approved, the remaining proposals will not be submitted to stockholders and warrantholders for their approval.

TRIPLECROWN’S BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS (EXCEPT FOR MR. WATSON WHO ABSTAINS FROM THE RECOMMENDATION DUE TO HIS RELATIONSHIP WITH CULLEN AGRITECH) THAT TRIPLECROWN’S STOCKHOLDERS VOTE “FOR” THE APPROVAL OF EACH OF THE INITIAL CHARTER PROPOSALS. YOU SHOULD BE AWARE, HOWEVER, THAT THE TRIPLECROWN FOUNDERS HAVE CONFLICTS OF INTEREST IN APPROVING THE TRANSACTION AS INDICATED IN THE SECTION ENTITLED “INTERESTS OF TRIPLECROWN’S DIRECTORS AND OFFICERS AND OTHERS IN THE MERGER” APPEARING ON PAGE 40 OF THIS PROXY STATEMENT/PROSPECTUS.

TABLE OF CONTENTS

THE MERGER PROPOSAL

The discussion in this proxy statement/prospectus of the merger and the principal terms of the merger agreement by and among Triplecrown, CAH, Triplecrown Merger Sub, Cullen Agritech and Cullen Holdings is subject to, and is qualified in its entirety by reference to, the merger agreement. A copy of the merger agreement is attached as Annex A to this proxy statement/prospectus and is incorporated into this proxy statement/prospectus by reference.

The Parties

Triplecrown

Triplecrown Acquisition Corp. is a specified purpose acquisition company (“SPAC”), formed on June 8, 2007 as a vehicle to effect a merger, capital stock exchange, asset acquisition or other similar business combination with an operating business in the financial services industry.

On October 25, 2007, Triplecrown closed its IPO of 55,200,000 units, including 7,200,000 units subject to the underwriters’ over-allotment option, with each unit consisting of one share of its common stock and one warrant, each to purchase one share of its common stock at an exercise price of $7.50 per share. The units from the IPO (including the over-allotment option) were sold at an offering price of $10.00 per unit, generating total gross proceeds of $552,000,000. Simultaneously with the consummation of the IPO, Triplecrown consummated the private sale of 5,000,000 Sponsors’ Warrants at $1.00 per warrant to Eric J. Watson and Jonathan J. Ledecky for an aggregate purchase price of $5,000,000. After deducting the underwriting discounts and commissions and the offering expenses, $536,930,000 was deposited into the trust account and the remaining proceeds became available to be used to provide for business, legal and accounting due diligence on prospective business combinations and continuing general and administrative expenses.

If the merger is consummated, Triplecrown intends to use the funds held in the trust account to pay approximately $4 million to $6 million transaction fees and expenses, up to approximately $7 million for the balance of the purchase price for the land to be used by CAH following consummation of the merger up to approximately $19.3 million of deferred underwriting discounts and commissions, as well as tax liabilities, if any, and approximately $150,000 to $250,000 of reimbursement of expenses of the Triplecrown Founders and to make purchases of Public Shares, if any. The balance of the funds will be released to CAH to pay Triplecrown stockholders who properly exercise their conversion rights and for working capital and general corporate purposes of CAH and Cullen Agritech. Although Cullen Agritech would need approximately $400 million to fully implement its business plan, Cullen Agritech anticipates initially implementing its business plan with only $150 million after the consummation of the transactions contemplated by this proxy statement/prospectus. Accordingly, if CAH has access to more than $150 million after closing of the merger, CAH intends to use such funds in excess of $150 million, depending on market conditions, to repurchase shares of common stock at prices and in amounts to comply with rule 10b-18 under the Exchange Act. The funds available to CAH after the consummation of the transactions, up to $150 million, will be used to initially implement Cullen Agritech’s business model. If less than $150 million is available to Cullen Agritech, the business model will be initially implemented to such lesser extent and Cullen Agritech would attempt to raise additional capital from other sources. If a significant amount of the trust fund proceeds are used to purchase Public Shares or for conversions, Cullen Agritech may not have any funds available to implement its business plan. Cullen Agritech has not taken any steps to secure any additional financing or funding and there is no assurance that such financing or funding would be available on terms favorable to Cullen Agritech or at all. If such financing or funding is not available, Cullen Agritech may not be able to implement its business plan to any extent and therefore would not be worth the $155 million being paid for it by Triplecrown.

It is possible that the present holders of 30.0% or more of the Public Shares will affirmatively vote against the merger and seek conversion of their Public Shares into cash in accordance with Triplecrown’s amended and restated certificate of incorporation. If such event were to occur, the merger could not be completed. To preclude such possibility, Triplecrown, the Triplecrown Founders, CAH, Cullen Agritech and their respective affiliates may enter into arrangements to provide for the purchase of the Public Shares from holders thereof who indicate their intention to vote against the merger and seek conversion or who otherwise wish to sell their Public Shares or other arrangements that would induce holders of Public Shares not to vote against the merger proposal. It is likely that such arrangements would involve the purchase by Triplecrown, after the

TABLE OF CONTENTS

merger, of the Public Shares that are held by the persons or entities who enter into such arrangements using funds from Triplecrown’s trust account. The maximum cash purchase price that will be offered to holders of Public Shares for such shares would be the per-share conversion price at the time of the business combination. As a consequence, it is likely that the amount of funds available to CAH and Cullen Agritech for working capital and general corporate purposes from the trust account would be diminished. Definitive arrangements have not yet been determined but some possible methods are described in the section titled “The Merger Proposal — Actions That May Be Taken to Secure Approval of Triplecrown’s Stockholders.” Regardless of the specific arrangements that are made to purchase Public Shares, there will be sufficient funds from the trust account funds transferred to Triplecrown to pay the holders of all Public Shares that are properly converted and Triplecrown will use such funds for such purpose.

If the merger is not consummated by the date on which Triplecrown is required to be liquidated, either party may terminate the merger agreement. If Triplecrown is unable to complete the merger or another business combination by October 22, 2009, its amended and restated certificate of incorporation provides that its corporate existence will automatically terminate and it will liquidate and promptly distribute to its public stockholders the amount in its trust account plus any remaining non-trust account funds after payment of its liabilities. Accordingly, a holder would have to wait until Triplecrown liquidates in connection with its dissolution to receive liquidation proceeds, which liquidation could take 60 days or more to complete.

Triplecrown’s common stock, units and warrants are currently listed on the NYSE Amex under the symbols TCW, TCW.U and TCW.WS, respectively. Triplecrown’s common stock, units and warrants will cease trading upon consummation of the merger.

The mailing address of Triplecrown’s principal executive office is 970 West Broadway, PMB 402, Jackson, Wyoming 83001. Its telephone number is (307) 633-2831.

CAH

Cullen Agricultural Holding Corp. is a Delaware corporation wholly owned by Triplecrown that was incorporated on August 27, 2009 solely for the purpose of effecting the merger with Triplecrown described herein and becoming the publicly traded company thereafter. CAH owns no material assets and does not operate any business. Mr. Watson’s only role in CAH’s formation was to serve as its initial director and officer in anticipation of consummating the transaction with Cullen Agritech.

CAH’s principal executive office is currently located at 970 West Broadway, PMB 402, Jackson, Wyoming 83001 and its telephone number is (307) 633-2831. Following the merger, CAH’s principal executive office will be located at 22 Barnett Shoals Road, Watkinsville, Georgia 30677 and its telephone number will be (706) 614-4931.

Triplecrown Merger Sub

CAT Merger Sub, Inc. is a Delaware corporation wholly owned by CAH that was incorporated on August 31, 2009 solely for the purpose of effecting the merger with Cullen Agritech described herein. Triplecrown Merger Sub owns no material assets and does not operate any business.

The mailing address of Triplecrown Merger Sub’s principal executive office is 970 West Broadway, PMB 402, Jackson, Wyoming 83001. Its telephone number is (307) 633-2831.

Cullen Agritech

Cullen Agricultural Technologies Inc. is a Georgia corporation that was organized on June 3, 2009. Cullen Agritech’s formation followed more than 12 months of investigations by Cullen Investments Ltd., an entity affiliated with Mr. Watson, to ascertain the viability of establishing and operating a US dairy farming business as a newly formed business. These investigations included the activities conducted on the research farms by Cullen Investments, Hart Acquisitions and Dr. Richard Watson (“Research Partners”). Further information regarding the research farms, the activities conducted thereon and the Research Partners is set forth in the section titled “Business of Cullen Agritech — Intellectual Property” on page 136. Mr. Watson was intimately involved throughout this entire process in evaluating Cullen Agritech’s proposed business. Cullen Agritech was not formed in anticipation of a possible business combination with Triplecrown. Cullen

TABLE OF CONTENTS

Agritech’s first proposed written business plan was created on May 6, 2008. Dr. Richard Watson, Mr. Watson’s half-brother, was previously employed by Cullen Investments from June 12, 2008 to September 1, 2009 for the purpose of managing and overseeing the development and operation of an agricultural business initially within the United States. Effective September 1, 2009, Dr. Watson became an employee of Natural Dairy pursuant to an employment agreement entered on August 31, 2009. He is currently the sole officer of Natural Dairy. On June 27, 2009, the parties entered into the land contract and on August 11, 2009, Cullen Agritech entered into the strategic cooperation agreement with New Zealand Agritech. Prior to the formation of Cullen Agritech, Dr. Richard Watson engaged in discussions with individuals over a number of months with a view of developing an Advisory Board made up of pastoral and dairy scientists. These individuals confirmed acceptance to join Cullen Agritech’s Advisory Board in writing by letter dated August, 2009. Although Cullen Agritech has an advisory board, such members are not currently party to any type of consultancy agreement and no amount of consideration has been paid or promised to these individuals in exchange for their agreement to join the advisory board. On September 3, 2009, Cullen Agritech acquired the rights to certain intellectual property, including a proprietary farming system, from Cullen Investments Ltd. and Hart Acquisitions LLC, an affiliate of Richard Watson, pursuant to the IP Transfer Agreement, contingent on the consummation of the business combination with Triplecrown.

Cullen Agritech is wholly owned by Cullen Inc Holdings Ltd. Cullen Agritech is a newly formed company committed to the development and commercialization of advanced agricultural technologies. Cullen Agritech’s principal focus will be to improve agricultural yields through forage and animal sciences. Cullen Agritech will primarily be engaging in dairy farming operations in the Southeastern United States through its wholly owned subsidiary, Natural Dairy. It will also provide advisory services associated with the development and implementation of efficient farming techniques both in the United States and abroad.

Cullen Agritech’s principal executive office is currently located at 22 Barnett Shoals Road, Watkinsville, Georgia 30677 and its telephone number is (706) 614-4931.

Structure of the Merger

The merger agreement provides for (i) Triplecrown to merge with and into CAH with CAH surviving the merger and becoming the new publicly-traded corporation of which the present holders of Triplecrown securities will be security holders and (ii) Triplecrown Merger Sub to merge with and into Cullen Agritech with Cullen Agritech surviving the merger and becoming a wholly-owned subsidiary of CAH.

Upon completion of the transactions contemplated by this proxy statement/prospectus, assuming no holders of the Public Shares elect to convert their shares into a portion of Triplecrown’s trust account, the current holders of common stock of Triplecrown will own 57,740,000 shares of CAH stock (assuming the officers, directors and founders of Triplecrown cancel an aggregate of 11,260,000 shares they will receive upon exchange of their Triplecrown common stock in connection with the merger as described in more detail in this proxy statement/prospectus), representing 78.6% of CAH’s outstanding common stock, and the current holder of common stock of Cullen Agritech will own 15,881,148 shares of CAH common stock, representing 21.4% of CAH’s outstanding common stock, excluding warrants held by Mr. Watson. Assuming that holders of approximately 29.99% of the Public Shares elect to convert their shares into a portion of Triplecrown’s trust account, the current holders of common stock of Triplecrown will own 41,180,000 shares of CAH stock (assuming the officers, directors and founders of Triplecrown cancel an aggregate of 11,260,000 shares they will receive upon exchange of their Triplecrown common stock in connection with the merger as described in more detail in this proxy statement/prospectus), representing 72.4% of CAH’s outstanding common stock, and the current holder of common stock of Cullen Agritech will own 15,881,148 shares of CAH common stock, representing 27.6% of CAH’s outstanding common stock, excluding warrants held by Mr. Watson. Cullen Holdings has agreed that it will not sell any of the shares it receives in the merger until the 12-month anniversary of the consummation of the merger. Assuming CAH purchases shares after the closing so that $150 million is left available to operate CAH’s business, the holders of Triplcrown common stock will own 56.8% and Cullen Holdings will own 43.2% of CAH’s outstanding common stock.

Prior to Triplecrown’s IPO, the Triplecrown Founders acquired 13,800,000 Founders’ Units, representing 13,800,000 Founders’ Shares and 13,800,000 Founders’ Warrants. All of such securities are held in escrow

TABLE OF CONTENTS

under an escrow agreement with Continental Stock Transfer & Trust Company, pursuant to which such securities will not be released from escrow until one year after the consummation of Triplecrown’s initial business combination (except in certain limited situations). In connection with the merger, the Triplecrown Founders have agreed to have cancelled an aggregate of 11,260,000 shares of common stock of CAH they will receive in exchange for 11,260,000 Founders’ Shares upon consummation of the merger. The remaining 2,540,000 shares, as well as all of the warrants of CAH that the Triplecrown Founders will receive in exchange for their Founders’ Warrants, will continue to be held in escrow pursuant to the original terms of the escrow agreement and will be released one year after the consummation of the merger.

Name; Headquarters; Stock Exchange

After completion of the merger:

Indemnification

To provide a fund to secure the indemnification obligations of Cullen Holdings to Triplecrown against losses that the surviving entity of the merger may sustain as a result of (i) the inaccuracy or breach of any representation or warranty made by Cullen Agritech in the merger agreement or any schedule or certificate delivered by it in connection with the merger agreement and (ii) the non-fulfillment or breach of any covenant or agreement made by Cullen Agritech in the merger agreement, an aggregate of approximately 10% of the initial shares to be issued in the merger (1,588,114 shares of CAH common stock) will be placed in escrow (with an independent escrow agent), which will be canceled to the extent that Triplecrown has damages for which it is entitled to indemnification. The escrow will be the sole remedy for Triplecrown for its rights to indemnification pursuant to the merger agreement. Claims for indemnification may be asserted against the escrow by Triplecrown once its damages exceed a deductible and will be reimbursable to the full extent of the damages in excess of such amount up to a maximum of the escrowed shares. Claims for indemnification may be asserted until the 30^th day after the date CAH has filed with the SEC its Annual Report on Form 10-K for the year ending December 31, 2010 (but in any event no later than April 16, 2011). As a consequence of these limitations, Triplecrown may not be able to be entirely compensated for indemnifiable damages that it may sustain. A copy of the escrow agreement is attached to this proxy statement/prospectus as Annex E.

Employment Agreement

Dr. Richard Watson has entered into an employment agreement with Natural Dairy. The employment agreement is for a 3-year term subject to earlier termination in certain circumstances, and may be extended by mutual agreement of the executive and Cullen Agritech.

Lock-Up

Pursuant to a lock-up agreement, dated September 4, 2009, Cullen Holdings has agreed that it will not sell any shares of CAH common stock it receives in the merger until one year after the consummation of the merger. A copy of the lock-up agreement is attached to this proxy statement/prospectus as Annex J.

Background of the Merger

The following is a brief discussion of the background of the negotiations, the merger agreement and related transactions.

Triplecrown was formed on June 8, 2007 to effect a merger, capital stock exchange, asset acquisition or other similar business combination with an operating business. Triplecrown’s amended and restated certificate of incorporation provides that Triplecrown must liquidate unless it has consummated a business combination by October 22, 2009. As of June 30, 2009, $539,328,529 was held in deposit in the trust account.

TABLE OF CONTENTS

Promptly following the IPO of Triplecrown, Triplecrown contacted several investment bankers, private equity firms, consulting firms, legal and accounting firms, as well as numerous other business relationships. Through these and further efforts, Triplecrown identified and reviewed information with respect to approximately 250 potential target companies, including some that were start-up companies with no assets or operations and some that were established companies facing difficulties due to the current economic crisis.

The majority of these situations were in the financial services and related sectors. Triplecrown held over 200 preliminary, and in some cases, multiple detailed due diligence meetings with respect to these target companies drawn from commercial banking firms, asset management companies, hedge funds, investment banks, life insurance, life insurance brokerage and life settlement companies, credit card companies and credit card processors, Small Business Investment Companies, Business Development Companies, Real Estate Investment Trusts, debt collection companies, and pension management firms. These target companies were situated both domestically and internationally. Triplecrown delivered and negotiated over two dozen letters of intent to those prospective target companies in which it believed a suitable transaction could be structured. These included:

In each of these cases, the parties engaged in detailed discussions and undertook company and industry specific due diligence. However, in each case, disagreements arose related to items such as consideration to be paid by Triplecrown as well as the perceived inherent shortcomings of Triplecrown’s operating structure, dilution and warrant overhang. Accordingly, none of the letters of intent were ever executed by the targets.

On May 21, 2009, Eric J. Watson indicated to Jonathan J. Ledecky that he planned on forming an entity, which became Cullen Agritech, which Mr. Watson believed might be an attractive opportunity for Triplecrown to pursue. At this time, neither Cullen Agritech nor CAH was formed. The parties then commenced discussions regarding a potential transaction involving Cullen Agritech and Triplecrown. On May 22, 2009, Mr. Ledecky visited the research farms where systems that will be acquired by Cullen Agritech upon consummation of the merger were being deployed. For further information regarding the research farms, see the section titled “Business of Cullen Agritech — Intellectual Property” set forth on page 136. At that time, such property was owned by Hart Acquisitions LLC and there were no contractual arrangements in place for Cullen Investments or any of its affiliates to acquire such property. Additionally, at that time, Triplecrown’s board of directors had not formally authorized Mr. Ledecky to negotiate with Mr. Watson with respect to the proposed transaction.

Mr. Watson then formed Cullen Agritech on June 3, 2009 and began the process of transferring the intellectual property and personnel to Cullen Agritech. For further information regarding the transfer, see the section titled “Business of Cullen Agritech — Intellectual Property” set forth on page 136.

On July 9, 2009, Mr. Ledecky met with Edward J. Mathias, chairman of Triplecrown’s audit committee, to discuss a proposed transaction with Cullen Agritech and to determine whether to continue discussions with Mr. Watson on such transaction.

In connection with such potential business combination, on June 27, 2009, Triplecrown and Natural Dairy entered into a contract to purchase a separate piece of land owned by Grimsly, LLC, an unaffiliated third party seller, to be utilized in connection with such business combination. The total purchase price of the property was $8,662,500 on which Triplecrown paid a deposit of $866,250 on June 30, 2009. The contract was negotiated and executed by Mr. Ledecky on behalf of Triplecrown. The seller agreed that if Triplecrown could not close on the land, its only remedies would be against Natural Dairy and Triplecrown would have no further obligations under the contract.

On August 7, 2009, a meeting of the Triplecrown board of directors and audit committee was held. All directors attended, as did, by invitation, Brian L. Ross and Jeffrey M. Gallant of Graubard Miller. On

TABLE OF CONTENTS

August 6, 2009, information concerning the proposed transaction with Cullen Agritech was delivered to the directors via email by Petrina Advisors and Miles Leahy. Mr. Ledecky discussed Triplecrown’s efforts to find a suitable candidate for a business combination, the benefits of selecting Cullen Agritech as well as its risks as set forth below. Mr. Watson’s participation was limited to providing additional information and answered questions posed to him by the board. The board also discussed the necessary deposits to be paid by Triplecrown to secure the piece of land to be used by CAH following consummation of the merger. After considerable discussion by Mr. Ledecky and members of the board of directors other than Mr. Watson, it was unanimously agreed (except for Mr. Watson who abstained from the vote due to his relationship with Cullen Agritech) that Triplecrown should continue to negotiate the potential transaction with Cullen Agritech and authorized and ratified Triplecrown paying the initial June 30, 2009 deposit and a second deposit for the land provided that the agreement calling for such payment would require Cullen Agritech or an affiliate to reimburse Triplecrown for the deposits if the parties were not able to execute the merger agreement. The second deposit in the amount of $885,337.53 was paid on August 11, 2009. Except for Eric Watson, all of the Triplecrown board members and audit committee members were disinterested as to these transactions. The reason Triplecrown paid the deposit prior to obtaining authorization from the board and committee was due to the fact that the land would have been sold to another party had Triplecrown not acted at this time and management could not schedule a meeting prior to the deadline.

On August 22, 2009, Messrs. Ledecky and Watson met to discuss a general framework for the proposed transaction. On each day during the week of August 24, 2009 through August 28, 2009, the parties met in person or telephonically and negotiated various terms and conditions of the proposed transaction telephonically and continued their due diligence work. On August 28, 2009, drafts of a merger agreement and proxy statement were circulated by Triplecrown counsel to Cullen Agritech and its counsel. The structure of the transaction was determined so as to be as tax-efficient as possible, while also allowing for potential changes in the valuation of the consideration, if necessary. The consideration was arrived at by the parties based on their evaluation of the other party’s structure and potential outlook, which consideration was later supported by the opinion Triplecrown received from Duff & Phelps (described below).

During that same time period, Triplecrown entered into negotiations with the underwriters in its IPO regarding the reduction of their deferred underwriting commissions payable at the consummation of the merger. Negotiations are ongoing. Additionally, because (i) the sole stockholder of CAH is controlled by Eric J. Watson, Triplecrown’s chairman of the board and treasurer, (ii) Triplecrown will ultimately be acquired by CAH and therefore not acquire at least 50% of the voting securities of the target business, (iii) Cullen Agritech is not an operating business in the financial services industry and (iv) the fair market value of Cullen Agritech on the date of the transaction is only approximately 29% of the balance of the trust account, the proposed transaction does not meet the IPO and amended and restated certificate of incorporation requirements discussed elsewhere in this proxy statement/prospectus. Therefore, Triplecrown also entered into discussions with the underwriters to obtain their consent to any necessary amendments to the agreements entered into in connection with the IPO in order to consummate the transactions described herein. If Triplecrown is unable to obtain such consent but still determines to proceed with the transaction, Triplecrown will be exposing itself to a claim by the underwriters that it proceeded without their consent. Although the parties do not believe such a claim would be viable, because it is unclear what damages the underwriters would be able to claim, Triplecrown cannot assure you of this fact.

On August 31, 2009, another meeting of the board of directors and audit committee of Triplecrown was held to consider approval of the transactions. All directors attended, as did David Alan Miller, Brian L. Ross and Jeffrey M. Gallant of Graubard Miller. Also attending were Philip Wisler and Abhijeet Shekdar from Duff & Phelps, financial advisors to Triplecrown. At this meeting, Messrs. Wisler and Shekdar of Duff & Phelps made a presentation regarding the fairness of the valuation of Cullen Agritech negotiated between Triplecrown and Cullen Agritech. Messrs. Wisler and Shekdar advised the board that it was the opinion of Duff & Phelps that the valuation of Cullen Agritech negotiated between Triplecrown and Cullen Agritech was fair to Triplecrown from a financial point of view. Messrs. Wisler and Shekdar then detailed for the board the analysis performed by Duff & Phelps and made a presentation concerning how Duff & Phelps had arrived at its opinion. Messrs. Wisler and Shekdar discussed at length with Triplecrown’s board the different analyses used to determine whether the valuation of Cullen Agritech negotiated between Triplecrown and Cullen Agritech was

TABLE OF CONTENTS

fair from a financial point of view to Triplecrown. For a more detailed description of the Duff & Phelps fairness opinion, see the section entitled “Fairness Opinion” below. After considerable review and discussion, the merger agreement and related documents were unanimously approved (except for Mr. Watson who abstained from the vote as a result of his relationship with Cullen Agritech), subject to final negotiations and modifications, and the board determined to recommend the approval of the merger agreement.

The merger agreement was signed on September 4, 2009. The signed agreement did not differ materially from the draft previously circulated on August 28, 2009. Prior to the market open on September 8, 2009, Triplecrown issued a press release and subsequently filed a Current Report on Form 8-K on the same day announcing the execution of the merger agreement and discussing the terms of the merger agreement.

Triplecrown’s Board of Directors’ Reasons for the Approval of the Merger

Triplecrown’s board of directors carefully evaluated the agreements relating to the proposed merger and reviewed industry and financial data in order to determine that the transaction terms were reasonable and that the merger was in the best interests of Triplecrown’s stockholders. The following is a summary of all of the material factors that the Triplecrown board of directors considered:

Cullen Agritech’s advisors and officer have extensive experience in improving yields through applying forage based farming techniques

Cullen Agritech will rely on members of its Advisory Board made up of experienced scientists, policy analysts and business leaders in the agricultural arena. Additionally, Cullen Agritech’s Chief Scientific Officer, Dr. Richard H. Watson, has an extensive background in pastoral science and technology, from the lab bench through commercialization and industry application of technologies.

The Advisory Board also includes members that are quantitative geneticists that have the ability to develop lines of dairy cattle designed to produce milk efficiently on pasture. Cullen Agritech has exclusive access to embryo, semen and genetic screening technologies (SNP-chip) to accelerate genetic improvement and deployment of these lines in the United States dairy industry. Only Cullen Agritech and its customers will have access to these grazing lines.

Richard Watson is employed by Natural Dairy pursuant to an employment agreement entered on August 31, 2009, pursuant to which he will receive a base salary of $100,000 and be entitled to receive a bonus of up to 50% of the base salary subject to the sole discretion of Natural Dairy’s board of directors. Cullen Agritech does not have any constultancy or employment agreement with any of the Advisory Board members and no amount of consideration has been paid or promised to these individuals in exchange for their agreement to serve on the Advisory Board.

Tested Model through research farms developed by key Cullen Agritech personnel to provide key cost advantages

Key personnel now associated with Cullen Agritech developed the farming system that Cullen Agritech will acquire and has been tested on research farms in Girard, Georgia, the first of which was established in late 2007. These farms were established to develop and test Cullen Agritech’s proprietary grazing system that will be rolled-out in the Southeast United States through Natural Dairy. The first research farm began producing milk in March 2008. During 2008, it was used to refine and develop the Cullen Agritech’s farming system, the know-how of which makes up Cullen Agritech’s intellectual property. This research was focused on the development of a forage crop system to maximize the production and utilization of grown pasture. Breeding and calving season trials have been conducted to optimize the relationship between feed grown on farm and the feed demand of the herd. During 2009, the research farm implemented its refined strategy and has been able to achieve favorable production cost results, proving the efficiency of the system.

All research and testing was carried out by the Research Partners, led by Dr. Richard Watson, the majority of which took place in 2008 and 2009. Using his experience in forage sciences and grazing systems in the Southeast United States, Dr. Watson developed the farming system through research on, and testing of, various elements of the farming system. This testing can broadly be split into five different categories as follows: forage systems, animal genetics and type evaluations, supplemental feed inputs, nutrient management and animal welfare. For a further description of these elements of research and testing, see the section titled “ Business of Cullen Agritech – Intellectual Property.” The primary goal of the research was to develop a

TABLE OF CONTENTS

system that could significantly reduce cost per cwt of production. The efficacy of this farming system was analyzed by the Research Partners through review of production and cost figures produced primarily during 2009. None of the testing procedures or results have been independently verified by a third party.

Forage based system provides Lower Cost per CWT of Dairy Production

The cost of producing milk will vary greatly depending on the region, the exact management practices and the quality of farmers. For a significant majority of dairy farmers, the high dependence on the use of corn-based concentrate as a feedstock results in an extremely challenging cost base. The use of forage as a replacement for corn-based concentrate in Cullen Agritech’s model reduces this expense substantially, creating a much more economically-sustainable cost structure. Cullen Agritech’s model is also less labor intensive and has reduced animal health costs due to healthier and less confined conditions.

Natural Dairy is strategically located in a region of high demand coupled with a shortage in supply

Natural Dairy’s roll-out is focused on the Southeastern United States where there is currently a shortage in the supply of fresh liquid milk. (Sources: “The Components of Grazing – profitability,” Joe Horner, Missouri Grazing Conference 2009; DFA “Retrenched and positioned for the future,” Dairy Business, March 26, 2009; “Redesigning our Dairy Industry,” Randy Mooney, Missouri Dairy Grazing Conference, 2009). In addition, the United States represents the third largest liquid milk market in the world (Source: Tetra Pak Dairy Index, Issue: June 2009; “Herd Slaughter a reality for U.S. farmers,” NZ Herald, June 23, 2009), a large portion of which is represented by the Eastern Seaboard. Natural Dairy is strategically positioned to help fill that supply gap and produce milk for this market. Management estimates that $2 billion of capital would be needed to be deployed to satisfy the current shortage.

There has been a recent depression in milk prices in the United States, which has resulted in the U.S. Government purchasing surplus milk powder and other dairy products in order to help maintain prices. Liquid milk cannot be stored for long periods of time, so this is not purchased by the Government. Instead, the primary dairy product which is stockpiled is milk powder. This stockpiling process helps to maintain a floor on the expected price to be received by farmers for their milk, so it is beneficial to the industry during a time of reducing prices, as has been experienced in the industry during 2008 and 2009. If the U.S. Government decided to release all stockpiled products back into the domestic market, it could lead to a slower recovery in milk prices. However, the milk price forecasts are still anticipated to rise even after taking into account this stockpiling.

Cullen Agritech’s systems can achieve a high production per cow

Cullen Agritech utilizes forage production systems that optimize seasonal qualitative attributes of the pasture to best match the energy demands of the cow. Under these systems, the cow is provided sufficient nutrients to meet her needs for body maintenance and milk production. Cullen Agritech uses energy balances to ensure that the cows at pasture are fed to achieve the highest possible production targets in the most cost effective manner. This level of feed management sets Cullen Agritech apart from other grazing operations in the USA.

Cullen Agritech’s system results in healthier livestock and increased longevity.

The common United States dairy industry cow is the US Holstein. Cullen Agritech’s model is more suited to smaller framed livestock such as Jersey/Holstein cross-breeds or a Friesian Holstein. Research completed by the scientific community in the US and elsewhere indicates that these breeds of livestock generally have longer productive lives than a typical US Holstein, which is further lengthened by the healthier conditions associated with Cullen Agritech’s pasture-based farming system. This longevity has been documented in many scientific studies. For example, one of the major determining factors of culling rate is the ability of the cow to get in calf — a study completed by White et al., 2002, demonstrated that, over a 75-day breeding season a Jersey cows had a 78% conception rate compared with only 58% for Holsteins over the same period. In another study comparing cow breeds culling rate was 1.8 times higher in Holsteins compared with Jerseys (Wasburn et al., 2002). This longevity will result in reduced livestock culling rates resulting in additional revenue from surplus livestock sales. Livestock managed under a pasture-based system such as Cullen Agritech’s are also likely to have fewer health issues due to increased exercise and exposure to cleaner, less confined living conditions. This maintains a healthier animal and reduces the speed at which infection can

TABLE OF CONTENTS

spread throughout a herd. Such improvements in health are also well documented by the scientific community — many scientific trials comparing pasture and confinement feeding of dairy cows have shown improvements in reproductive performance, mastitis, somatic cell counts (an important health indicator in milk), hoof health and general cow health in pasture-fed animals versus animals fed in a confinement system (Goldberg et al., 1992; and Phillips, 1990). Such research would further indicate increased cow longevity as well as reduced health-related operating expenses on Cullen Agritech’s farms.

Reduced labor costs

Cullen Agritech will utilize state of the art milking systems which will be custom made to maximize efficiency and minimize labor costs. This technology, combined with a unique and efficient farm design and management strategy will result in reduced labor costs, further reducing the cost of production under Cullen Agritech’s unique system when compared to the traditional, confinement dairy model in the US.

The higher labor costs associated with a confinement system are substantially due to the manpower required to carry out the feeding and effluent management processes. Due to the nature of a pasture-based system, whereby the livestock primarily feed themselves and a large proportion of effluent is naturally recycled, the manpower required to manage these processes is considerably less than in a confinement system.

Potential to achieve higher pricing in the future

The demand for naturally produced animal products is increasing as the population’s concern with how their food is produced increases. General awareness of the animal ethics and human health benefits of the grazing-based production system have also grown. A USDA survey showed that 48% of United States consumers now recognize “Grass-fed” as a brand.

Products from animals fed on a pasture dominant diet have been found to contain higher levels of a number of naturally occurring metabolites that have proven human health benefits. The fermentation of the forage diet in grazing animals by rumen bacteria create higher levels of conjugated linoleic acid (CLA), omega-3 and 6 fatty acids and vitamins A&E in the milk. Production of these in confinement cows is reduced by the heavy-starch grain diet, which reduces the formation of these beneficial fermentation products.

Currently, there is a small but rapidly growing market for grass-fed or pasture-fed beef products. However, the grass-fed milk market is virtually non-existent due to dominance of the confinement model and the lack of producers who have the technical knowledge to produce milk on pasture year round.

Natural Dairy has the ability to produce grass-fed milk year round and its production levels may in the future cause separate processing, with Natural Dairy’s milk as a grass-fed product being processed separate from other milk. Initially, Natural Dairy milk will be initially sold as standard milk along with milk from confinement production. This means it will not initially receive any premium pricing on the basis of its grass-fed product. Accordingly, Natural Dairy has not included any premium pricing due to the grass-fed nature of its product in its financial projections.

Strategic agreements and relationships allow for efficient large scale rollout of pasture based system

Cullen Agritech entered into a strategic cooperation agreement with New Zealand Agritech Inc (“NZ Agritech”) to promote the interests of NZ Agritech and its members. Cullen Agritech will assist members of NZ Agritech to mitigate barriers of market entry and provide the opportunity to realize the potential growth in various markets. This alliance records an important connection to participants of New Zealand’s agricultural technology industry and enables Cullen Agritech to offer its customers the benefit of advanced technologies.

No Minimum Amount Necessary to Complete the Merger

Many of the business combinations that similarly structured blank check companies are entering into require a minimum amount of funds to remain in the company’s trust account after taking into account purchases of Public Shares and holders seeking conversion in order for the transaction to be consummated. As a result, numerous transactions have failed since many stockholders of such companies have simply voted against a transaction and sought conversion to get their portion of the trust account, regardless of whether the transaction is valued attractively for the company. In this transaction, Cullen Agritech did not require such a minimum amount of funds to remain in the trust account. Accordingly, this was viewed very favorably when comparing the transaction to others that Triplecrown analyzed.

TABLE OF CONTENTS

Adverse Factors Considered by Triplecrown

Triplecrown’s board also evaluated several adverse factors in its consideration of the acquisition of Cullen Agritech. These included:

Lack of operating history

Cullen Agritech was incorporated in June 2009, is a development stage company and has no operating history. Cullen Agritech has no significant assets and will commence operations only upon consummation of the transactions described in this proxy statement/prospectus. Accordingly, it may not be able to operate its business successfully or implement its policies and strategies as described in this proxy statement/prospectus.

Adverse general economic conditions

In its evaluation of Cullen Agritech, Triplecrown’s board of directors considered the current adverse economic conditions and the impact such conditions could have on Cullen Agritech’s business. It was the board’s belief that the trends evidenced in the overall dairy market and Cullen Agritech’s strategy outweighed concerns about general economic conditions.

The board of Triplecrown was cognizant of Triplecrown’s liquidation date of October 22, 2009, but ultimately evaluated the potential business combination with Cullen Agritech strictly on the quantitative and qualitative information regarding Cullen Agritech and its business that was available. Since completion of Triplecrown’s IPO, the board has been regularly kept apprised of potential business combination targets and management’s discussions and evaluation of such targets. As discussed above, Triplecrown engaged in an ongoing and systematic search for potential business combination candidates, deciding on its own accord in various situations to terminate discussions with potential candidates when determined by management that such candidates did not ultimately represent the investment opportunity that Triplecrown wanted to present to its stockholders.

Fairness Opinion

Triplecrown engaged Duff & Phelps, LLC (“Duff & Phelps”) on August 17, 2009 to render an opinion to its board of directors as to the fairness, from a financial point of view, to the Company of the valuation of Cullen Agritech negotiated between Triplecrown and Cullen Holdings. Pursuant to the engagement letter, Duff & Phelps did not specifically opine regarding the fairness of the transaction to stockholders and warrantholders. Triplecrown selected Duff & Phelps because Duff & Phelps is a leading independent financial advisory firm, offering a broad range of valuation, investment banking and consulting services, including fairness and solvency opinions, mergers and acquisitions advisory, mergers and acquisitions due diligence services, financial reporting and tax valuation, fixed asset and real estate consulting, ESOP and ERISA advisory services, legal business solutions and dispute consulting. Duff & Phelps is regularly engaged in the valuation of businesses and securities and the preparation of fairness opinions in connection with mergers, acquisitions and other strategic transactions. Furthermore, Duff & Phelps has extensive industry expertise within the dairy sector.

On August 31, 2009, Duff & Phelps rendered its oral opinion to Triplecrown’s board of directors, which was subsequently confirmed in a written opinion dated August 31, 2009, a copy of which is attached as Annex K to this proxy statement/prospectus, that, subject to the limitations, exceptions, assumptions and qualifications set forth therein, as of August 31, 2009, the valuation of Cullen Agritech negotiated between the parties in connection with the merger is fair, from a financial point of view, to the Company.

The Duff & Phelps opinion is directed to Triplecrown’s board of directors and addresses only the fairness to Triplecrown, from a financial point of view, of the valuation of Cullen Agritech negotiated between the parties to the merger. The Duff & Phelps opinion is not a recommendation as to how any stockholder should vote or act with respect to any matters relating to the merger (including, without limitation, with respect to the exercise of rights to convert Public Shares into cash). Further, the Duff & Phelps opinion does not in any manner address Triplecrown’s underlying business decision to engage in the merger or the relative merits of the merger as compared to any alternative business transaction or strategy (including, without limitation, a liquidation of Triplecrown after not completing a business combination transaction within the allotted time). The decision as to whether to approve the merger or any related transaction may depend on an assessment of

TABLE OF CONTENTS

factors unrelated to the financial analysis on which the Duff & Phelps opinion is based. Duff & Phelps’ opinion should not be construed as creating any fiduciary duty on the part of Duff & Phelps to any party.

Triplecrown has advised Duff & Phelps that it intends to issue 15,881,148 shares of CAH common stock at an agreed value of $9.76 per share (as to which value Duff & Phelps expressed no opinion) as provided in the merger agreement. Based on the aggregate merger consideration of 15,881,148 shares of CAH common stock and an assumed value of CAH common stock of $9.76 per share, which is Triplecrown’s prevailing trust account cash balance on a per share basis, Duff & Phelps noted that the aggregate merger consideration implied a total value of Cullen Agritech of $155 million.

Triplecrown has also advised Duff & Phelps that, upon consummation of the merger, CAH intends to deploy Cullen Agritech’s intellectual property in concert with CAH’s own capital to make additional investments in land, infrastructure, livestock and working capital in the furtherance of its U.S. based dairy business plan which is to establish 40 new dairy farms operating within the Southeast United States (the “U.S. Dairy Business Plan”).

The following is a summary of the material analyses performed by Duff & Phelps in connection with rendering its opinion. Duff & Phelps noted that the basis and methodology for the opinion have been designed specifically for this purpose and may not translate to any other purposes. While this summary describes the analysis and factors that Duff & Phelps deemed material in its presentation and opinion to the Triplecrown board of directors, it does not purport to be a comprehensive description of all analyses and factors considered by Duff & Phelps. The opinion is based on the comprehensive consideration of the various analyses performed.

In arriving at its opinion, Duff & Phelps did not attribute any particular weight to any particular analysis or factor considered by it, but rather made qualitative judgments as to the significance and relevance of each analysis and factor. Several analytical methodologies were employed by Duff & Phelps in its analyses, and no one single method of analysis should be regarded as critical to the overall conclusion reached by Duff & Phelps. Each analytical technique has inherent strengths and weaknesses, and the nature of the available information may further affect the value of particular techniques. Accordingly, Duff & Phelps believes that its analyses must be considered as a whole and that selecting portions of its analyses and of the factors considered by it, without considering all analyses and factors in their entirety, could create a misleading or incomplete view of the evaluation process underlying its opinion. The conclusion reached by Duff & Phelps, therefore, is based on the application of Duff & Phelps’ own experience and judgment to all analyses and factors considered by Duff & Phelps, taken as a whole.

In connection with preparing the opinion, Duff & Phelps made such reviews, analyses and inquiries as Duff & Phelps deemed necessary and appropriate under the circumstances, including, but not limited to, the following:

TABLE OF CONTENTS

In its review and analysis, and in arriving at its opinion, Duff & Phelps, with Triplecrown’s consent:

TABLE OF CONTENTS

As indicated above, Duff & Phelps’ opinion assumed that Cullen Agritech had access to the capital needed to implement the U.S. Dairy Business Plan to the fullest extent possible. Accordingly, if Cullen Agritech does not have access to the capital necessary to implement such business plan to the fullest extent possible, Cullen Agritech could be worth significantly less than the value that Duff & Phelps arrived at.

In its analysis and in connection with the preparation of its opinion, Duff & Phelps made numerous assumptions with respect to industry performance, regulatory and environmental (e.g., weather), general business, market and economic conditions and other matters, many of which are beyond the control of any party involved in the merger. To the extent that any of the foregoing assumptions or any of the facts on which the Duff & Phelps opinion is based proves to be untrue in any material respect, Duff & Phelps has advised Triplecrown’s board of directors that the Duff & Phelps opinion cannot and should not be relied upon.

Duff & Phelps did not make any independent evaluation, appraisal or physical inspection of Triplecrown’s solvency or of any of its specific assets or liabilities (contingent or otherwise). The Duff & Phelps opinion should not be construed as a valuation opinion, credit rating, solvency opinion, or analysis of Triplecrown’s creditworthiness, as tax advice or as accounting advice. Duff & Phelps has not made, and assumes no responsibility to make, any representation, or render any opinion, as to any legal matter.

In rendering its opinion, Duff & Phelps did not express any opinion with respect to the amount or nature of any compensation to any of Triplecrown’s officers, directors, employees or any class of such persons, relative to the consideration to be received by the public stockholders of Triplecrown in the proposed transaction, or with respect to the fairness of any such compensation.

Duff & Phelps has not been requested to, and did not, (a) initiate any discussions with, or solicit any indications of interest from, third parties with respect to the proposed merger, Cullen Agritech, the assets, businesses or operations of Triplecrown, or any alternatives to the proposed merger, (b) negotiate the terms of the proposed merger, and therefore, Duff & Phelps has assumed that such terms are the most beneficial terms, from Triplecrown’s perspective, that could, under the circumstances, be negotiated among the parties to the merger agreement and the merger or (c) advise Triplecrown’s board of directors or any other party with respect to alternatives to the proposed merger. In addition, Duff & Phelps is not expressing any opinion as to the market price or value of the Shares or Share equivalents either as part of the proposed merger or after announcement of the merger.

Duff & Phelps prepared its opinion as of August 31, 2009. The opinion was necessarily based upon market, economic, financial and other conditions as they existed and could be evaluated as of such date, and Duff & Phelps disclaims any undertaking or obligation to advise any person of any change in any fact or matter affecting its opinion coming or brought to the attention of Duff & Phelps after the date of the Duff & Phelps opinion or otherwise to update, revise or reaffirm its opinion. Notwithstanding and without limiting the foregoing, in the event that there is any change in any fact or matter affecting the Duff & Phelps opinion after the date of the opinion and prior to the completion of the merger, Duff & Phelps reserves the right to change, modify or withdraw the opinion.

Summary of Financial Analyses by Duff & Phelps

For the purpose of determining whether the valuation of Cullen Agritech negotiated between the parties to the merger agreement was fair, from a financial point of view, to Triplecrown, Duff & Phelps relied on several generally accepted valuation techniques, including a calculation based on discounted cash flow, and valuation multiples determined based on an analysis of selected public companies and M&A transactions. Given Cullen Agritech’s greenfield business model, Duff & Phelps also focused its analysis on determining value indications for the primary asset of Cullen Agritech — its intellectual property.

The following is a summary of the material financial analyses used by Duff & Phelps in connection with providing its opinion to Triplecrown’s board of directors. The financial analyses summarized below include information presented in tabular format. In order to fully understand the financial analyses used by Duff &

TABLE OF CONTENTS

Phelps, the tables must be read together with the text of each summary. The tables alone do not constitute a complete description of the financial analyses. Rather, the analyses listed in the tables and described below must be considered as a whole; considering any portion of such analyses and of the factors considered, without considering all analyses and factors, could create a misleading or incomplete view of the process underlying Duff & Phelps’ opinion.

Discounted Cash Flow Analysis

A discounted cash flow analysis is a traditional valuation methodology used to derive a valuation of an asset by calculating the “present value” of estimated future cash flows of the asset. “Present value” refers to the current value of future cash flows or amounts and is obtained by discounting those future cash flows or amounts by a discount rate that takes into account macro-economic assumptions and estimates of risk, the opportunity cost of capital, expected returns and other appropriate factors.

Duff & Phelps performed its discounted cash flow analysis by adding (1) the present value of projected “free cash flows” for Cullen Agritech for the fiscal years 2009 through 2018 to (2) the present value of the “terminal value” for Cullen Agritech as of 2018. “Free cash flow” is defined as cash that is available to either reinvest or to distribute to securityholders and “terminal value” refers to the value of all future cash flows from an asset at a particular point in time.

The methodology used by Duff & Phelps to determine the present value of the free cash flows of Cullen Agritech is summarized below:

Discounted Cash Flow Analysis Methodology

Adjusted for

Less

Equals

Multiplied by

Equals

The projected financial information that Duff & Phelps used in its discounted cash flow analysis is based on financial forecasts and estimates provided by Petrina Advisors and Miles Leahy, consultants to Triplecrown, and Richard Watson and Andrea Scown, officers and advisors to Cullen Agritech. Duff & Phelps conducted an independent benchmarking analysis and adjusted the projections to reflect industry estimates of forward milk prices, inflationary growth in costs and a sustainable earnings before interest, taxes, depreciation and amortization (“EBITDA”) margin. The forward milk prices were adjusted to reflect the Class III forecasts provided by the Food and Agricultural Policy Research Institute (“FAPRI”) and the price premium of $3.80 per cwt observed in the Southeast. The EBITDA margin utilized was based on an assumption of a long-term sustainable margin and Duff & Phelps industry experience. Triplecrown’s basis and expertise in preparing and evaluating financial projections is derived from decades of experience of its board and management as it

TABLE OF CONTENTS

The projected revenues, EBITDA and free cash flow figures used by Duff & Phelps in its discounted cash flow analysis for Cullen Agritech are presented below. EBITDA is not a presentation made in accordance with U.S. generally accepted accounting principles. Duff & Phelps used EBITDA because it believes EBITDA is a measure that is generally accepted by the financial community in the valuation of assets.

Cullen Agritech Projected Financial Information ($ in Millions)
		2009				2010				2011				2012				2013				2014				2015				2016				2017				2018
Revenues		$	0			$	46			$	150			$	184			$	189			$	193			$	204			$	215			$	218			$	222
EBITDA			(0	)			9				48				78				83				89				100				113				116				121
Free Cash Flow(1)			0				(281	)			(7	)			57				63				66				69				69				72				74

Duff & Phelps calculated the projected free cash flows for Cullen Agritech for fiscal years 2009 through 2018 based on its projected net operating profit after tax, plus depreciation, less increases in net working capital, less capital expenditures. Duff & Phelps also calculated a terminal value for Cullen Agritech as of 2018 by applying a commonly used method of assigning an exit multiple to the sustainable level of EBITDA achieved by the end of the discrete projection period. The EBITDA multiple used for this purpose was 6.0x. Duff & Phelps believes that the multiple used in the determination of terminal value is supported by various benchmarks and the growth rates exhibited by the publicly traded companies that Duff & Phelps selected for purposes of its analysis.

Finally, Duff &Phelps discounted the projected free cash flows and the terminal value for Cullen Agritech to their respective present value equivalents using cost of capital assumptions ranging from 11.5% to 13.5%.

The foregoing discounted cash flow analysis indicated a range of values for Cullen Agritech of $110 million to $160 million.

Selected Public Company/Selected M&A Transaction Analysis

The selected public company analysis is based upon a comparison of the subject company to publicly held companies whose stocks are actively traded and whose market multiples may be used to provide indications of value for comparable companies. As part of this analysis, Duff & Phelps identified six publicly-traded companies that share many of the same operating characteristics and are affected by many of the same economic forces as Cullen Agritech, and which Duff & Phelps considered to be reasonably comparable to Cullen Agritech in terms of investment risks and attributes, as well as products provided and markets served.

Duff & Phelps also identified six recent merger and acquisition (“M&A”) transactions involving target companies operating in the dairy and dairy products industries, and derived implied valuation multiples for the targets in those transactions.

None of the companies utilized for comparative purposes in this analysis are identical to Cullen Agritech. Accordingly, a complete valuation analysis cannot be limited to a quantitative review of the selected companies and involves complex considerations and judgments concerning differences in financial and operating characteristics of such companies, as well as other factors that could affect their value relative to that of Cullen Agritech.

TABLE OF CONTENTS

The specific steps applied by Duff & Phelps in its selected public company/selected M&A transaction analysis are summarized below:

Selected Public Company/Selected M&A Transaction Analysis Methodology

Multiplied by

Equals

Multiplied by

Equals

Less

Equals

Relevant market data for the six public companies used in the selected public company portion of the analysis is summarized in the table below:

Company Information

Market Data ($ in Millions, Except per Share Price)

Market Multiples Enterprise Value as a Multiple of:

Company Name

Equity Value

EV

FY 2009 Revs

FY 2010 Revs

FY 2011 Revs

FY LTM EBITDA

FY 2010 EBITDA

FY 2011 EBITDA

Bongrain SA

$

639

$

1,134

0.3x

0.3x

0.2x

6.2x

5.3x

5.0x

Glanbia plc

747

1,207

0.6x

0.6x

0.5x

7.4x

7.3x

6.3x

Saputo, Inc.

5,435

6,056

1.0x

0.9x

N/A

10.9x

8.9x

8.4x

Dairy Crest Group plc

426

878

0.5x

0.5x

0.5x

6.5x

6.1x

5.9x

Warrnambool Cheese And Butter Factory Company Holdings Limited

87

164

0.4x

0.4x

0.4x

9.4x

5.5x

4.7x

China Excluded

Highest

$

5,435

$

6,056

1.0x

0.9x

0.5x

10.9x

8.9x

8.4x

Lowest

$

87

$

164

0.3x

0.3x

0.2x

6.2x

5.3x

4.7x

Mean

$

1,467

$

1,888

0.6x

0.6x

0.4x

8.1x

6.6x

6.1x

Median

$

639

$

1,134

0.5x

0.5x

0.5x

7.4x

6.1x

5.9x

Relevant market data for the six target companies in the M&A transactions used in the selected M&A transactions portion of the analysis is summarized in the table below:

TABLE OF CONTENTS

Company Information		Growth Rates																Margin Analysis
Company Name		LTM Revs				2009 Revs				2010 Revs				2011 Revs				LTM EBITDA				2009 EBITDA				2010 EBITDA				2011 EBITDA
Bongrain SA			14.0	%			(3.1	)%			2.8	%			1.4	%			5.1	%			5.5	%			6.1	%			3.7	%
Glanbia plc			1.2	%			(6.5	)%			3.0	%			4.6	%			7.3	%			7.4	%			7.7	%			8.5	%
Saputo, Inc.			13.2	%			8.2	%			6.1	%			N/A				9.5	%			9.8	%			10.6	%			N/A
Dairy Crest Group plc			11.2	%			0.0	%			0.2	%			(0.4	)%			8.2	%			8.6	%			8.8	%			9.1	%
Warrnambool Cheese And Butter Factory Company Holdings Limited			20.6	%			(23.1	)%			(5.3	)%			8.5	%			3.4	%			2.9	%			7.9	%			8.6	%
China Mengniu Dairy Co. Ltd.			19.2	%			0.5	%			15.3	%			18.6	%			(102.3	)%			7.0	%			7.5	%			7.8	%
Highest			20.6%				8.2%				15.3%				18.6%				9.5%				9.8%				10.6%				9.1%
Lowest			1.2%				(23.1)%				(5.3)%				(0.4)%				(102.3)%				2.9%				6.1%				3.7%
Mean			13.2%				(4.0)%				3.7%				6.5%				(11.5)%				6.9%				8.1%				7.5%
Median			13.6%				(1.5)%				2.9%				4.6%				6.2%				7.2%				7.8%				8.5	%

Date Announced

Acquiror Name

Target Name

Enterprise Value

LTM Revenue

LTM EBITDA

EBITDA Margin

EV/ Revenue

EV/ EBITDA

6/23/2009

Saputo, Inc.

F&A Dairy of California, Inc.

$

44.50

$

140.00

N/A

N/A

0.3x

N/A

6/15/2009

KKR & Co.

Ma Anshan Modern Farming Co

750.0

N/A

N/A

N/A

N/A

N/A

6/15/2009

Dean Foods Co.

Alpro NV

325.0

260.0

N/A

N/A

1.3x

N/A

10/22/2008

Saputo, Inc.

William Neilson, Ltd.

465.0

600.0

50

8.33

%

0.8x

9.3x

1/29/2008

Saputo Cheese USA, Inc.

Alto Dairy Cooperative

160.0

378.0

19.6

5.19

%

0.4x

8.2x

10/16/2007

Wimm-Bill-Dann Foods OJSC

Georgian Foods Limited

5.0

2.0

N/A

N/A

2.5x

N/A

Duff & Phelps used the selected public company and selected M&A transaction multiples shown in the tables above as data points in determining the appropriate valuation multiples to use in its analysis. Duff & Phelps noted that the selected M&A transaction multiples were in line with the selected public company multiples. Although publicly available multiples data was not available for the Ma Anshan, Duff & Phelps believes that including the transaction demonstrates investment activity in the sector. China Mengniu Dairy Co. Ltd. was analyzed in Duff & Phelps’ Selected Public Company Analysis; however its valuation multiples were well above the range of the other selected companies and were therefore excluded.

Duff & Phelps considered several key business and financial factors in the selection of the valuation multiples:

Duff & Phelps noted that Cullen Agritech’s revenue growth is at the high end of the peer group because it is a start-up company unlike most of the companies to which it is being compared. In addition, Duff &

TABLE OF CONTENTS

Phelps noted that there are no public dairy farms, and none of the selected comparable companies are identical to Cullen Agritech and its greenfield business model. Based on the foregoing, Duff & Phelps concluded that it would be appropriate to use an EBITDA multiple for the analysis in line with the dairy industry benchmarks.

Based on the foregoing. Duff & Phelps relied on the following determinations in deriving indications of value from its selected public company/selected M&A transaction analysis:

The foregoing selected public company/selected M&A transaction analysis indicated a range of values for Cullen Agritech of $90 million to $162 million.

Summary of Analyses

The range of values for Cullen Agritech that Duff & Phelps derived from its discounted cash flow analysis was $110 million to $160 million, and the range ofvalues for Cullen Agritech that Duff & Phelps derived from its selected public company/selected M&A transaction analysis was $90 million to $162 million. Duff & Phelps noted that the valuation of Cullen Agritech of $155 million negotiated by the parties to the merger falls near the top of each of the ranges of value indications resulting from the discounted cash flow analysis and the selected public company/selected M&A transaction analysis. Accordingly, although the consideration to be paid by Triplecrown in the transaction was within the valuation ranges that Duff & Phelps derived, such consideration was near the top of such range.

Duff & Phelps’ opinion and financial analyses were only one of the many factors considered by Triplecrown’s board of directors in its evaluation of the merger and should not be viewed as determinative of the views of its board of directors.

Fees and Expenses

The Duff & Phelps engagement letter with Triplecrown, dated August 17, 2009, provides that, for its services, Duff & Phelps is entitled to receive a fee of $150,000 from Triplecrown, which was due and paid as follows: $85,000 non-refundable retainer upon execution of the engagement letter and $65,000 upon Triplecrown formally requesting Duff & Phelps to issue its opinion. The engagement letter also provides that Duff & Phelps will be paid additional fees at its standard hourly rates for any time incurred should Duff & Phelps be called upon to support its findings subsequent to the delivery of the opinion, or assist in the preparation of or review of relevant sections of required SEC disclosures, proxy materials, or other documents associated with the merger. In addition, Triplecrown has agreed to reimburse Duff & Phelps for its reasonable out-of-pocket expenses and to indemnify Duff & Phelps and certain related persons against liabilities arising out of Duff & Phelps’ service as a financial advisor to the board of directors of Triplecrown.

Other than the preparation of the opinion in connection with the merger, during the two years preceding the date of its opinion, Duff & Phelps has not had any material relationship with any party to the merger for which compensation has been received or is intended to be received, nor is any such material relationship or related compensation mutually understood to be contemplated. As of the date of the Duff & Phelps opinion, Cullen Agritech is considering utilizing the services of Duff & Phelps Securities, LLC, an affiliate of Duff & Phelps, LLC in connection with capital raising efforts Cullen Agritech may undertake if the proposed merger does not occur. Duff & Phelps Securities, LLC is qualified to perform such services. Duff & Phelps has advised Triplecrown that the professional fees Duff & Phelps Securities, LLC would receive if it is awarded this additional project, some of which may be contingent upon the amount and type of capital raised, would not be material to the financial and operating results of Duff & Phelps.

TABLE OF CONTENTS

Recommendation of Triplecrown’s Board of Directors

After careful consideration of the matters described above, Triplecrown’s board of directors determined that the merger proposal is fair to and in the best interests of Triplecrown and its stockholders and that the merger agreement is no more favorable to Cullen Agritech than it would be to an unaffiliated third party. Triplecrown’s board of directors has approved and declared advisable and recommend that you vote or give instructions to vote “FOR” the merger proposal.

The foregoing discussion of the information and factors considered by the Triplecrown board of directors is not meant to be exhaustive, but includes the material information and factors considered by the Triplecrown board of directors.

Conversion Rights

Any of Triplecrown’s stockholders holding Public Shares as of the record date who affirmatively vote their Public Shares against the merger proposal may also demand that such shares be converted into a pro rata portion of the trust account, calculated as of two business days prior to the consummation of the merger. If demand is properly made and the merger is consummated, these shares will be converted into a pro rata portion of funds deposited in the trust account plus interest, calculated as of such date.

Triplecrown stockholders who seek to exercise this conversion right (“converting stockholders”) must affirmatively vote against the merger proposal. Abstentions and broker non-votes do not satisfy this requirement. Additionally, holders demanding conversion must deliver their shares (either physically or electronically through the Depository Trust Company at the holder’s option) to Triplecrown’s transfer agent up to the vote at the meeting. Accordingly, a holder will have at least fourteen days from the date notice of the meeting is mailed to stockholders to obtain a certificate if they intend to comply with the conversion requirements by physically delivering their shares to Triplecrown’s transfer agent. As the delivery process can be accomplished by the stockholder in a matter of hours by simply contacting the transfer agent or his broker and requesting delivery of his shares through the Depository Trust Company, it is believed that this time period is sufficient for an average investor. If you hold the shares in street name, you will have to coordinate with your broker to have your shares certificated or delivered electronically. Shares that have not been tendered (either physically or electronically) in accordance with these procedures will not be converted into cash. There is a nominal cost associated with the above-referenced tendering process and the act of certificating the shares or delivering them through the Depository Trust Company. The transfer agent will typically charge the tendering broker $35 per transaction and it would be up to the broker whether or not to pass this cost on to the converting holder. This fee may discourage stockholders from seeking conversion rights and may make it more beneficial for such stockholders to try to sell their shares in the open market.

If the holders of at least 16,559,999 or more Public Shares (an amount equal to 30.0% or more of the Public Shares) vote against the merger proposal and properly demand conversion of their shares, Triplecrown will not be able to consummate the merger.

The closing bid price of Triplecrown’s common stock on September 30, 2009 (the record date for the Triplecrown special meetings) was $9.70. The cash held in the trust account on September 30, 2009 was approximately $538,796,312 ($9.76 per Public Share). Prior to exercising conversion rights, stockholders should verify the market price of Triplecrown’s common stock as they may receive higher proceeds from the sale of their common stock in the public market than from exercising their conversion rights if the market price per share is higher than the conversion price. Triplecrown cannot assure its stockholders that they will be able to sell their shares of Triplecrown common stock in the open market, even if the market price per share is higher than the conversion price stated above, as there may not be sufficient liquidity in Triplecrown’s securities when Triplecrown’s stockholders wish to sell their shares.

If you exercise your conversion rights, then you will be exchanging your shares of Triplecrown common stock for cash and will no longer own those shares. You will be entitled to receive cash for these shares only if you affirmatively vote against the merger proposal, properly demand conversion, and deliver your stock certificate (either physically or electronically) to Triplecrown’s transfer agent up to the vote at the special meetings; provided, however, that due to the short period of time between the date of this proxy statement/prospectus and

TABLE OF CONTENTS

the meeting date, Triplecrown will allow holders of certificates to deliver such certificates after the meeting in order to properly exercise conversion rights.

If the merger is not consummated by the date Triplecrown must liquidate, either party may terminate the merger agreement. If Triplecrown is unable to complete the merger or another business combination by October 22, 2009, its amended and restated certificate of incorporation provides that its corporate existence will terminate on that date and, upon its resulting liquidation, the holders of Public Shares will receive an amount equal to the amount of funds in the trust account, inclusive of interest not previously released to Triplecrown, as well as any remaining net assets outside of the trust account, at the time of the liquidation distribution divided by the number of Public Shares. If the transaction is not consummated, a holder would have to wait until Triplecrown liquidates in connection with its dissolution to receive liquidation proceeds. Triplecrown would expect to make such liquidating distributions prior to December 31, 2009. The amount a holder of Public Shares would receive at liquidation may be more or less than the amount such a holder would have received had it sought conversion of its shares in connection with the merger because (i) there will be greater earned interest in the trust account at the time of a liquidation distribution since it would occur at a later date than a conversion and (ii) Triplecrown may incur expenses it otherwise would not incur if Triplecrown consummates the merger, including, potentially, claims requiring payment from the trust account by creditors who have not waived their rights against the trust account. Eric J. Watson, Triplecrown’s chairman and treasurer, and Jonathan J. Ledecky, Triplecrown’s president and secretary, will be personally liable under certain circumstances (for example, if a vendor successfully makes a claim against funds in the trust account) to ensure that the proceeds in the trust account are not reduced by the claims of prospective target businesses and vendors or other entities that are owed money by Triplecrown for services rendered or products sold to it, but only if such target business, vendor or other entity does not execute a waiver. While Triplecrown has no reason to believe that Messrs. Watson and Ledecky will not be able to satisfy those obligations, there cannot be any assurance to that effect. See the section entitled “Other Information Related to Triplecrown — Liquidation If No Business Combination” for additional information.

Actions that May Be Taken to Secure Approval of Triplecrown’s Stockholders

Based on recently completed business combinations by other similarly structured blank check companies, it is believed by Triplecrown that the present holders of 30.0% or more of the Public Shares may have the intention to vote against the merger and seek conversion of their Public Shares into cash in accordance with Triplecrown’s amended and restated certificate of incorporation. If such event were to occur, the merger could not be completed. To preclude such possibility, Triplecrown, the Triplecrown Founders (including Eric Watson), Cullen Agritech and their respective affiliates may negotiate arrangements to provide for the purchase of the Public Shares from holders who indicate their intention to vote against the merger and seek conversion or who otherwise wish to sell their Public Shares. The Triplecrown Founders, including Mr. Watson, are not limited in any way in purchasing Public Shares, although none of them have indicated any intention to purchase such shares at this time. The maximum cash purchase price that will be offered to the holders of Public Shares by Triplecrown, the Triplecrown Founders, Cullen Agritech and their respective affiliates for their shares will be the per-share conversion price at the time of the business combination. In addition, in no event will any person be reimbursed by Triplecrown for any amounts paid to holders of Public Shares in excess of the per-share conversion price at the time of the business combination. Although holders of Public Shares that enter into these types of arrangements with Triplecrown will not receive a higher purchase price than a holder that properly seeks conversion of his shares, entering into such arrangements (and agreeing to vote in favor of the merger) provides the holder with greater certainty that the transaction will be consummated, in which event such holder will receive his conversion proceeds promptly. If the transaction is not consummated, a holder would have to wait until Triplecrown liquidates in connection with its dissolution to receive liquidation proceeds, which liquidation could take 60 days or more to complete.

The Triplecrown Founders, Cullen Holdings and their respective affiliates may also enter into transactions with potential investors or existing holders of Public Shares in order to induce them to purchase Public Shares and/or vote in favor of the merger proposal with respect to currently owned Public Shares and, in each case, to remain a stockholder of CAH following consummation of the merger. There would be no limit on the consideration paid pursuant to these arrangements and such consideration could be cash or non-cash consideration (such as the transfer of shares or warrants held by the Triplecrown Founders that were to be held in

TABLE OF CONTENTS

escrow following consummation of the transaction). Because neither Triplecrown nor Cullen Agritech will enter into these types of transactions and neither Triplecrown nor Cullen Agritech will reimburse any of the Triplecrown Founders, Cullen Holdings or their respective affiliates who enter into these types of transactions, there will be no material economic cost to Triplecrown or Cullen Agritech as a result of such arrangements. Although the Triplecrown Founders have fiduciary obligations in their positions as board members of Triplecrown, when they are not acting on behalf of Triplecrown, they may purchase shares and enter into transactions for their own benefits, just like any public stockholder, provided they comply with all applicable state laws and federal securities laws.

Any purchases would be made in private transactions in specific individual instances with institutional or sophisticated investors. It is anticipated that Triplecrown and/or Cullen Agritech would approach a limited number of large holders of Triplecrown stock that have voted against the merger proposal and demanded conversion of their shares, or that have indicated an intention to do so, and engage in direct negotiations for the purchase of such holders’ positions. Arrangements of such nature would only be entered into and effected in accordance with applicable law at a time when Triplecrown, the Triplecrown Founders, Cullen Agritech and/or their respective affiliates are not aware of any material nonpublic information regarding Triplecrown and its securities or pursuant to agreements between the buyer and seller of such shares in a form that would not violate insider trading rules. Definitive arrangements have not yet been determined but might include:

All such activity will be carried out in full compliance with applicable state laws and federal securities laws.

As a result of the purchases that may be effected through such arrangements, it is likely that the number of shares of common stock of Triplecrown in its public float will be reduced and that the number of beneficial holders of Triplecrown’s securities also will be reduced. This may make it difficult to obtain the quotation, listing or trading of Triplecrown’s securities on the New York Stock Exchange or any other national securities exchange.

The purpose of such arrangements would be to increase the likelihood of satisfaction of the requirements that the holders of a majority of Triplecrown common stock outstanding vote in favor of the merger proposal, the merger proposal is approved by the necessary vote of the holders of the Public Shares and that holders of fewer than 30.0% of the Public Shares vote against the merger proposal and demand conversion of their Public Shares into cash where it appears that such requirements would otherwise not be met. The maximum cash purchase price that will be offered by Triplecrown, the Triplecrown Founders, Cullen Agritech and their respective affiliates to holders of public shares for their shares will be the per-share conversion price at the time of the business combination. In addition, in no event will any person be reimbursed by Triplecrown for any amounts paid to holders of Public Shares in excess of the per-share conversion price at the time of the business combination. However, if holders refuse to enter into arrangements with Triplecrown to sell their Public Shares, Triplecrown may determine to engage a third party “aggregator” to buy shares prior to the meeting from such holders that have already indicated an intention to sell their shares and/or vote against the merger proposal. In such a case, the aggregator would purchase the shares from the original holder and then subsequently sell such shares to Triplecrown. The maximum purchase price that will be offered by such

TABLE OF CONTENTS

aggregators to holders of public shares for their shares will be the per-share conversion price at the time of the business combination. Triplecrown would, in addition to paying the purchase price of such shares (which would be the per-share conversion price) to this aggregator, pay it a fee. Such fee would typically be a small percentage of the aggregator’s total purchase price for such shares. Although the parties do not anticipate needing to engage the services of such an aggregator, if one is needed, the parties believe it will be in the best interests of stockholders that are voting in favor of the transaction since the retention of the aggregator can help ensure that the transaction will be completed and the additional fee payable to the aggregator is not significant. All shares purchased pursuant to such arrangements would remain outstanding until the closing of the transaction and would be voted in favor of the merger proposal. Any agreement between the parties will provide for the holder to withdraw or revoke any exercise of its conversion exercise and grant a proxy to Triplecrown’s designees to vote such shares in favor of the merger proposal at the meeting. Accordingly, this will effectively render the 30.0% threshold established in Triplecrown’s IPO prospectus and amended and restated certificate of incorporation ineffective and make it easier for the parties to complete the transaction because such purchased shares would no longer be counted towards the 30.0% threshold. If, for some reason, the merger is not closed despite such purchases, the purchasers would be entitled to participate in liquidation distributions from Triplecrown’s trust account with respect to such shares.

Triplecrown and CAH will file a Current Report on Form 8-K to disclose arrangements entered into or significant purchases or transfers made by any of the aforementioned persons, including aggregators, that would affect the vote on the merger proposal or the conversion threshold. Any such report will include descriptions of any arrangements entered into or significant purchases or transfers by any of the aforementioned persons. If members of Triplecrown’s board of directors or officers make purchases or transfer shares pursuant to such arrangements, they will be required to report these purchases or transfers on beneficial ownership reports filed with the SEC.

Purchases pursuant to such arrangements ultimately paid for with funds in Triplecrown’s trust account would diminish the funds available to CAH after the merger for working capital and general corporate purposes. However, in no event will Triplecrown (i) pay a holder of Public Shares an amount greater than the per-share conversion price at the time of the business combination for their shares or (ii) reimburse any person for any amounts paid to holders of Public Shares in excess of the per-share conversion price at the time of the business combination. Since there is no minimum amount of funds that must be left for CAH after such purchases are made, the parties could use all of the funds held in the trust account to make such purchases (and for conversions) and the parties could consummate the mergers contemplated by this proxy statement/prospectus leaving CAH with no funds for additional working capital. Nevertheless, in all events there will be sufficient funds available to Triplecrown from the trust account to pay the holders of all Public Shares that are properly converted.

It is possible that the special meetings could be adjourned to provide time to seek out and negotiate such transactions if, at the time of the meetings, it appears that the requisite vote will not be obtained or that the limitation on conversion will be exceeded, assuming that the stockholder adjournment proposal is approved. Also, under Delaware law, the board of directors may postpone the meetings at any time prior to it being called to order in order to provide time to seek out and negotiate such transactions.

Rescission Rights

Triplecrown’s amended and restated certificate of incorporation and the prospectus issued by Triplecrown in its IPO (i) states that Triplecrown is required to complete a business combination in which it acquired a target business in the financial services industry having a fair market value equal to at least 80% of Triplecrown’s trust account balance (excluding deferred underwriting discounts and commissions) and resulting in the ownership by Triplecrown of not less than 50% of the voting securities of the target business and prohibits Triplecrown from completing a business combination with a business affiliated with any of the Triplecrown Founders, (ii) did not disclose that funds in the trust account might be used to purchase Public Shares from holders thereof who have indicated their intention to vote against the merger and convert their shares into cash, and (iii) stated that specific provisions in Triplecrown’s amended and restated certificate of incorporation may not be amended prior to the consummation of an initial business combination but that Triplecrown had been advised that such provision limiting its ability to amend its amended and restated certificate of incorporation may not be enforceable under Delaware law. Accordingly, each person who purchased Public Shares in the IPO

TABLE OF CONTENTS

and still held such shares upon learning of these facts may have securities law claims against Triplecrown for rescission (under which a successful claimant has the right to receive the total amount paid for his or her securities pursuant to an allegedly deficient prospectus, plus interest and less any income earned on the securities, in exchange for surrender of the securities) or damages (compensation for loss on an investment caused by alleged material misrepresentations or omissions in the sale of a security).

Such claims may entitle stockholders asserting them to as much as $10.00 or more per share, based on the initial offering price of the IPO units comprised of stock and warrants, less any amount received from sale of the original warrants purchased with them, plus interest from the date of Triplecrown’s IPO (which, in the case of holders of Public Shares, may be more than the pro rata share of the trust account to which they are entitled on conversion or liquidation).

In general, a person who purchased shares pursuant to a defective prospectus or other representation must make a claim for rescission within the applicable statute of limitations period, which, for claims made under Section 12 of the Securities Act and some state statutes, is one year from the time the claimant discovered or reasonably should have discovered the facts giving rise to the claim, but not more than three years from the occurrence of the event giving rise to the claim. A successful claimant for damages under federal or state law could be awarded an amount to compensate for the decrease in value of his or her shares caused by the alleged violation (including, possibly, punitive damages), together with interest, while retaining the shares. Claims under the anti-fraud provisions of the federal securities laws must generally be brought within two years of discovery, but not more than five years after occurrence. Rescission and damages claims would not necessarily be finally adjudicated by the time the merger may be completed, and such claims would not be extinguished by consummation of that transaction.

Even if you do not pursue such claims, others, who may include all holders of Public Shares, may. Neither Triplecrown nor CAH can predict whether Triplecrown stockholders will bring such claims, how many might bring them or the extent to which they might be successful.

Appraisal Rights

In the event CAH’s securities are not listed on a national securities exchange at the time the merger of CAH and Triplecrown is consummated, appraisal rights will be available to all Triplecrown stockholders pursuant to Section 262 of the DGCL. Appraisal rights are not available to holders of Triplecrown warrants. If appraisal rights are available, holders of shares of Triplecrown common stock who do not vote in favor of the merger proposal and who properly demand appraisal of their shares will be entitled to appraisal rights in connection with the merger under Section 262 of the DGCL. If the common stock of CAH is listed on a national securities exchange at the time the merger of CAH and Triplecrown is consummated, Triplecrown stockholders will not be entitled to assert appraisal rights under Section 262.

Holders of Public Shares electing to exercise conversion rights will not be entitled to appraisal rights.

The following discussion is not a complete statement of the law pertaining to appraisal rights under the DGCL and is qualified in its entirety by the full text of Section 262, which is attached to this proxy statement/prospectus as Annex L. The following summary does not constitute any legal or other advice nor does it constitute a recommendation that stockholders exercise their appraisal rights, if any, under Section 262. All references in Section 262 and in this summary to a “stockholder” are to the record holder of the shares of common stock of Triplecrown as to which appraisal rights are asserted. A person having a beneficial interest in shares of common stock of Triplecrown held of record in the name of another person, such as a broker, fiduciary, depositary or other nominee, must act promptly to cause the record holder to follow the steps summarized below properly and in a timely manner to perfect appraisal rights, if available.

In the event that appraisal rights are available, under Section 262, holders of shares of common stock of Triplecrown who do not vote in favor of the merger proposal and who otherwise follow the procedures set forth in Section 262 will be entitled to have their shares appraised by the Delaware Court of Chancery and to receive payment in cash of the “fair value” of the shares, exclusive of any element of value arising from the accomplishment or expectation of the merger of CAH and Triplecrown, together with a fair rate of interest, if any, as determined by the court.

TABLE OF CONTENTS

Under Section 262, where a merger or consolidation agreement is to be submitted for adoption at a meeting of stockholders, the corporation, not less than 20 days prior to the meeting, must notify each of its stockholders entitled to appraisal rights that appraisal rights are available and include in the notice a copy of Section 262. To the extent appraisal rights are available in connection with the merger of CAH and Triplecrown, this proxy statement/prospectus shall constitute the notice, and the full text of Section 262 is attached to this proxy statement as Annex L. In the event appraisal rights are available in connection with the merger of CAH and Triplecrown, any holder of common stock of Triplecrown who wishes to exercise appraisal rights, or who wishes to preserve such holder’s right to do so, should review the following discussion and Annex L carefully because failure to timely and properly comply with the procedures specified will result in the loss of appraisal rights. Moreover, because of the complexity of the procedures for exercising the right to seek appraisal of shares of common stock, Triplecrown believes that if a stockholder considers exercising such rights, such stockholder should seek the advice of legal counsel.

Filing Written Demand

If appraisal rights are available in connection with the merger of CAH and Triplecrown, any holder of common stock of Triplecrown wishing to exercise appraisal rights must deliver to Triplecrown, before the vote on the merger proposal, a written demand for the appraisal of the stockholder’s shares, and that stockholder must not vote in favor of the adoption of the merger agreement. A stockholder of Triplecrown wishing to exercise appraisal rights must hold of record the shares on the date the written demand for appraisal is made and must continue to hold the shares of record through the effective time of the merger of CAH and Triplecrown. The stockholder must not vote in favor of the merger proposal. A proxy that is submitted and does not contain voting instructions will, unless revoked, be voted in favor of the merger proposal, and it will constitute a waiver of the stockholder’s right of appraisal and will nullify any previously delivered written demand for appraisal. Therefore, a stockholder who submits a proxy and who wishes to exercise appraisal rights must submit a proxy containing instructions to vote against the merger proposal or abstain from voting on the adoption of the merger agreement. Neither voting against the adoption of the merger agreement nor abstaining from voting or failing to vote on the merger proposal will, in and of itself, constitute a written demand for appraisal satisfying the requirements of Section 262. The written demand for appraisal must be in addition to and separate from any proxy or vote on the merger proposal. The demand must reasonably inform Triplecrown of the identity of the holder, as well as the intention of the holder to demand an appraisal of the “fair value” of the shares held by the holder. A stockholder’s failure to make the written demand prior to the taking of the vote on the merger proposal will constitute a waiver of appraisal rights.

If appraisal rights are available in connection with the merger of CAH and Triplecrown, only a holder of record of shares of Triplecrown common stock is entitled to assert appraisal rights for the shares registered in that holder’s name. A demand for appraisal in respect of shares of common stock of Triplecrown should be executed by or on behalf of the holder of record, fully and correctly, as the holder’s name appears on the holder’s stock certificates, should specify the holder’s name and mailing address and the number of shares registered in the holder’s name and must state that the person intends thereby to demand appraisal of the holder’s shares in connection with the merger of CAH and Triplecrown. If the shares are owned of record in a fiduciary capacity, such as by a trustee, guardian or custodian, execution of the demand should be made in that capacity, and if the shares are owned of record by more than one person, as in a joint tenancy and tenancy in common, the demand should be executed by or on behalf of all joint owners. An authorized agent, including an agent for two or more joint owners, may execute a demand for appraisal on behalf of a holder of record; however, the agent must identify the record owner or owners and expressly disclose that, in executing the demand, the agent is acting as agent for the record owner or owners. If the shares are held in “street name” by a broker, bank or nominee, the broker, bank or nominee may exercise appraisal rights with respect to the shares held for one or more beneficial owners while not exercising the rights with respect to the shares held for other beneficial owners; in such case, however, the written demand should set forth the number of shares as to which appraisal is sought, and where no number of shares is expressly mentioned, the demand will be presumed to cover all shares of common stock of Triplecrown held in the name of the record owner. Stockholders who hold their shares in brokerage accounts or other nominee forms and who wish to exercise appraisal rights are urged to consult with their brokers to determine the appropriate procedures for the making of a demand for appraisal by such a nominee.

TABLE OF CONTENTS

All written demands for appraisal pursuant to Section 262 should be sent or delivered to Triplecrown Acquisition Corp. at 590 Madison Avenue, 21^st Floor, New York, New York 10022, Attention Paul Vassilakos.

Any holder of common stock of Triplecrown may withdraw his, her or its demand for appraisal and accept the consideration offered pursuant to the merger agreement by delivering to CAH as the surviving entity of the merger, a written withdrawal of the demand for appraisal. However, any such attempt to withdraw the demand made more than 60 days after the effective date of the merger will require written approval of the surviving corporation. No appraisal proceeding in the Delaware Court of Chancery will be dismissed without the approval of the Delaware Court of Chancery, and such approval may be conditioned upon such terms as the Court deems just.

Notice by the Surviving Corporation

If appraisal rights are available in connection with the merger of CAH and Triplecrown, within 10 days after the effective time of the merger, CAH, as the surviving corporation, must notify each holder of common stock of Triplecrown who has made a written demand for appraisal pursuant to Section 262, and who has not voted in favor of the merger proposal, that the merger has become effective.

Filing a Petition for Appraisal

Within 120 days after the effective time of the merger of CAH and Triplecrown, but not thereafter, CAH, as the surviving entity of the merger, or any holder of common stock of Triplecrown who has so complied with Section 262 and is entitled to appraisal rights under Section 262 may file a petition in the Delaware Court of Chancery demanding a determination of the fair value of the shares held by all dissenting holders. CAH, as the surviving entity is under no obligation to and has no present intention to file a petition, and holders should not assume that CAH will file a petition. Accordingly, it is the obligation of the holders of common stock of Triplecrown to initiate all necessary action to perfect their appraisal rights in respect of shares of common stock of Triplecrown within the time prescribed in Section 262.

Within 120 days after the effective time of the merger, any holder of common stock of Triplecrown who has complied with the requirements for exercise of appraisal rights will be entitled, upon written request, to receive from CAH a statement setting forth the aggregate number of shares not voted in favor of the merger proposal and with respect to which demands for appraisal have been received and the aggregate number of holders of such shares. The statement must be mailed within 10 days after a written request therefor has been received by the surviving corporation.

If a petition for an appraisal is timely filed by a holder of shares of common stock of Triplecrown and a copy thereof is served upon the surviving corporation, the surviving corporation will then be obligated within 20 days to file with the Delaware Register in Chancery a duly verified list containing the names and addresses of all stockholders who have demanded an appraisal of their shares and with whom agreements as to the value of their shares have not been reached. After notice to the stockholders as required by the court, the Delaware Court of Chancery is empowered to conduct a hearing on the petition to determine those stockholders who have complied with Section 262 and who have become entitled to appraisal rights thereunder. The Delaware Court of Chancery may require the stockholders who demanded payment for their shares to submit their stock certificates to the Register in Chancery for notation thereon of the pendency of the appraisal proceeding, and if any stockholder fails to comply with the direction, the Court of Chancery may dismiss the proceedings as to such stockholder.

Determination of Fair Value

After determining the holders of common stock of Triplecrown entitled to appraisal, the Delaware Court of Chancery will appraise the “fair value” of their shares, exclusive of any element of value arising from the accomplishment or expectation of the merger of CAH and Triplecrown, together with a fair rate of interest, if any, to be paid upon the amount determined to be the fair value. In determining fair value and, if applicable, a fair rate of interest, the Delaware Court of Chancery will take into account all relevant factors. In Weinberger v. UOP, Inc., the Supreme Court of Delaware discussed the factors that could be considered in determining fair value in an appraisal proceeding, stating that “proof of value by any techniques or methods that are generally considered acceptable in the financial community and otherwise admissible in court” should be considered, and that “fair price obviously requires consideration of all relevant factors involving the value of

TABLE OF CONTENTS

a company.” The Delaware Supreme Court stated that, in making this determination of fair value, the court must consider market value, asset value, dividends, earnings prospects, the nature of the enterprise and any other facts that could be ascertained as of the date of the merger that throw any light on future prospects of the merged corporation. Section 262 provides that fair value is to be “exclusive of any element of value arising from the accomplishment or expectation of the merger.” In Cede & Co. v. Technicolor, Inc., the Delaware Supreme Court stated that such exclusion is a “narrow exclusion that does not encompass known elements of value,” but which rather applies only to the speculative elements of value arising from such accomplishment or expectation. In Weinberger, the Supreme Court of Delaware also stated that “elements of future value, including the nature of the enterprise, which are known or susceptible of proof as of the date of the merger and not the product of speculation, may be considered.”

Stockholders considering seeking appraisal should be aware that the fair value of their shares as so determined could be more than, the same as or less than the consideration they would receive pursuant to the merger if they did not seek appraisal of their shares and that an investment banking opinion as to the fairness from a financial point of view of the consideration payable in a merger is not an opinion as to fair value under Section 262. Although Triplecrown believes that the exchange of Triplecrown common stock for CAH common stock is fair, no representation is made as to the outcome of the appraisal of fair value as determined by the Delaware Court of Chancery, and stockholders should recognize that such an appraisal could result in a determination of a value higher or lower than, or the same as, this consideration. Neither Triplecrown nor CAH anticipate offering more than the applicable shares of common stock of CAH to any stockholder of Triplecrown exercising appraisal rights, and each of Triplecrown and CAH reserves the right to assert, in any appraisal proceeding, that for purposes of Section 262, the “fair value” of a share of common stock of Triplecrown is less than the applicable shares of common stock of CAH, and that the methods which are generally considered acceptable in the financial community and otherwise admissible in court should be considered in the appraisal proceedings. In addition, Delaware courts have decided that the statutory appraisal remedy, depending on factual circumstances, may or may not be a dissenter’s exclusive remedy. The Delaware Court of Chancery will also determine the amount of interest, if any, to be paid upon the amounts to be received by persons whose shares of common stock of Triplecrown have been appraised. If a petition for appraisal is not timely filed, then the right to an appraisal will cease. The costs of the action (which do not include attorneys’ fees or the fees and expenses of experts) may be determined by the Court and taxed upon the parties as the Court deems equitable under the circumstances. The Court may also order that all or a portion of the expenses incurred by a stockholder in connection with an appraisal, including, without limitation, reasonable attorneys’ fees and the fees and expenses of experts utilized in the appraisal proceeding, be charged pro rata against the value of all the shares entitled to be appraised.

If any stockholder who demands appraisal of shares of common stock of Triplecrown under Section 262 fails to perfect, or successfully withdraws or loses, such holder’s right to appraisal, the stockholder’s shares of common stock of Triplecrown will be deemed to have been converted at the effective time of the merger into the right to receive common stock of CAH. A stockholder will fail to perfect, or lose or withdraw, the holder’s right to appraisal if no petition for appraisal is filed within 120 days after the effective time of the merger or if the stockholder delivers to the surviving corporation a written withdrawal of the holder’s demand for appraisal and an acceptance of the common stock of CAH in accordance with Section 262.

From and after the effective time of the merger of CAH and Triplecrown, no dissenting stockholder shall have any rights of a stockholder of Triplecrown with respect to that holder’s shares for any purpose, except to receive payment of fair value and to receive payment of dividends or other distributions on the holder’s shares of common stock of Triplecrown, if any, payable to stockholders of Triplecrown of record as of a time prior to the effective time of the merger; provided, however, that if a dissenting stockholder delivers to the surviving company a written withdrawal of the demand for an appraisal within 60 days after the effective time of the merger, or subsequently with the written approval of the surviving company, then the right of that dissenting stockholder to an appraisal will cease and the dissenting stockholder will be entitled to receive only the merger consideration in accordance with the terms of the merger agreement. Once a petition for appraisal is filed with the Delaware court, however, the appraisal proceeding may not be dismissed as to any stockholder of Triplecrown without the approval of the court.

TABLE OF CONTENTS

Failure to comply strictly with all of the procedures set forth in Section 262 of the DGCL may result in the loss of a stockholder’s statutory appraisal rights. Consequently, any stockholder wishing to exercise appraisal rights is urged to consult legal counsel before attempting to exercise those rights.

Anticipated Accounting Treatment

As a result of the proposed merger, CAH will own all of the outstanding Cullen Agritech shares. Since, Cullen Agritech’s Chief Executive Officer is currently the sole officer and director of CAH, Cullen Agritech is deemed to be a related party. Consequently, CAH’s accounting for the purchase of Cullen Agritech will include consolidating Cullen Agritech’s assets and liabilities at carrying value with those of CAH. The value of the common stock issued will be recorded at the historical cost basis of the intellectual property received from Cullen Agritech. Furthermore, for accounting purposes, Cullen Agritech will not qualify as a “buiness” under the guidance of SFAS 141(R), paragraphs A4 through A9, defined as an integrated set of activities and assets that is capable of being conducted and managed for the purpose of providing a return in the form of dividends, lower costs, or other economic benefits directly to investors or other owners, members, or participants. A business consists of inputs and processes applied to those inputs that have the ability to create outputs. An input is defined as any economic resource that creates, or has the ability to create, outputs when one or more processes are applied to it. Currently, Cullen Agritech has not performed any activities other than its corporate formation as described in this proxy statement/prospectus. The only input Cullen Agritech has is the intellectual property and knowledge it will obtain upon closing of the transactions. Cullen Agritech does not have certain essential inputs (i.e. operating farm, livestock and certain equipment) necessary to be considered a business. Additionally, Cullen Agritech does not have economic resources necessary to obtain additional inputs from third parties at this time. A process is defined as any system, standard, protocol, convention, or rule that, when applied to an input or inputs, creates or has the ability to create outputs. Cullen Agritech has no processes and no organized workforce having the necessary skills and experience that are capable of being applied to inputs to create outputs. Although outputs are not required to qualify as a business, Cullen Agritech does not currently have any outputs. Moreover, Cullen Agritech has not commenced planned activities and has not obtained processes that would be required to be applied to inputs and does not have the ability to obtain access to customers that will purchase the outputs.

Regulatory Matters

The merger and the transactions contemplated by the merger agreement are not subject to any additional federal or state regulatory requirement or approval, except for filings with the State of Delaware necessary to effectuate the merger and the registration statement, of which this proxy statement/prospectus forms a part, shall have become effective and no stop order suspending its effectiveness, or proceeding to that effect, shall have been implemented by the SEC.

Required Vote

The approval of the merger proposal will require (i) the affirmative vote of the holders of a majority of Triplecrown common stock outstanding on the record date and (ii) the affirmative vote of the holders of a majority of the Public Shares present (in person or represented by proxy) and entitled to vote at the Triplecrown special meeting. Additionally, the merger will not be consummated if the holders of 30% or more of the Public Shares vote against the merger proposal and properly demand that Triplecrown convert their Public Shares into their pro rata share of the trust account.

THE TRIPLECROWN BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS (EXCEPT FOR MR. WATSON WHO ABSTAINS FROM THE RECOMMENDATION DUE TO HIS RELATIONSHIP WITH CULLEN AGRITECH) THAT THE TRIPLECROWN STOCKHOLDERS VOTE “FOR” THE APPROVAL OF THE MERGER PROPOSAL. YOU SHOULD BE AWARE, HOWEVER, THAT THE TRIPLECROWN FOUNDERS HAVE CONFLICTS OF INTEREST IN APPROVING THE TRANSACTION AS INDICATED IN THE SECTION ENTITLED “INTERESTS OF TRIPLECROWN’S DIRECTORS AND OFFICERS AND OTHERS IN THE MERGER” APPEARING ON PAGE 40 OF THIS PROXY STATEMENT/PROSPECTUS.

TABLE OF CONTENTS

THE MERGER AGREEMENT

For a more detailed discussion of the merger structure, merger consideration and indemnification provisions of the merger agreement, see the section entitled “The Merger Proposal.” Such discussion and the following summary of other material provisions of the merger agreement is qualified by reference to the complete text of the merger agreement, a copy of which is attached as Annex A to this proxy statement/prospectus and is incorporated herein by reference. All stockholders are encouraged to read the merger agreement in its entirety for a more complete description of the terms and conditions of the merger. The merger agreement has been included as an annex to this proxy statement/prospectus to provide investors and security holders with information regarding its terms. It is not intended to provide any other factual information about Triplecrown, Cullen Agritech or their respective subsidiaries and affiliates. The representations, warranties and covenants contained in the merger agreement were made only for purposes of that agreement and as of specific dates, were solely for the benefit of the parties to the merger agreement, may be subject to limitations agreed upon by the contracting parties, including being qualified by confidential disclosures made for the purposes of allocating contractual risk between the parties to the merger agreement instead of establishing these matters as facts, and may be subject to standards of materiality applicable to the contracting parties that differ from those applicable to investors. Stockholders are not third-party beneficiaries under the merger agreement and should not rely on the representations, warranties and covenants or any descriptions thereof as characterizations of the actual state of facts or condition of Triplecrown or Cullen Agritech or any of their respective subsidiaries or affiliates. Moreover, information concerning the subject matter of the representations, warranties and covenants may change after the date of the merger agreement, which subsequent information may or may not be fully reflected in public disclosures by CAH and Triplecrown.

Structure of the Merger

The merger agreement provides for (i) the merger of Triplecrown with and into CAH with CAH surviving the merger and becoming the new publicly-traded corporation of which the present holders of Triplecrown securities will be security holders and (ii) the merger of Triplecrown Merger Sub with and into Cullen Agritech with Cullen Agritech surviving the merger and becoming a wholly-owned subsidiary of CAH.

Closing and Effective Time of the Merger

The closing of the merger will take place promptly following the satisfaction of the conditions described below under the subsection entitled “Conditions to Closing of the Merger,” unless Triplecrown and Cullen Agritech agree in writing to another time. The merger is expected to be consummated promptly after the special meetings of Triplecrown’s stockholders and warrantholders described in this proxy statement/prospectus.

Indemnification

To provide a fund to secure the indemnification obligations of Cullen Holdings to Triplecrown against losses that the surviving entity of the merger may sustain as a result of (i) the inaccuracy or breach of any representation or warranty made by Cullen Agritech in the merger agreement or any schedule or certificate delivered by it in connection with the merger agreement and (ii) the non-fulfillment or breach of any covenant or agreement made by Cullen Agritech in the merger agreement, an aggregate of approximately 10% of the initial shares to be issued to Cullen Holdings in the merger (1,588,114 shares of CAH common stock) will be placed in escrow (with an independent escrow agent), which will be canceled to the extent that Triplecrown has damages for which it is entitled to indemnification. The escrow will be the sole remedy for Triplecrown for its rights to indemnification pursuant to the merger agreement. Claims for indemnification may be asserted against the escrow by Triplecrown once its damages exceed a deductible and will be reimbursable to the full extent of the damages in excess of such amount up to a maximum of the escrowed shares. Claims for indemnification may be asserted until the 30^th day after the date CAH has filed with the SEC its Annual Report on Form 10-K for the year ending December 31, 2010 (but in any event no later than April 16, 2011). As a consequence of these limitations, Triplecrown may not be able to be entirely compensated for indemnifiable damages that it may sustain. A copy of this escrow agreement is attached to this proxy statement/prospectus as Annex E.

TABLE OF CONTENTS

Representations and Warranties

The merger agreement contains representations and warranties of each of Triplecrown, CAH, Triplecrown Merger Sub, Cullen Agritech and Cullen Holdings relating, among other things, to:

Covenants

The parties have each agreed to use commercially reasonable efforts to take such actions as are necessary, proper or advisable to consummate the merger. Triplecrown, CAH and Cullen Agritech have each also agreed to continue to operate their respective businesses in the ordinary course or in a commercially reasonable manner prior to the closing and, unless otherwise required or permitted under the merger agreement, not to take the following actions, among others, without the prior written consent of the other party:

TABLE OF CONTENTS

TABLE OF CONTENTS

Additionally, Cullen Holdings has agreed not to do any of the foregoing with respect to itself to the extent it prevents the consummation of the transactions contemplated by the merger agreement. No Cullen Capital Raise shall be consummated during the period commencing on the date of effectiveness of the Proxy Statement/Prospectus and ending on the earlier of the date of consummation of the Mergers or the termination of this Agreement.

The merger agreement also contains additional covenants of the parties, including covenants providing for:

TABLE OF CONTENTS

Conditions to Closing of the Merger

General Conditions

Consummation of the merger is conditioned on (i) the holders of (a) a majority of the Public Shares present and entitled to vote at a meeting called for this and other related purposes, approving the merger and (b) a majority of Triplecrown’s outstanding common stock on the record date, at a meeting called for this and other related purposes, approving the merger proposal, (ii) the holders of fewer than 30.0% of the Public Shares voting against the merger and properly demanding that their Public Shares be converted into a pro-rata portion of the trust account, calculated as of two business days prior to the anticipated consummation of the merger, (iii) the holders of a majority of Triplecrown’s common stock outstanding on the record date approving the initial charter proposals and the subsequent filing of Triplecrown’s second amended and restated certificate of incorporation, (iv) the holders of a majority of Triplecrown’s common stock outstanding on the record date approving the secondary charter proposals and (v) the holders of a majority of Triplecrown’s warrants outstanding on the record date approving the warrant amendment proposals.

In addition, the consummation of the transactions contemplated by the merger agreement is conditioned upon, among other things:

TABLE OF CONTENTS

Cullen Agritech’s and Cullen Holdings’ Conditions to Closing

The obligations of Cullen Agritech and Cullen Holdings to consummate the transactions contemplated by the merger agreement also are conditioned upon, among other things:

Although a condition to closing is the warrant amendment proposals being approved, such condition may be waived by Cullen Agritech or Cullen Holdings as indicated below under the section titled “Waiver.” Accordingly, in determining how to vote on the transaction, holders should understand that the transaction may be consummated without the warrants being amended if such condition is waived.

Triplecrown’s Conditions to Closing

The obligations of Triplecrown to consummate the transactions contemplated by the merger agreement also are conditioned upon each of the following, among other things,

Waiver

If permitted under applicable law, either Triplecrown or Cullen Agritech may waive any inaccuracies in the representations and warranties made to such party contained in the merger agreement or in any document delivered pursuant to the merger agreement and waive compliance with any agreements or conditions (including but not limited to the condition that the warrant amendment proposals are approved) for the benefit of itself or such party contained in the merger agreement or in any document delivered pursuant to the merger agreement. The conditions requiring that the holders of fewer than 30.0% of the Public Shares affirmatively vote against the merger proposal and demand conversion of their shares into cash and that the initial charter amendments be approved may not be waived. Due to the timing of this transaction, the only material condition that may be waived by the parties is the condition that the warrant amendment proposals are approved. No other waiver that is material to investors will be granted by the parties. Triplecrown would file a Current Report on Form 8-K and issue a press release to disclose any waiver of any representation, warranty or condition to the merger agreement. Since the disclosure in this proxy statement/prospectus already indicates that the condition that the warrant amendment proposals be approved may be waived, no proxy statement/prospectus supplement would be sent to stockholders if such condition was in fact waived. There can be no assurance that all of the conditions will be satisfied or waived.

At any time prior to the closing, either Triplecrown or Cullen Agritech may, in writing, to the extent legally allowed, extend the time for the performance of any of the obligations or other acts of the other parties to the merger agreement.

The existence of the financial and personal interests of the directors may result in a conflict of interest on the part of one or more of them between what he may believe is best for Triplecrown and what he may believe is best for himself in determining whether or not to grant a waiver in a specific situation.

Termination

The merger agreement may be terminated at any time, but not later than the closing, as follows:

TABLE OF CONTENTS

Effect of Termination

In the event of proper termination by either Triplecrown or CAH, the merger agreement will become void and have no effect, without any liability or obligation on the part of Triplecrown or CAH, except that:

Fees and Expenses

All fees and expenses incurred in connection with the merger agreement and the transactions contemplated thereby will be paid by the party incurring such expenses whether or not the merger is consummated, except that Triplecrown and CAH have agreed to reimburse Cullen Holdings, Cullen Agritech and their subsidiaries for costs incurred in connection with the transactions in the event such transactions are consummated.

Confidentiality; Access to Information

Triplecrown and Cullen Agritech will afford to the other party and its financial advisors, accountants, counsel and other representatives prior to the completion of the merger reasonable access during normal business hours, upon reasonable notice, to all of their respective properties, books, records and personnel to obtain all information concerning the business, including the status of product development efforts, properties, results of operations and personnel, as each party may reasonably request. Triplecrown and Cullen Agritech will maintain in confidence any non-public information received from the other party, and use such non-public information only for purposes of consummating the transactions contemplated by the merger agreement, subject to customary exceptions.

Amendments

The merger agreement may be amended by the parties thereto at any time by execution of an instrument in writing signed on behalf of each of the parties. Triplecrown would file a Current Report on Form 8-K and issue a press release to disclose any amendment to the merger agreement entered into by the parties. If such amendment is material to investors, a proxy statement/prospectus supplement would also be sent to holders of Public Shares as promptly as practicable.

TABLE OF CONTENTS

Public Announcements

The parties have agreed that until closing or termination of the merger agreement, the parties will:

TABLE OF CONTENTS

THE MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS TO TRIPLECROWN AND TRIPLECROWN STOCKHOLDERS AND WARRANTHOLDERS

The following section is a summary of the opinion of Graubard Miller, counsel to Triplecrown, regarding the material United States federal income tax consequences of the business combination and the merger to Triplecrown and holders of Triplecrown common stock and warrants. This discussion addresses only those Triplecrown security holders that hold their securities as a capital asset within the meaning of Section 1221 of the Code and does not address all the United States federal income tax consequences that may be relevant to particular holders in light of their individual circumstances or to holders that are subject to special rules, such as:

The Graubard Miller opinion is based upon the Code, applicable treasury regulations thereunder, published rulings and court decisions, all as currently in effect as of the date hereof, and all of which are subject to change, possibly with retroactive effect. Tax considerations under state, local and foreign laws, or federal laws other than those pertaining to the income tax, are not addressed.

Neither Triplecrown nor CAH intends to request any ruling from the Internal Revenue Service as to the U.S. federal income tax consequences of the business combination and the mergers.

It is the opinion of Graubard Miller the business combination and the merger of Triplecrown and CAH will constitute a tax-free transaction pursuant to Section 351 and a reorganization within the meaning of Section 368(a) of the Internal Revenue Code and that no gain or loss will be recognized by Triplecrown or by the stockholders of Triplecrown if their conversion rights are not exercised.

The U.S. federal tax basis of the stock of CAH received by the holder of Triplecrown common stock in the merger will be the same as the adjusted tax basis of the Triplecrown common stock surrendered in exchange therefore. The holding period of the stock of CAH received in the merger by a holder of Triplecrown common stock will include the period during which such Triplecrown common stock was held as a capital asset on the date of the merger.

It is also the opinion of Graubard Miller that a stockholder of Triplecrown who exercises conversion rights and effects a termination of the stockholder’s interest in Triplecrown will be required to recognize gain or loss upon the exchange of that stockholder’s shares of common stock of Triplecrown for cash. Such gain or loss will be measured by the difference between the amount of cash received and the tax basis of that stockholder’s shares of Triplecrown common stock. This gain or loss will be a capital gain or loss if such shares were held as a capital asset on the date of the business combination and will be a long-term capital gain or loss if the holding period for the share of Triplecrown common stock is more than one year.

Although an exchange of warrants in a reorganization generally does not result in gain or loss to the warrant holder, it is the opinion of Graubard Miller that the approval of the warrant amendment proposals and the resulting exchange of a Triplecrown warrant for a CAH warrant constitutes an exchange for a materially different property under the applicable rules of the Internal Revenue Service, resulting in the recognition of gain or loss measured by the difference between the fair market value of the new CAH warrant received and the tax basis of the Triplecrown warrant surrendered.

The conclusions expressed above are based on current law. Future legislative, administrative or judicial changes or interpretations, which can apply retroactively, could affect the accuracy of those conclusions. The

TABLE OF CONTENTS

tax opinion issued to Triplecrown by Graubard Miller, its counsel, is attached to this proxy statement/prospectus as Annex F. Graubard Miller has consented to the use of its opinion in this proxy statement/prospectus.

This discussion is intended to provide only a summary of the material United States federal income tax consequences of the merger. It does not address tax consequences that may vary with, or are contingent on, a securityholder’s individual circumstances. In addition, the discussion does not address any non-income tax or any foreign, state or local tax consequences of the business combination. Accordingly, holders of Triplecrown stock and warrants are strongly urged to consult with their tax advisor to determine the particular United States federal, state, local or foreign income or other tax consequences to such holders of the business combination.

TABLE OF CONTENTS

UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION
(IN DOLLARS)

Cullen Agritech and Triplecrown are providing the following unaudited pro forma condensed combined financial information to aid you in your analysis of the financial aspects of the merger.

The following unaudited pro forma condensed combined statement of operations for the six months ended June 30, 2009, statement of operations for the year ended December 31, 2008 and balance sheet at June 30, 2009 are based on the historical financial statements of Triplecrown and Cullen Agritech after giving effect to the merger.

The unaudited condensed combined pro forma statements of operations for the six months ended June 30, 2009 and the year ended December 31, 2008 give pro forma effect to the merger as if it had occurred on January 1, 2008. The unaudited pro forma condensed combined balance sheet at June 30, 2009 assumes that the merger was effective on June 30, 2009.

The unaudited condensed combined pro forma statement of operations for the six months ended June 30, 2009 was derived from Triplecrown’s unaudited condensed financial statements for the six months ended June 30, 2009, and the unaudited condensed combined pro forma statement of operations for the year ended December 31, 2008 was derived from Triplecrown’s audited financial statements for the year ended December 31, 2008. The unaudited pro forma condensed combined balance sheet at June 30, 2009 was derived from Triplecrown’s unaudited condensed financial statements and Cullen Agritech’ audited financial statements as of June 30, 2009 and August 18, 2009, respectively.

As a result of the proposed merger, CAH will own all of the outstanding Cullen Agritech shares. Since, Cullen Agritech’s Chief Executive Officer is currently the sole officer and director of CAH, Cullen Agritech is deemed to be a related party. Consequently, CAH’s accounting for the purchase of Cullen Agritech will include consolidating Cullen Agritech’s assets and liabilities at carrying value with those of CAH. The value of the common stock issued will be recorded at the historical cost basis of the intellectual property received from Cullen Agritech.

Cullen Agritech and Triplecrown have assumed that no warrants will be exercised immediately following the consummation of the merger because the expected book value per share of Cullen Agritech’s common stock will be below the amended strike price of the warrants. Accordingly, the unaudited pro forma condensed combined financial statements do not reflect the modification of the warrants. The increase in the exercise price and the extended expiration date of the warrants would not result in any incremental fair value adjustment as a result of the modification of the warrants.

Consummation of the merger is conditioned on (i) the holders of (a) a majority of the Public Shares present and entitled to vote at a meeting called for this and other related purposes, approving the merger and (b) a majority of Triplecrown’s outstanding common stock on the record date, at a meeting called for this and other related purposes, approving the merger proposal, (ii) the holders of fewer than 30.0% of the Public Shares voting against the merger and properly demanding that their Public Shares be converted into a pro-rata portion of the trust account, calculated as of two business days prior to the anticipated consummation of the merger, (iii) the holders of a majority of Triplecrown’s common stock outstanding on the record date approving the initial charter proposals and the subsequent filing of Triplecrown’s second amended and restated certificate of incorporation, (iv) the holders of a majority of Triplecrown’s common stock outstanding on the record date approving the secondary charter proposals and (v) the holders of a majority of Triplecrown’s warrants outstanding on the record date approving the warrant amendment proposals (although this condition may be waived upon mutual consent of Triplecrown and Cullen Agritech):

Notwithstanding the foregoing, since there is no minimum amount of funds that must be left for CAH after any purchases of Public Shares are made (as described elsewhere in this proxy statement/prospectus), the parties could use all of the funds held in the trust account to make such purchases (and for conversions) and

TABLE OF CONTENTS

the parties could consummate the mergers contemplated by this proxy statement/prospectus leaving CAH with no funds for additional working capital. The unaudited pro forma condensed combined financial statements do not reflect this scenario.

The unaudited pro forma condensed combined financial statements are provided for informational purposes only and are subject to a number of uncertainties and assumptions and do not purport to represent what the companies’ actual performance or financial position would have been had the transaction occurred on the dates indicated and does not purport to indicate the financial position or results of operations as of any future date or for any future period. Please refer to the following information in conjunction with the accompanying notes to these pro forma financial statements and the historical financial statements and the accompanying notes thereto and the sections entitled “Unaudited Pro Forma Condensed Combined Financial Data,” “Other Information Related To Triplecrown — Triplecrown’s Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and “Cullen Agritech’ Management’s Discussion and Analysis of Financial Condition and Results of Operations” Cullen Agritech Investment Corp and Subsidiaries Unaudited Condensed Combined Pro Forma Statement of Operations For the Year Ended December 31, 2008.

TABLE OF CONTENTS

UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS
DECEMBER 31, 2008
(in dollars)

		Triplecrown Acquisition Corp.				Cullen Agricultural Technologies Inc.				Note				Pro Forma Adjustments No Conversion				Pro Forma No Conversion				Pro Forma Adjustments Maximum Conversion				Note				Pro Forma Combined –  Maximum Conversion
		USD $				USD $								USD $				USD $				USD $								USD $
Net sales		$	—			$	—							$	—			$	—			$	—							$	—
Cost of goods sold			—				—								—				—				—								—
Gross profit			—				—								—				—				—								—
Selling, general and administrative			1,484,138				—				3				100,000				1,584,138												1,584,138
Organizational Costs			—				6,200								—				6,200				—								6,200
Professional Fees							15,013												15,013												15,013
Travel							753												753												753
Website Costs			—				396								—				396				—								396
Income (loss) from operations			(1,484,138	)			(22,362	)							(100,000	)			(1,606,500	)			—								(1,606,500	)
Interest and other (income) expense
Interest expense			—				—								—				—				—								—
Dividend and Interest income			(8,443,326	)			—				1				383,728				(8,059,598	)			2,541,551				5				(5,518,047	)
			(8,443,326	)			—								383,728				(8,059,598	)			2,541,551								(5,518,047	)
Income (loss) before income taxes			6,959,188				(22,362	)							(483,728	)			6,453,098				(2,541,551	)							3,911,547
Income tax provision (benefit)			2,300,380				—								—				2,300,380				—								2,300,380
Net income (loss)			4,658,808				(22,362	)							(483,728	)			4,152,718				(2,541,551	)							1,611,167
Accretion of trust account, relating to Common Stock subject to possible conversion			583,997				—				2				(583,997	)			—				—								—
Change in fair value of currency option			—				—								—				—				—								—
Net income (loss) available to common stockholders		$	4,074,811			$	(22,362	)						$	100,269			$	4,152,718			$	(2,541,551	)						$	1,611,167
Shares Outstanding			69,000,000												5,076,148				74,076,148				(16,559,999	)							57,516,149
Weighted average number of shares			52,440,001								4				21,636,147				74,076,148				(16,599,999	)			6				57,516,149
Basic and diluted net income per share		$	0.08			$	—											$	0.06											$	0.03

TABLE OF CONTENTS

NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS
DECEMBER 31, 2008
(in dollars)

Pro Forma Income Statement Adjustments

Assuming no conversions:

Decrease interest income			383,728

Decrease accretion of trust account, relating to common stock			583,997

Increase in selling, general and administrative expense			100,000

Existing Triplecrown Shares			69,000,000
New shares issued to consultants			455,000
Shares cancelled by Founders and Board			(11,260,000	)
Shares issued to Cullen Agritech stockholder in connection with merger			15,881,148
Total			74,076,148
Increase Weighted average shares outstanding-basic			74,076,148

Assuming maximum conversions

Decrease interest income			2,541,551

Decrease Maximum number of shares to be converted			16,559,999
Total Weighted average shares outstanding, basic and diluted			57,516,149

Common stock equivalents consisting of warrants were not included in the calculation of the diluted per share because it is not certain that these securities would be in the money subsequent to the merger. Potentially dilutive securities of 55,200,000 warrants (included within the units sold in the IPO), 5,000,000 Sponsors’ Warrants and 13,800,000 Founders’ Warrants as part of the Founder Units have been excluded from the computation of diluted net income (loss) per share, because the effect would be anti-dilutive.

TABLE OF CONTENTS

UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET
June 30, 2009

		Triplecrown Acquisition Corp.				Cullen Agricultural Technologies Inc.				Note				Pro Forma Adjustments No Conversion				Pro Forma No Conversion				Pro Forma Adjustments Maximum Conversion				Note				Pro Forma Combined –  Maximum Conversion
		USD $				USD $								USD $				USD $				USD $								USD $
		Note 7				Note 8
Assets
Current Assets
Cash and cash equivalents		$	2,856,870			$	—				3,9,14,16			$	514,433,993			$	517,290,863			$	(161,662,987	)			17			$	355,627,876
Accounts receivable			—				—								—				—				—								—
Prepaid expenses and other current assets			1,232,761				19,241								—				1,252,002				—								1,252,002
Inventories, net			—				—								—				—				—								—
Other current assets			—				—								—				—				—								—
Total current assets			4,089,631				19,241								514,433,993				518,542,865				(161,662,987	)							356,879,878
Cash held in Trust Account			539,259,567				—				9				(539,259,567	)			—				—								—
Accrued Interest			68,962				—								—				68,962				—								68,962
Intangible assets, net			—				3,327								—				3,327				—								3,327
Total assets		$	543,418,160			$	22,568							$	(24,825,574	)		$	518,615,154			$	(161,662,987	)						$	356,952,167
Liabilities and stockholders' equity
Current liabilities
Cash overdraft		$	505,574			$	—							$	(505,574	)		$	—			$	—							$	—
Accounts payable and Accrued expenses			265,025				44,730								—				309,755				—								309,755
Total current liabilities			770,599				44,730								(505,574	)			309,755				—								309,755
Long-term debt, net of current portion			—				—								—				—				—								—
Total liabilities			770,599				44,730								(505,574	)			309,755				—								309,755
Common stock, subject to possible conversion			161,798,549				—				11,15				(161,798,549	)			—												—
Stockholders' equity
Common stock, no par value,
Common stock			5,244				200				12				308				5,752				—								5,752
Treasury Stock			—				—								—								—
Additional paid-in capital			375,094,887				—				11,12,13,14,15				137,455,879				512,550,766				(161,662,987	)			17				350,887,779
Accumulated other comprehensive income (loss)			—				—								—				—				—								—
Retained earnings			5,748,881				(22,362	)			13				22,362				5,748,881				—								5,748,881
Total stockholders' equity			380,849,012				(22,162	)							137,478,549				518,305,399				(161,662,987	)							356,642,412
Total liabilities and stockholders' equity		$	543,418,160			$	22,568							$	(24,825,574	)		$	518,615,154			$	(161,662,987	)						$	356,952,167